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The CD1 molecules are a family of ß2microglobulin- associated glycoproteins with strong structural 
homology, but weaker sequence homology, to the MHC class I antigens. In contrast to the classical 
class I antigens, CD1 molecules exhibit restricted tissue expression (cortical thymocytes, dendritic 
cells, a subset of B cells and some intestinal epithelial cells), and are nonpolymorphic. Five CD1 genes 
have been identified in humans, two in the mouse and several in other mammalian species (Calabi et al, 
1991). CD1 expression has also been detected by immunohistological techniques in the cow, sheep 
and pig. 
The MHC class I -like structure of CD1 and the expression on classical antigen presenting cells of the 
immune system has pointed to a role for CD1 in antigen presentation. Indeed, evidence has been 
accumulating over the past few years to support this view, with several reports suggesting that CD4 -8- 
T cells in particular may be able to recognise nonclassical presentational elements including MHC class 
lb molecules such as TLa and Qa, as well as CD1. Most recently, CD1b molecules on human monocytes 
have been demonstrated to restrict the response of CD4 -8- T cells to antigens derived from M. 
tuberculosis (Porcelli et al, 1992). 
Previous studies on the ovine CD1 family have involved the use of monoclonal antibodies to assess 
tissue expression and distribution, and biochemical analyses of the ovine CD1 antigens. However, no 
studies have been carried out to investigate ovine CD1 at the molecular level. Therefore, a human CD1 C 
a3 probe was used to screen several sheep thymocyte cDNA libraries. The HCD1 B -like clone SCD1 A25 
was isolated from a foetal thymocyte library. A homologous probe comprising the a3/TM /CYT domains 
from this clone was derived by PCR amplification and used to identify a further three ovine clones - 
SCD1 B -42, SCD1 B -52 and SCD1T10. Three of the four clones are truncated at the 5' end, with 
sequences beginning towards the end of the al domain or the start of the a2 domain. These 5' 
truncation events probably reflect poor reverse transcriptase activity during library preparation. The 
fourth clone, SCD1 B -52, represents a transcript containing a precise a3 deletion. The PCR technique 
was used to amplify the missing 5' ends from two of the three truncated$equences, thus generating full 
length coding sequence for two of the four ovine CD1's identified. 
Comparison of the ovine CD1 sequences amongst themselves has shown them to be 81 -96% identical 
at the nucleotide level and 79 -90% identical at the amino acid level, suggesting that the four clones 
represent different gene products rather than allelic variants of CD1. The sheep sequences have also 
been analysed by comparison to the human, mouse and rabbit coding seqences. Perhaps 
unexpectedly, given the existence of five different human CD1 genes, all of the ovine CD1 sequences 
are most homologous to human CD1 B at both the nucleotide and amino acid levels. The sheep CD1 
sequences also show a high percentage sequence identity to the cottontail rabbit sequence, which is 
itself most similar to HCD1 B. 
Southern blot analysis of genomic DNA digested with a variety of enzymes and probed with the 
homologous a3 probe has indicated the possible existence of up to seven ovine CD1 genes. Further 
studies are required to determine which of these genes are expressed and to identify the genes 
encoding the CD1 molecules recognised by the monoclonal antibodies. The significance and 
implications of these results are discussed and potential further experiments suggested. 
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1. Literature Review 
The vertebrate immune system has evolved to recognise and eliminate infectious material 
from the body. The body is protected by innate mechanisms, which are not intrinsically 
affected by prior exposure to the infectious agent. Higher organisms have also evolved the 
adaptive immune response, which is characterised by the specificity and memory of the 
response. 
The ability to recognise foreign antigen in a specific manner is the hallmark of the adaptive 
immune response. There are three types of antigen recognition molecules- the 
immunoglobulins, the T cell receptors (TCR), and the major histocompatibility complex 
molecules (MHC). The genes encoding all three types of molecule are related and may have 
evolved from a single common precursor (Hunkapiller and Hood, 1990). Antigen recognition 
molecules are characterised by their diversity and heterogeneity. All three types are cell 
surface molecules- the immunoglobulins and TCR's act as antigen specific receptors for B and 
T cells respectively. In addition to cell surface expression, the immunoglobulins can be 
secreted as soluble proteins and act to trigger effector mechanisms. The MHC molecules are 
not antigen specific receptors as such, but are essential components in TCR recognition of 
antigen. Three classes of MHC molecules have been identified (class I, II and Ill), but only the 
class I and II gene products are directly involved in the presentation of antigen to T cells. 
The CD1 genes are not encoded in the MHC gene complex but their gene products are 
structurally similar to the MHC class I molecules. The CD1 molecules are particularly similar to 
the nonclassical class I molecules in both mouse and man. This group of molecules are 
collectively referred to as the class lb proteins and are characterised by limited polymorphism 
and restricted tissue distribution in comparison to the classical class I molecules (Stroynowski 
and Fischer Lindahl, 1994). The structural relatedness of CD1 molecules to MHC class I 
molecules, and their preferential expression on cells involved in antigen presentation to T 
cells, suggests that they may function in a similar manner to the class I molecules. 
Furthermore, it has been proposed that the CD1 molecules, like the MHC class I molecules, 
may be able to present antigen to T cells and in particular to y6 T cells (Strominger, 1989; 
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Porcelli et al, 1991). This literature review therefore includes a review of T cell biology and 
MHC structure and function in addition to a full review of CD1 biology, including the CD1 
genes and antigens, and the proposed functions of the CD1 molecules. 
1.1 Overview Of Antigen Recognition By T Cells. 
There are two main types of T lymphocytes- T cells which express the aß TCR and T cells 
which express the -y6 TCR. Both types of receptor are noncovalently associated with the CD3 
complex. aß T lymphocytes recognise foreign antigen via the TCR /CD3 complex when the 
antigen is presented as a peptide in the context of a self MHC molecule. aß T cells can be 
subdivided into CD4 +T cells and CD8 +T cells. In general, CD4 +T cells are referred to as 
helper cells (TH) because they chiefly function to promote T and B cell proliferation and 
immunoglobulin synthesis, although CD4 +T cells which perform cytotoxic functions have 
been detected. Helper T cells usually recognise antigen in association with self MHC class II 
molecules. The CD8 +T cells are normally referred to as cytotoxic T cells (Tc) because of their 
ability to kill infected target cells. Again, exceptions to this "rule" have been observed i.e. 
CD8+ T cells which perform helper functions. Cytotoxic T cells recognise antigen in 
association with self MHC class I molecules. The CD4 +T cells can be further subdivided, 
particularly in mice, into TH1 and TH2 cells, depending on their cytokine secretion profiles 
(Mosmann and Coffman, 1989). 
1.2 T Cell Biology. 
1.2.1 aß T Cells. 
The aß T cell receptor was identified when clone- specific monoclonal antibodies (mAbs) were 
raised against T cell lymphomas, hybridomas and clones (reviewed by Allison and Lanier, 
1987). All of the monoclonal antibodies recognise an 80 -90kD heterodimer composed of a 
39 -46kD a chain disulphide bonded to a 40 -44kD ßchain. These clone- specific mAbs are 
capable of affecting antigen specific activation, suggesting that they recognise the T cell 
antigen receptor. Co- capping experiments revealed that the clonotypically variable a3TCR 
was associated with a group of invariant proteins called the CD3 complex (Meuer et al, 1983). 
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The first TCR a and 3 genes were identified and cloned using subtractive or differential 
hybridisation techniques (Yanagi et al, 1984; Hedrick et al, 1984a). The polypeptides 
encoded by the a and f3 genes have significant structural homology to the immunoglobulin 
genes (Hedrick et al, 1984b; Yanagi et al, 1984). The TCR a and 5 chains are encoded by 
genes constructed by rearrangement of several germline segments in a manner analogous to 
human and mouse immunoglobulin genes. 
The variable region of the human f3 chain gene is assembled from three segments- variable 
(V[3), diversity (Dß) and joining (Jß). There appear to be 75 -100 V(3gene segments, 2 Dß 
regions and 13 Jß gene segments (Toyonaga and Mak, 1987). In the mouse there are only 
-20 Vß gene segments. The human a chain gene complex consists of a large number of Va 
segments (50 -100) and 60 -80 Ja segments, upstream from a single constant region gene 
(Ca). Diversity in the variable regions of the a and ß chains results from germline diversity, 
combinatorial diversity, N region diversity (addition of extra nucleotides at junctional sites) and 
from multiple translational reading frames in the Dß segment (Kronenberg et al, 1986). The 
potential diversity of the a(3 TCR repertoire has been estimated at 1013 different (3 chain 
forms and 1012 different a chain forms (Hunkapiller and Hood, 1990). 
The T cell antigen receptors are multimeric protein complexes composed of the variable a 
and ß chains in noncovalent association with the invariant CD3 polypeptides. The CD3 
complex comprises the y, 8, e and ( chains (Clevers et al, 1988). The stoichiometry of the 
CD3 complex is thought to be two e heterodimers, composed of either c yor eb, in 
association with one homodimer (although (Tl and ( y heterodimers have also been 
detected) (Chan et al, 1992; Weiss, 1993). This model is based on the acidic and basic amino 
acid content of the transmembrane domains of each subunit, which are known to play a critical 
role in polypeptide chain pairing. Murine T cells are able to generate an T1 chain by alternative 
splicing of the mRNA transcript (Jin et al, 1990), although there is as yet no evidence for an 
equivalent chain in humans. The CD3 ( polypeptide chain is also a component of the 
immunoglobulin G (IgG) Fc receptor CD16, and the transmembrane segment of CD3( is highly 
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homologous to the y subunit of the IgE Fc receptor (Terhorst and Regueiro, 1993). The a 
and ßchains of the TCR are responsible for antigen recogniticn whilst the CD3 complex and 
chains are involved with regulation of TCR /CD3 assembly and signal transduction. A critical 
role for the CD3 and rt gene products in signal transduction and intrathymic T cell 
differentiation has been established based on the results obtained from transgenic mice in 
which these genes were disrupted (Ohno et al, 1993; Malissen et al, 1993). Several lines of 
evidence have now suggested that a functional cell surface TCR is composed of two aß units 
in association with one CD3 complex (Chan et al, 1992; Terhorst and Regueiro, 1993). 
The discovery of MHC restricted recognition of antigen by T cells (Zinkernagel and Doherty, 
1974) led to the proposal of two possible explanatory mechanisms- A) that T cells have a 
single receptor which can interact with a combination of antigen and MHC, or B) that T cells 
have two separate receptors, one specific for antigen and the second for MHC. Several 
studies have now provided compelling evidence to show that TCR's have dual specificity for 
both antigen and MHC (Allison and Lanier, 1987). Conclusive evidence of the dual 
recognition model for both MHC class I and class it restricted T cells came when it was 
demonstrated that transfer of functional a and ß chain genes from one T cell to another is 
sufficient to transfer specificity for both antigen and MHC from the first T cell to the second 
(Dembic et al, 1986; Saito et al, 1987). 
1.2.2 yS T Cells. 
During attempts to clone a murine a chain gene, a third type of T cell receptor cDNA was 
isolated (Saito et al, 1984). The deduced amino acid sequence of the cDNA had clear 
similarities to the immunoglobulin and TCR ßchains in structure and sequence, and the 
corresponding gene was rearranged in T cell clones (reviewed by Raulet, 1989a). However, a 
chains were known to be glycosylated on asparagine residues, while the deduced protein 
sequence from this cDNA contained no consensus sites for asparagine- linked glycosylation. 
Soon after, authentic a chain cDNA clones were isolated and this cDNA clone was renamed 
"y ". In the following few years, evidence was provided for the expression of a second 
heteodimeric TCR, the 75 TCR, which is also found in association with the CD3 complex , and 
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several yS T cell lines and clones were derived (Brenner et al, 1986). The S chain gene was 
subsequently isolated from both man and mouse (Chien et al, 1987; Hata et al, 1987). 
In man, the y chain gene complex comprises 7 -8 functional Vy gene segments (although 14 
segments, which divide into 4 subgroups, have been identified) and 5 Jy gene segments 
which can rearrange with 2 Cy gene segments (Porcelli et al, 1991). In the mouse, there are 7 
V-y gene segments which subdivide into 5 families, 4 Cy gene segments (1 of which is a 
pseudogene) and 4 Jy gene segments (Raulet, 1989). The 6 chain gene complex in man 
contains 6 VS, 3 06, 3 JO and 1 CO gene segment (Moretta et al, 1991). In the mouse, the S 
chain gene locus contains 8 VS subfamilies, several of which have only one member but some 
have two or more members. In addition, there are 2 JO, 2 DO and 1 CO gene segment. Unlike 
other rearrangement gene families, assembled 6 genes in the human adult thymus often 
contain two or three D regions (Porcelli et al, 1991). 
The TCR y and S loci contain relatively few V gene segments so that the combinatorial 
repertoire produced by gene recombination in the thymus was initially thought to be smaller 
than for the aj3 TCR, which utilises large pools of different gene segments (Porcelli et al, 
1991). However, there is considerable potential for extensive junctional diversity in both the y 
and S gene families so that the yS TCR repertoire is actually much larger than the a(3 TCR 
repertoire. Imprecise joining can result in variable inclusion of nucleotides at all 6 DNA ends 
involved in these DNA rearrangements, and N regions can be added at all 3 junctions. The 
use of up to 3 D segments in the rearranged human S gene also contributes to diversity. 
Interestingly, the yS TCR repertoire that is actually available in the periphery is restricted 
because cells localised at specific sites preferentially use certain V gene combinations in their 
receptors. In mice, yS T cells at different mucosal surfaces have distinct and limited receptor 
diversities. Similarly, 50 -70% of human peripheral blood yS T cells express the Vy9 and V52 
gene segments (de Libero et al, 1991). 
The majority of yS T cell studies have been conducted in the "y6 low" species of mice and 
humans, and current perceptions of yS T cell diversity, development and function have been 
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based almost entirely on these studies. Interestingly, recent studies of y6 T cells in the sheep, 
a species in which y6 T cells are quantitatively more significant, have revealed that the sheep 
ya T cell repertoire is more diverse than that in humans and mice due to the presence of a 
greater number of germline variable and constant region gene segments (Hein and Dudler, 
1993). The sheep contains 28 Va regions belonging to 4 families and 10 Vy regions 
belonging to 6 families. The ontogeny of the peripheral repertoire was found to be strictly 
regulated by the thymus. The authors suggest that these results, together with the 
prominence of y6 cells in the sheep immune system ( Hein and MacKay, 1991), argue that 
this T cell lineage may perform a more "elaborate function" in the sheep than in the "ya low" 
species where 16T cells may be redundant. 
Despite intensive investigation, no consensus has yet emerged regarding the potential 
ligands for y8 TCR. To date, a heterogeneous group of 76 TCR ligands have been identified 
(reviewed in Haas et al, 1993) which include classical MHC proteins (Haas et al 1993), MHC - 
like molecules including the nonclassical MHC class lb and CD1 molecules (reviewed in 
Porcelli et al, 1991), and mycobacterial and heat shock proteins (Raulet, 1989b; Young and 
Elliott, 1989; Kaufmann, 1990; Born et al, 1990). It has generally been assumed that ya T cell 
recognition is analogous to c43 T cell recognition, although the exact nature of y8 TCR ligand 
recognition has yet to be established. However, the results presented in a recent paper have 
provided challenging evidence that ya T cells require neither MHC class I nor class II antigen 
processing pathways and that peptides do not confer specificity (Schild et al, 1994). The data 
suggest that y6 cells can recognise antigen in a manner akin to that of immunoglobulins and 
distinct from that of a33 T cells. 
Much of the early work on y6 T cells focused on the possibility that these cells represent an 
immature stage in T cell ontogeny- y mRNA levels were observed to be highest in thymocytes 
and lowest in most resting peripheral T cells (Raulet et al, 1985; Snodgrass et al, 1985). 
However, the discovery that y and 6 chain genes were not functionally rearranged in cloned 
c43 T cells raised doubts about this model (Traunecker et al 1986). Subsequent studies on y6 
T cell lines and clones revealed that these cells can carry out typical T cell effector functions 
including cytolysis of target cells, lymphokine secretion and helper activity for immunoglobulin 
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production (Raulet, 1989a; Porcelli et al, 1991). For this reason it is presumed that activated 
y8 T cells contribute to host defence in a manner akin to a(3 T cells. However, y8 T cells are 
distinct from aß T cells in their localisation patterns, in their lack of demonstrable MHC 
restriction, and in their bias towards recognition of microbial antigens and heat shock proteins 
(Porcelli et al, 1991; Born et al, 1990). Despite extensive research, the role of y5 T cells in 
host defence against infection has yet to be defined precisely. One suggestion has been that 
yS T cells may function as a first line of defence to eliminate stressed, damaged or 
transformed cells at epithelial sites (Janeway et al, 1988). It seems likely that the reason for our 
current lack of understanding regarding yS T cell function is that most investigations have 
been designed on the basis that 78 T cells are just another type of aj3 T cell, and further 
analyses will be necessary to elucidate their true function. 
1.2.3 T Cell Development 
The early stages of thymic development are characterised by ordered changes in expression 
of cell surface molecules and ordered rearrangements of TCR genes (Robey, 1994; 
Rothenberg, 1992). In adults, thymocyte precursors originate in the bone marrow and migrate 
to seed the thymus rudiment. This migration process is probably mediated by 
chemoattractants and homing receptors. T cell development progresses in ordered stages as 
thymic immigrants migrate through the cortex to the medulla, from which selected, mature T 
cells emerge into the periphery. The earliest immature thymocytes express Pgp -1 (CD44) and 
IL -2Ra (CD25), but do not express CD4 or CD8 and the TCR genes remain in the germline 
configuration. In human thymocytes, TCR y and 8 transcripts are detectable in the absence of 
the a gene transcript, which only appears later in ontogeny. It was initially suggested that T cell 
precursors sequentially rearrange their y and 6 loci followed by their a and 13 loci. However, 
examination of the 6 gene deleted as circular DNA during a gene rearrangement showed that 
the 6 gene was in the germline configuration, implying that these lymphocytes were already 
committed to the a(3 lineage before TCR 6 rearrangement took place (reviewed in Porcelli et 
al, 1991). In the aß T cell lineage, rearrangements at the TCR (3 locus occur, followed by a 
switching off of IL -2Ra expression and gene rearrangement at the TCR a locus. The double 
negative (CD4 -CD8 -or DN) cells progress to a double positive stage accompanied by cellular 
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proliferation. The double positive (DP) cells ultimately differentiate into mature single positive 
(SP) CD4 +or CD8 +thymocytes with high TCR expression and these cells are exported to the 
periphery. 
The T cell repertoire is shaped by the processes of positive and negative selection that occur 
in the thymus (Rothenberg, 1992). T cells are positively selected for recognition of antigen in 
the context of self- MHC molecules (reviewed by von Boehmer, 1994). This process is 
thought to be mediated by engagement of TCR's on immature thymocytes with self -MHC 
expressed on thymic cortical epithelial cells (Benoist and Mathis, 1989). Only those 
thymocytes expressing TCR's with sufficient affinity for self -MHC are thought to be given the 
signal to avoid programmed cell death (Sprent and Webb, 1987). Hence, all positively 
selected T cells are self -MHC restricted. During this process, class I restricted T cells become 
CD4 -CD8 +, whereas class II restricted T cells become CD4 +CD8- i.e. committment to the CD4 
helper lineage or to the CD8 cytotoxic lineage. Negative selection eliminates those T cells 
which are potentially autoreactive and is also thought to involve engagement of TCR's on 
immature thymocytes (reviewed by Nossal, 1994). In this case, the peptide /MHC complexes 
recognised by the TCR's are expressed on bone marrow derived thymic medullary stromal 
cells (macrophages and dendritic cells). Thymocytes expressing TCR's with too high an 
affinity for the peptide /self -MHC complexes are deleted by programmed cell death. The 
selection processes occuring in the thymus lead to the death of >95% of thymocytes. The 
enduring paradox for immunologists is that both positive and negative selection are mediated 
through the TCR but have very different outcomes. 
1.2.3.1 Positive Selection. 
The current model for the positive selection of thymocytes is essentially a two -step process, 
the first step regulating TCR gene rearrangement and the second step shaping the TOR 
repertoire for antigen recognition (Robey, 1994; von Boehmer, 1994).TOR ßchain 
rearrangement has been shown to be crucial in the early phase of T cell development. 
Introduction of a TOR ßtransgene into variousrearrangement leficient mice promoted the 
development of thymocytes (von Boehmer, 1994). These experiments established that a 
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rearranged TCR f3 gene is essential for the regulation of allelic exclusion of TCR p and for 
promoting the maturation and proliferation of thymocytes. This view was supported by the fact 
that >75% of TCR 3 rearrangements in the thymus of TCR a deficient mice were productive, 
indicating that a selection process had occurred (Mallick et al 1993). It now appears that early T 
cells display an immature pre -TCR at the cell surface which is composed of a TCR (3 chain 
disulphide linked to the developmentally regulated protein gp33, and that this heterodimer is 
associated with a partial CD3 complex (Groettrup et al, 1993; Groettrup and von Boehmer, 
1993). It is likely that this pre- TOR complex can mediate the first stage of positive selection of 
DN immature thymocytes by transmitting a signal via CD3 which may require the protein 
tyrosine kinase, p561ck Consequently, further TCR f3 rearrangement is suppressed in the 
selected cells, ensuring expression of a single TCR ß allele. Interestingly, the TCR a protein 
does not feed back to control gene rearrangement and it is possible that mature T cells may 
have two productive TCR a genes. Indeed, this has now been observed at both the mRNA 
level and at the cell surface of human T lymphocytes (Padovan et al, 1993). 
The first evidence which implicated peptides in the process of positive selection was 
provided by studies performed to assess the effects of class I MHC mutations on T cell 
selection (Nikolic -Zugic and Bevan, 1990; Jacobs et al, 1990). Mutations located exclusively 
in the MHC groove, presumably inaccessible to the TCR, were found to influence positive 
selection. More recent experiments using TCR transgenic and class I deficient mice models 
suggest that a variety of peptides are more efficient at positive selection than a single peptide 
(Hogquist et al, 1994; Hogquist et al, 1993; Ashton -Rickardt et al, 1994). These studies 
support the idea that the endogenous peptide repertoire contains peptides which are 
collectively able to select an entire T cell repertoire which is able to respond to almost any 
pathogen (Allen, 1994). 
The mechanism by which T cells with class I specific TCR's become CD4 -CD8 +cytotoxic cells 
and T cells with class Il restricted TCR's become CD4+ CD8- helper T cells has been the 
subject of intense investigation in recent years (von Boehmer and Kisielow, 1993). Two 
models have been proposed- the instructive model (von Boehmer, 1986) and the 
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stochastic /selective model (Robey, 1994; Robey et al, 1991; Davis et al, 1993; Chan et al, 
1993). The instructive model predicts that a class I MHC- specific TCR and CD8 coreceptor 
engaged by the same class I molecule generate a different signal from a class II MHC- engaged 
receptor complex, thus instructing the cell to differentiate into either a helper or cytotoxic cell 
precursor. In the stochastic/ selective model, lineage commitment is essentially random and 
by crosslinking a "matched" coreceptor to an MHC molecule i.e. CD4 with class II MHC and 
CD8 with class I MHC, the cell would be selected for survival. Neither model has been 
effectively proven or disproven and further work is necessary to elucidate the exact nature of 
CD4 /CD8 lineage commitment. 
1.2.3.2 Negative Selection. 
The process of negative selection in the thymus ensures that T cells which are potentially 
autoreactive are eliminated, a process referred to as clonal deletion (reviewed by Nossal, 
1994). In addition, other tolerance mechanisms operate in the periphery, since many self -T 
cell epitopes are not present in the thymus to induce clonal deletion. In the past few years, 
many of the investigations into the mechanisms of negative selection have been performed in 
superantigen or transgenic mouse model systems (Simpson, 1992; Herman et al, 
Kisielow et al, 1988). Induction of negative selection in the thymus is thought to be the 
consequence of high affinity TCR engagement of self -MHC /peptide complexes. These 
complexes seem to be expressed at high density on bone marrow derived stromal cells. As 
for positive selection, the mechanisms of thymic negative selection and peripheral tolerance 
have yet to be fully elucidated. 
1.2.4 T Cell Activation. 
The activation of antigen specific T cells is a pivotal event in the generation of many immune 
responses. The initiation of T cell activation involves the interaction of multiple 
receptor /coreceptor pairs necessary for both signal transduction and cell adhesion (reviewed 
in Chan et al, 1994; Terhorst and Ruguiero, 1993). The trigger for T cell activation is the 
engagement of the TCR by antigen /MHC complexes. Other surface molecules including 
CD4, CD8, CD45, CD2 and LFA -1 (CD11a/CD18) are also important in Tcell activation. As a 
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consequence of activation, T cells undergo a programme of gene expression and de novo 
synthesis of various surface molecules, including the IL -2 receptor. Activated T cells also 
produce a wide range of cytokines which enable them to regulate growth, differentiation and 
function of cells involved in the immune response. 
CD2 and CD11a/CD18 (LFA -1) are the major adhesion molecules that contribute to the 
binding avidity between a T lymphocyte and an APC (Terhorst and Rugueiro, 1993). APC's 
express the ligands for these molecules- CD58 (LFA -3) and CD54 (ICAM -1) respectively. A 
nonspecific adhesion interaction between a T cell and an APC allows the T cell to "screen" 
potential APC's. Specific interaction between the TCR and antigen /MHC leads to an 
intensification of adhesion. For example, activation of PKC leads to phosphorylation of the f3 
chain of LFA -1 (CD18), initiating high affinity adhesion. Adhesion is aborted if the TCR does 
not specifically recognise antigen /MHC. 
Strategies utilising chimeric receptors have permitted much recent progress in understanding 
the relationship between TCR /CD3 structure and signal transduction. The current view of the 
TCR complex is that it may comprise at least two autonomous signal transducing units, one 
which couples the ( chains to a protein tyrosine kinase (PTK) pathway and one which couples 
the CD3 E chain to a PTK pathway (Weiss, 1993; Izquierdo and Cantrell, 1992). 
It has been clear for several years that the TCR is coupled to two parallel signal transduction 
cascades- phosphatidylinositol turnover and PTK activation. The current view is that these 
pathways are coupled and do not represent independent activation pathways (Terhorst and 
Rugueiro, 1993). The phosphatidylinositol pathway involves phosphorylation of PLC y1 
(phospho -lipase C). Activated PLC hydrolyses PIP2 (phosphatidylinositol -4,5 -bis phosphate) 
yielding the second messengers IP3 (inositol- 1,4,5- triphosphate) and DAG (diacylglycerol). 
These messengers can in turn induce the mobilisation of intracellular calcium and the 
activation of protein kinase C (PKC). 
A second signal transduction route consists of PTK pathways. Three cytoplasmic PTK's, 
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p59fyn p561ck and ZAP -70, have been implicated in T cell signalling (Weiss, 1993). Fyn and 
Ick are members of the src family while ZAP -70 is a member of the syk family (Chan et al, 
1994). It has been demonstrated that the cytoplasmic domains of both the CD4 and CD8 
coreceptors are tightly associated with the PTK p561ck The engagement of the TCR as well 
as CD4 or CD8 with the same antigen /MHC complex is required for optimal signal 
transduction- this interaction can facilitate signalling by 30 -300 fold (Janeway, 1992). The role 
of p59fyn in signal transduction remains unclear, although it is known to be associated with 
both the CD3 E and chains. Recent studies have implicated CD45, a molecule whose 
surface expression is obligatory for TCR stimulation via PTK pathways, in the regulation of 
PTK activity (Chan et al, 1994). The cytoplasmic domain of CD45 contains two protein tyrosine 
phosphatase (PTPase) domains, and in model systems it can modulate the activity of 
CD4 /CD8 associated p561ck by dephosphorylation of PTK's (Janeway, 1992). 
The activation of T cells via the TCR /CD3 complex is, as outlined above, a very complex 
process. A conformational change in the aß heterodimer as a result of ligand binding is 
thought to induce tyrosine phosphorylation at specific motifs in CD3 and chains by the src 
family of PTK's. Phosphorylation of these motifs recruits the ZAP -70 PTK to propagate TCR - 
mediated signalling events. Current studies are investigating the roles of downstream 
mediators of PTK and PKC action such as the ras family of GTP binding proteins and kinases 
such as MAP2 and c -raf (lzquiedo and Cantrell, 1992; Moodie and Woolf man, 1994). 
A two signal model of lymphocyte activation was originally proposed by Bretscher and Cohn 
(1970), but it is only recently that putative costimulatory receptors have actually been 
identified. Activation of the TCR in the presence of costimulatory signals results in T cell clonal 
expansion and the induction of effector functions (June et al, 1994; Fraser et al, 1993). 
However, antigen- specific activation of the T cell in the absence of the second signal leads to 
a state of unresponsiveness or anergy (Jenkins, 1992). The costimulatory signal is thought to 
act via a distinct, as yet uncharacterised, signal transduction pathway. 
The cell surface molecule CD28 has been identified as a major costimulatory molecule. It is 
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expressed on the majority of resting human and murine T cells (June et al, 1994). Prevention 
of CD28 activation using anti -CD28 antibodies during the activation of a T cell clone by 
antigen primed APC's results in the failure of the clone to respond to subsequent challenge. 
The identification of a ligand for CD28 was first reported by Linsley and coworkers when they 
demonstrated that antibodies to B7 could block the adhesion of B cells to CD28 transfectants 
(reviewed by Linsley and Ledbetter, 1993). Subsequently it was shown that cells transfected 
with B7 could provide the second signal to antigen or mitogen activated T cells. However, 
antibodies to this original B7 (now known as B7 -1) did a poor job of blocking the costimulatory 
signal in some systems (Cohen, 1993). Furthermore, a B7 -1 knockout mouse was found to 
have virtually no immune defects, implying that another molecule could also transmit the 
second signal. A second member of the B7 family, B7 -2, was then identified in both humans 
and mice by two independent laboratories (Freeman et al, 1993a; Azuma et al, 1993). Several 
other studies have now provided additional evidence for the functional importance of B7 -2 
(Hathcock et al, 1993; Freeman et al, 1993b; Razi -wolf et al, 1993). Many of these studies 
have utilised a soluble form of the alternative B7 receptor CTLA -4, a molecule structurally 
related to CD28 which can bind to B7 with 20 -fold higher affinity. B7 -1 is only detected -24 -48 
hours after delivery of the first signal (Lenschow et al, 1993). Since several studies have 
demonstrated that a T cell must receive the second signal within 24 hours after the first, it 
seems that B7 -2, which appears virtually immediately after activation by the first signal, may be 
the major costimulatory molecule. Recent evidence has suggested the existence of a third 
member of the B7 family, tentatively named B7 -3 (Boussiotis et al, 1993). Many questions 
regarding the costimulatory family of receptors remain to be answered. In particular, the CD28 
signalling pathway requires detailed characterisation and the precise function of CTLA -4 
remains to be elucidated. 
1.3 The Major Histocompatibility Complex. 
Self /nonself discrimination was first demonstrated in mammals by the rejection of foreign 
tissue grafts in mice. The genetic loci involved in this rejection process were subsequently 
mapped to a region known as the major histocompatibility complex (MHC). The highly 
polymorphic cell surface structures involved in rejection were initially characterised using 
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alloantibodies produced in one inbred strain of mice immunised with cells of a second strain 
differing only at the MHC. The MHC gene complex is located on chromosome 17 in mice (the 
H -2 region) and on chromosome 6 in humans (the HLA region) (Trowsdale and Owen, 1993). 
The human MHC genes have been mapped and the MHC molecules analysed in detail using 
biochemical and molecular biology techniques (Campbell and Trowsdale, 1993). 
Three classes of MHC molecules have beeen identified in the MHC complexes of both mouse 
and man- classes I, II and Ill. The class Ill region contains a diverse collection of >20 genes 
which are not involved in triggering T cell activation, and are therefore not discussed here. 
Class I molecules are glycoproteins composed of a 44kDa alpha chain in noncovalent 
association with j32- microglobulin, and are expressed on most nucleated cells. The class II 
molecules are heterodimers composed of a 30 -34kDa alpha chain and a 26 -29kDa beta chain. 
Class II molecules are predominantly expressed on B cells and APC's (macrophages, 
monocytes and dendritic cells) but may also be expressed on other cell types under particular 
conditions e.g. on activated human and unactivated ovine T cells. Expression of class II has 
additionally been detected on other cell types in certain pathological conditions as a result of 
induction by the cytokine IFNy. Most class I and class Il molecules are highly polymorphic 
structures which function to present antigen to CD4 +and CD8 +T cells respectively. 
1.3.1 Classical Class I MHC Genes and Molecules. 
The classical class I genes comprise the HLA -A, B and C loci in humans and the H -2K, D and L 
loci in mice. Huge advances have been made in recent years in determining the detailed 
structure of the class I molecules and in particular the structure of the antigen binding site. 
Bjorkman and colleagues (1987a; 1987b) were the first to report a crystallographic structure 
for a human class I molecule, HLA -A2. A putative peptide binding site identified as a deep 
groove formed by polymorphic parts of the al and a2 domains was observed on the top 
surface of the molecule. The sides of the groove were formed by two alpha helices and the 
base was an eight stranded beta pleated sheet. Polymorphic residues were found to be 
concentrated at this binding cleft. Extra electron density within the groove was proposed to 
represent the image of a mixture of peptides bound by the HLA -A2 molecule. The refined 
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structure of HLA -A2 and the crystal structure of a second class I molecule, HLA -A68, provided 
further details of the peptide groove structure (Saper et al, 1991; Garrett et al, 1989). Six 
pockets or subsites were identified (A -F) within the groove, suggesting that polymorphism, by 
creating and altering such sites, can influence the range of peptides bound by a particular 
class I allele. The structure of a third class I molecule, HLA -B27, revealed a clearer picture of 
the peptides in the groove, indicating that peptides bind in an extended conformation with 
tight binding at either end of the groove between the peptide and conserved MHC residues 
(Madden et al, 1991; Madden et al, 1992). Solution of the crystal structure of the mouse class 
I molecule H -2Kb in association with two different bound peptides (H -2Kb+ an octamer from 
vesicular stomatitis virus, and H -2Kb+ a nonamer from Sendai virus) provided further details of 
the interaction between class I molecules and peptides (Zhang et al, 1992; Matsumara et al, 
1992; Freemont et al, 1992). It seems that peptides bound to class I molecules are restricted 
in length to eight or nine residues. The amino and carboxy termini are held tightly within 
conserved pockets at either end of the cleft, while the extra length of a nine residue peptide 
can beaccommodatedoy protrusion of residues in the middle of the peptide out of the groove 
(Parham, 1992). 
1.3.2 Non -classical Class I MHC Genes And Molecules. 
In addition to the polymorphic classical class I genes, the human and mouse MHC regions also 
contain a substantial number of nonclassical class I genes. These nonclassical genes are 
characterised by limited polymorphism, restricted tissue distribution and low cell surface 
expression (Stroynowski, 1990). Murine nonclassical class I molecules are encoded in the Q, 
T and M regions (formerly the Qa, TLa and Hmt regions) and human nonclassical class I 
molecules are encoded in the HLA -E, F, G, H, I and J regions (Shawar et al, 1994). Genes 
homologous to the murine Q and TL region genes have additionally been detected in the rat 
(Kirisits et al, 1994; Rothermel et al, 1993). 
The H -20 region of the mouse MHC is composed of at least 10 genes, of which the Q4 and 
Qa -2 genes are expressed in a wide variety of tissues (reviewed by Morse et al, 1990). The 
Q2, Q5 and 010 gene products have a more tissue specific expression pattern. The Q4, Qa- 
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2 and 010 gene products can be detected as secreted molecules. It has recently been 
reported that two forms of soluble Qa -2 exist- one form corresponds to the translation product 
of a truncated transcript, while the second form is derived from membrane -bound molecules 
(Tabaczewski et al, 1994). The membrane -bound form of Qa -2 is attached to the cell surface 
via a GPI (glycophosphatidylinositol) linkage and has been implicated in transmembrane 
signalling (Stroynowski, 1990). 
The H -2T region of the mouse MHC contains at least 20 genes including the T23 gene which 
encodes the inappropriately named Qa -1 molecule (reviewed by Chorney et al, 1990). T 
region gene products are predominantly expressed on normal thymocytes and thymic 
leukemia cells. Several studies have also reported the expression of T region gene products 
in the intestinal epithelium where they have been suggested to function as presentational 
elements for yS T cells (Wu et al, 1991: Herschberg et al, 1990; Eghtestady et al, 1992). 
Furthermore, cell surface expression of a transfected Qa -1 b molecule was stabilised following 
heatshock and by the addition of a tryptic mycobacterial digest Omani and Soloski, 1991), 
suggesting a role in peptide presentation. 
The most thoroughly studied nonclassical class I genes are the M region genes of the mouse 
MHC (reviewed by Fischer Lindahl et al, 1991). This region of the mouse MHC is presently 
known to contain 8 genes (Wang et al, 1993). H -2M3 is the best understood example of a 
nonclassical class I presentational element. The minor histocompatibility antigen Mta is a 
complex of MTF, HMT and f32-microglobulin. MTF is a polymorphic N- formylated hydrophobic 
peptide derived from the amino terminus of the mitochondrially encoded ND1 protein, and H- 
2M3 is a nonclassical class I gene. A peptide must fulfil three requirements for binding to HMT - 
1) have an N- formyl moiety at the amino terminus, 2) have a space filling R group at position 1, 
and 3) have the correct sterioisomer of the first amino acid (Vyas et al, 1992; Shawar et al, 
1990). Since bacterial as well as mitochondrial protein synthesis is initiated by an N- formyl 
methionine residue, it was suggested that HMT may function as a restriction element for 
peptides of bacterial origin (Shawar et al, 1991; Fischer Lindahl, 1991). It has subsequently 
been demonstrated that HMT can indeed present bacterial peptides to CTL during Listeria 
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monocytogenes infection (Pamer et al, 1992; Kurlander et al, 1992). Cell surface expression 
of HMT has recently been shown to be dependent on the availability of appropriate 
endogenous peptides (Vyas et al, 1994). Wang and colleagues have proposed that the HMT 
molecule may be considered as a neoclassical class I molecule, since the developmental 
expression and pattern of cytokine induction parallel that observed for classical class I 
molecules (Wang and Fischer Lindahl, 1993a). 
The human HLA -E, F and G nonclassical class I regions are much less well understood than 
their murine counterparts. HLA -F transcripts have been detected in large quantities in foetal 
liver and at much lower levels in other tissues (Houlihan et al, 1992). The HLA -E gene is 
transcribed at low levels in most adult tissues and in the placenta (Shawar et al, 1994). HLA -G 
transcripts have been detected in the trophoblasts of the placenta, and more recently, 
alternative splicing products have been observed in adult peripheral lymphocytes and in 
keratinocytes (Kirszenbaum et al, 1994; Ulbrecht et al, 1994; Houlihan et al, 1992). 
The putative functions of nonclassical class I molecules have been extensively debated down 
the years (Lawlor et al, 1990; Klein et al, 1983). Klein and colleagues have long held the view 
that the nonclassical class I genes constitute an evolutionary junkyard (Klein et al, 1991; Ram 
and Tyle, 1991). They consider that these genes have no functional significance and that 
they represent relics of genes once used in antigen presentation or are the products of 
unsuccessful attempts at producing new genes. It has been proposed that these genes may 
provide a source of donor sequences for the generation of sequence variation in classical 
class I genes (Lawlor et al, 1990). Others have suggested that the nonclassical genes may 
function in a manner analogous to the classical class I molecules (Strominger, 1989; 
Srivastava and Lambert, 1991). Various studies in recent years have now provided evidence 
for a presentational role for these molecules, as discussed more fully in conjunction with CD1 
function in section 1.7. 
1.3.3 MHC Class II Genes And Molecules. 
The class II genes comprise the HLA -D region in humans (three loci -DP, DQ and DR) and H2- 
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IA and IE in mice. The three dimensional structure of the class II molecule HLA -DR1 has 
recently been determined and is similar to that of class I molecules, as previously predicted 
(Brown et al, 1993; Brown et al, 1988). Peptides are bound in an extended conformation with 
the termini projecting from both ends of an open ended antigen binding groove. One 
prominent peptide side chain at -position 3 of a 15 -mer identifies a critical binding pocket, and 
other pockets are indicated by patches of polymorphic residues in the binding site. The major 
difference in comparison to class I structures is that DR1 crystallises as a dimer of the x3 
heterodimer i.e. a dimer of dimers. Site -directed mutagenesis would be required to rule out 
the possibility that this dimerisation is a crystallisation artefact. It has been suggested that the 
dimer of dimers may influence T cell signalling by affecting CD4 binding and TCR crosslinking 
(Ploegh and Benaroch, 1993; Brown et al, 1993). 
1.4 MHC- Dependent Antigen Processing And Presentation. 
The MHC class I and II molecules serve as "peptide binding and display proteins" (reviewed by 
Germain, 1994). The two classes of MHC molecules are specialised for the binding and 
presentation of peptides in distinct intracellular locations. In general, MHC class I molecules 
bind to peptides in the ER (endoplasmic reticulum) which have been derived from proteins 
actively synthesised in the cell or entering the cytosol. In contrast, MHC class II molecules 
primarily interact with peptides in the endocytic pathway derived from exogenous protein 
sources. 
1.4.1 Processing And Presentation Of Antigen In Association With Class I 
Molecules. 
Much of the current knowledge of class I associated processing pathways has been derived 
from work with mutant cell lines which have defects in class I heavy chain /ß2m assembly. For 
example the mutant cell line RMA/S expresses 95% less class I molecules at the cell surface 
than the normal cell line RMA. Addition of exogenous peptides to RMA/S cells restored cell 
surface class I expression by stabilising the heavy chain/j32m interaction (Monaco, 1992; 
Townsend et al, 1989). In the absence of peptide, the class I heavy chain does not fold in the 
correct conformation and is consequently unstable. The data imply that the defect in the 
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mutant cells arises from a lack of peptides in the ER which are necessary for effective class I 
assembly and cell surface expression. It was subsequently discovered that the defect in the 
RMA/S cell line, and in a second mutant cell line 721.134, could be corrected by transfection 
of cDNA encoding the TAP1 or TAP2 proteins (Spies and Demars, 1991; Attaya et al, 1992), 
providing strong evidence that TAP mediates peptide translocation into the ER. Transporter 
associated proteins (TAP) are members of the ABC (ATP binding cassette) family whose 
genes map to the class II region of the MHC (Deverson et al, 1990; Trowsdale et al, 1990; 
Spies et al, 1990). The TAP1 and TAP2 proteins are thought to form a heterodimer in the 
membrane of the ER (Kleijmeer et al, 1992). Polymorphisms in the TAP genes result in an 
alteration of the spectrum of class I bound peptides (Powis et al, 1992a; Powis et al, 1992b), 
providing further indirect evidence for the role of TAP in peptide translocation. It has been 
suggested that TAP may function as a molecular ruler, selecting those peptides of an 
appropriate length and with a suitable carboxy terminal residue for binding to a class I molecule 
(Germain, 1994; Momburg et al, 1994; Neefjes et al, 1993). However it has yet to be directly 
demonstrated that TAP1 and TAP2 constitute an active peptide transporter of cytosolic 
peptides. 
Cytosolic peptides can additionally enter the ER in a TAP independent manner via the normal 
SRP(signal recognition particle) dependent pathway (Forquet et al, 1993) and signal 
sequences of ER- targeted proteins are found to be presented by HLA -A2 molecules (van 
Bleek and Nathenson, 1993). However, the contribution of this TAP -independent pathway to 
antigen presentation during an immune response is not yet clear. 
Two additional genes encoded in the MHC class II region adjacent to the TAP genes have 
been implicated in the cytosolic degradation of proteins to peptides. The LMP2 and LMP7 
proteins, discovered by Monaco and McDevitt (1982), encode two subunits of a large 
cytoplasmic structure known as the LMP (low molecular weight polypeptide) complex. This 
complex is structurally and biochemically related to the proteasome, a multicatalytic proteinase 
complex which functions to degrade ubiquinylated proteins in the cytosol (Brown et al, 1991). 
However, two reports showed that defective class I expression in a mutant cell line lacking the 
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genes for both TAP and LMP2 /7, could be restored by transfection of the TAP genes alone, 
suggesting that the LMP genes are not crucial for the class I processing pathway. Several 
studies have now suggested that the LMP genes can influence the cleavage specificity of the 
proteasome and may favour the generation of peptides with appropriate carboxy termini for 
loading to class I molecules (Driscoll et al, 1993; Howard and Seelig, 1993). 
The efficient assembly and transport of class I molecules to the cell surface is critically 
dependent on the presence of suitable peptides. Peptide -free class I heavy chains appear to 
be associated with the ER protein calnexin which prevents movement of class I through the 
ER (Germain, 1994). Dissociation from calnexin and formation of stable heavy chain/ 
ß2m /peptide complexes allows class I transport to the cell surface to proceed. 
The typical view of class I processing and presentation is that proteasomes degrade cytosolic 
proteins to 8 or 9mer peptides which are then transported into the ER by ATP- dependent 
TAP transporters prior to association with class I molecules. However, processed peptide 
ligands for class I molecules cannot be detected in the cytosol. Furthermore, in order to be 
selected by class I molecules, the entire pool of peptides would need to be transported into 
the ER. Rammensee and colleagues have proposed an alternative model of class I 
processing which assumes an instructive role for class I molecules (Rammensee et al, 1993a; 
Rammensee et al, 1993b; Howard and Seelig, 1993). They suggest that proteins are first 
degraded into precursor peptides with appropriate carboxy termini for class I binding. These 
peptides would then be transported into the ER and interact with low affinity via the carboxy 
terminal residue to class I molecules. The amino terminus would then be trimmed allowing the 
peptide to snap into the groove and bind with high affinity. This model would require the 
transport of only a subset of available peptides and would fit with the current evidence for 
selectivity of the peptide transporters. 
Huge advances have been made in recent years in the analysis of peptides naturally 
presented by class I molecules. Peptides can now be eluted from purified class I molecules, 
separated by HPLC and their sequences analysed by Edmann degradation and /or mass 
spectrometry. These studies have revealed that each class I allelic molecule has its own 
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peptide specificity or peptide motif (van Bleek and Nathenson, 1993; Hunter et al, 1992; Falk 
et al, 1991). Peptides bound to class I molecules are restricted to 8 or 9 residues in length, 
and two of the 8 or 9 positions are typically occupied by a single amino acid or anchor residue. 
Most of these studies have performed pool sequencing of eluted peptides, although 
sequencing of individual peptides is now possible (Joyce et al, 1994). 
1.4.2 Processing And Presentation Of Antigen In Association With Class II 
Molecules. 
MHC class li molecules are c43 heterodimers which assemble in the ER and become 
complexed with a third protein, the nonpolymorphic invariant chain (li). The nine chain 
complex formed is composed of three class II dimers and three li chains (Lamb and Cresswell, 
1992). Various functions have been ascribed to the li chain and it is clear that it plays a central 
role in class II assembly and transport. The li chain has been shown to facilitate class Il folding 
and transport through the ER, and to interfere with peptide /class lí association (Roche and 
Cresswell, 1990; Sant and Miller, 1994; Cresswell, 1994) suggesting that it may act as a 
surrogate peptide to prevent peptide interaction prior to reaching the acidic peptide loading 
compartment. Recent studies have revealed that a particular region of the Ii chain, the CLIP 
(class II associated invariant chain peptide) region, interacts with the class II binding site to 
prevent class II /peptide association during early biosynthesis (Riberdy et al, 1992). The Ii 
chain is also thought to contain, in the cytoplasmic domain, an endosomal localisation signal 
which directs and /'or retains class ii molecules within the endocytic pathway (Loss and Sant, 
1993; Cresswell, 1994). Two groups have recently developed li negative transgenic mice 
( Vivifie et al, 1993; Bikoff et al, 1993) which exhibit dramatic defects in class II biosynthesis and 
function. These mice have decreased class II cell surface expression, altered class Il transport 
and inefficient selection of CD4+ T cells. The results confirm the importance of the li chain in 
class II assembly and transport. 
The precise location and nature of the acidic peptide loading compartment for class II 
molecules has, until very recently, been ill- defined. The prevailing view has been that class II /li 
complexes meet unprocessed antigen in an endosomal compartment and together proceed 
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along a proteolytic pathway so that unoccupied class II molecules are produced 
simultaneously with antigenic peptides. However, several papers published in May this year 
have reported the identification of a unique subcellular compartment, the CPL (compartment 
for peptide loading), in which class II peptide loading occurs (Amigorena et al, 1994; Tulp et al, 
1994; West et al, 1994; 4). The CPL have no detectable endosomal or 
lysosomal markers and have distinguishable subcellular fractionation behaviour (Schmid and 
Jackson, 1994). Most class II molecules in the CPL are not associated with the li chain. It has 
been suggested that CPL undergo a maturation process whereby li is degraded, class II 
dimers assume an intermediate conformation and peptide loading subsequently occurs. 
Sequencing of endogenous peptides eluted from MHC class II molecules has indicated that, 
in contrast to class I molecules, the peptides bound are much more variable in length, typically 
12 -24 residues long (Rudensky et al, 1991; Hunt et al, 1992). The majority of peptides are 
derived from transmembrane or secreted proteins present in large quantities in the 
endosomal pathway (Rudensky and Janeway, 1993). Class II peptides also have variable 
amino and carboxy termini which, together with the length variability, indicates that specific 
interactions between the peptide and class II molecule occur in the central part of the peptide 
rather than at the termini as for class I molecules (Forquet et al, 1993). 
1.5 The CD1 Genes. 
The CD1 molecules are a family of 132m- associated glycoproteins with broad structural 
homology and weaker sequence homology to the MHC class I antigens. The CD1 molecules 
are characterised by limited polymorphism, low surface expression and a restricted pattern of 
tissue distribution in comparison to the classical MHC class I gene products. The genes 
encoding the CD1 molecules have now been characterised in a variety of species. 
1.5.1 Identification And Isolation Of The CD1 Genes. 
The first human CD1 cDNA clone, encoding the CD1 a molecule, was isolated from the cell line 
NH17, a derivative of MOLT4 which expresses high levels of HTA -1, the human thymocyte 
antigen recognised by the mAb NA1 -34 (Calabi and Milstein, 1986). Two CD1 a- encoding 
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clones were identified- FCB6 and FCB1. There are three single base differences, which are 
probably cloning artefacts, between the two clones, and the FCB1 clone extends -180 
nucleotides further in the 5' direction. The FCB1 clone sequence begins near the end of the 
a1 domain. A Southern blot of human MOLT4 DNA digested with EcoR I and probed with the 
insert from FCB6 identified five hybridising bands (Martin et al, 1986). These were found to 
correspond in size to the EcoR I fragments of five different clones isolated from a genomic 
library (R4B3, R1 L5, R7L4, R3G1, and R2G4), and represent the five different human genes 
(HCD1A, B, C, D, and E). The a3 domains of the genomic clones were sequenced and the 
FCB6 cDNA clone was matched with the R4B3 genomic clone. Three of the genomic clones 
have been found to encode the serologically defined CD1 a, b, and c antigens, by analysing a 
series of transfectants with a panel of monoclonal antibodies (mAbs) (Martin et al, 1987). 
cDNA clones corresponding to the CD1A, B and C genes were identified and isolated using 
anti -CD1 mAbs to screen an HPB -ALL cDNA library expressed in COS cells (Aruffo and Seed, 
1989). A cDNA clone corresponding to the human CD1D gene was subsequently isolated 
from a thymus library using a mixture of full -length cDNA CD1A, B and C probes (Balk et al, 
1989a). The same probes, and gene specific probes corresponding to the 5'UT, al and 3'UT 
regions, were used to identify an equivalent genomic clone. The full -length DNA sequences 
from the genomic clones R2G4(CD1 E) and R3G1 (CD1 D), isolated by Martin and colleagues, 
were also reported at this time (Calabi et al, 1989a). All five human sequences are highly 
homologous in the region encoding the membrane -proximal a3 domain (80 -94% identity at 
the nucleotide level and 71 -88% identity at the amino acid level), which is likely to be the site 
of interaction with (3zm (Calabi et al, 1991). Comparison of the 5'UT, al and a2 domains 
indicates that CD1D is the most divergent member of the CD1 gene family (Balk et al, 1989a). 
Two mouse CD1 genes have been identified, both corresponding to the human CD1D gene 
( -76% nucleotide identity and -65% amino acid identity; Bradbury et al, 1988). The MCD1.1 
gene was isolated from a genomic library screened with the insert from the human CD1A 
clone FCB6 (Bradbury et al, 1988). The second gene, MCD1.2, was identified by screening a 
genomic library with an a3 region subclone of the MCD1.1 gene. cDNA clones corresponding 
to both murine genes have also been isolated using a probe corresponding to the a2 and a3 
domains of the human CD1D gene (Balk et al, 1991 a). There are only 19 amino acid 
differences in the extracellular domains of the derived murine CD1 polypeptide sequences. In 
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the nucleotide sequences, the homology between the two genes extends to the 5' UT 
region and to the first -120 nucleotides of the 3'UT region, but the sequences in the 3'UT 
region then diverge (Balk et al, 1991 a). 
The sequence of another rodent CD1 gene, rat CD1, has recently been reported (lchimiya et 
al, 1994). The cDNA clone encoding rat CD1 was isolated from a thymic lymphoma cDNA 
library using a rat a3 region probe. This probe was generated by PCR amplification using 
primers based on conserved sequences in other CD1 genes. Southern blot analysis using 
the a3 region probe indicates the existence of a single rat CD1 gene. The rat CD1 sequence 
is highly homologous to both murine sequences in the 5'UT region and in the coding 
domains. Sequence divergence in the 3'UT region indicates that rat CD1 is equivalent to the 
murine CD1.1 gene (80% identity) and not to the CD1.2 gene (52% identity). 
Two rabbit CD1 genes have been identified, although Southern blot analysis indicates the 
existence of up to 8 genes (Calabi et al, 1989b). The cottontail rabbit genomic CD1 clone 
encodes the a1, a2 and a3 domains, and is most related to the human and murine CD1 D 
genes. The domestic rabbit genomic CD1 clone encodes the 5'UT and a1 domains only and 
is most similar to human CD1 B. 
1.5.2 Chromosomal Localisation Of The CD1 Genes. 
The chromosomal localisation of the CD1 genes has been determined in both humans and 
mice. Analysis of the pattern of segregation of CD1 and MHC genes in mouse x human 
somatic hybrids by Southern blot analysis provided the first evidence that the CD1 genes do 
not map to the MHC region ( Calbi and Milstein, 1989b). In situ hybridisation using gene - 
specific probes and a sensitive fluorescent detection system was subsequently used to 
assign all five human genes to chromosome 1822 -23, confirming that they are not MHC linked 
(Albertson et al, 1988). The human genes constitute a tight linkage group spanning -190kb 
which has been mapped using 14 overlapping cosmid clones (Yu and Milstein, 1989). The 
linkage of the genes was established using pulse field gel electrophoresis, cosmid cloning 
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and walking techniques. The genes are arranged in the order CD1 D, A, C, B, E. It is 
interesting that the classical CD1 genes, encoding the serologically defined CD1a, b, and c 
antigens, are flanked by the most divergent genes in the family, and that CD1 D is 2 -3 times 
further away from CD1 A in comparison to other intergenic distances (20- 30kb). All of the 
human CD1 genes are in the same transcriptional orientation with the exception of CD1 B. 
The CD1 genes of the mouse are also non MHC- linked and have been mapped to 
chromosome 3 using Southern blot analysis of hamster /mouse somatic cell hybrids (Bradbury 
et al, 1991). The two mouse genes are arranged in a tail to tail orientation and are <10kb apart 
(Bradbury, PhD Thesis, 1987). The recently isolated rat homologue of CD1 is also unlikely to 
map to the MHC region, since no correlation was observed between MHC haplotype and CD1 
RFLP analysis (Ichimiya et al, 1994). 
1.5.3 CD1 Polymorphism. 
The extent of genetic polymorphism in the CD1 genes is extremely limited. Southern blot 
analysis of EcoR I digested genomic DNA with an a3 region probe revealed the existence of 5 
genes, and the same five EcoR I fragments were detected in 15 individuals (Calabi and 
Milstein, 1986; Martin et al. 1986). A number of CD1 genomic and cDNA clones derived from 
different individuals have now been sequenced- three for CD1A, and two for each of CD1 B, C 
and D (Calabi and Milstein, 1986; Martin et al, 1986; Balk et al, 1989; Aruffo and Seed, 1989). 
Only minor differences, mainly single base substitutions, have been detected within the 
coding regions of these sequences and ibis likely that these represent cloning and/or 
sequencing artefacts. 
In the mouse, Southern blot analysis of 11 inbred laboratory mice strains using an 0.3 probe 
detected only one RFLP (restriction fragment length polymorphism) (Bradbury, PhD Thesis, 
1987). A more sensitive analysis was conducted utilising nuclease protection assays and 
exon specific probes (Bradbury et al, 1988). This analysis was expected to detect most 
multiple mismatches and some but not all single base differences within the probe length. 
Two independent variants of the a3 domain were detected, probably involving single base 
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changes. 
The extent of CD1 polymorphism in the rat was similarly assessed by Southern blot analysis in 
12 strains of laboratory rat using the 5'UT /a 1 /a2 /a3 and TM /CYT /3'UT probes (lchimiya et al, 
1994). Three allelic variants of the rat CD1 gene were detected using the TM /CYT /3'UT 
probe. However, the nature of this probe did not enable variation in the TM /CYT domain to be 
distinguished from variation in the 3'UT domain. 
1.5.4 Subclasses of CD1 Genes And Evolutionary Implications. 
Comparison of the 5'UT, a1 and a2 domain sequences suggests that the CD1 genes can be 
divided into two distinct classes- the classical CD1 genes (human CD1A, B and C, and the 
domestic rabbit CD1 B ) and the human, mouse and cottontail rabbit CD1 D genes (Calbi et al, 
1991). The HCD1D gene is significantly more related to the murine CD1 genes than to any of 
the other human genes (Calabi et al, 1989a). It was suggested that these results indicate the 
generation of the CD1 gene family prior to primate /rodent divergence -80 mya and that the 
classical CD1 genes (CD1A, B and C) have been deleted in the rodent lineage. The 
separation into CD1 D -like and non CD1 D -like genes suggests a functional dichotomy within 
the CD1 gene family. The CD1 E gene is in an intermediate position between the classical 
genes and the CD 1 D -like genes. The two classes of genes can be distinguished by Southern 
blot analysis using a1 or a2 exon probes. A subsequent analysis of CD1 gene sequences 
and the construction of phylogenetic trees for evolutionary analysis was performed by 
Hughes (1991). The results of this study support the hypothesis of Calabi and colleagues 
(1989a) that the CD1 genes fall into different classes which arose by gene duplication prior to 
the divergence of the mammalian orders. However, in contrast to the Calabi results, HCD1 B 
was found to represent a separate lineage which diverged prior to the HCD1A/C grouping. 
The Hughes analysis suggests that the CD1 genes diverged at around the time of the 
bird /mammal separation, -250 -300 mya. 
1.5.5 CD1 Transcription Patterns And RNA Splicing. 
Investigations of CD1 mRNA synthesis and CD1 RNA splicing complexity have been 
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performed in various tissues and in several animal species. Northern blot analysis was 
performed on RNA from the MOLT4 cell line and from the daughter cell line NH17 (which 
expresses Cola at a high level) (Calabi and Milstein, 1986). The 3'UT CD1A-specific probe 
detected two main bands of -2.1 and 1.4- 1.6kb, although the same probe detected only one 
hybridising band by Southern blot. These results indicate the existence of multiple CD1 A 
mRNA transcripts derived from a single gene. Northern blot analysis of total RNA hybridised 
with CD1A, B and C cDNA probes revealed the presence of CD1 transcripts in thymocytes 
and several T cell leukemias but not in mature T or B cells, nor in myeloid -derived tumour lines 
(Aruffo and Seed, 1989). Similar hybridisation patterns and intensities were obtained with all 
three probes, indicating that CD1A, B and C are coordinately expressed in different cell lines. 
The CD1 transcripts detected ranged in size between 1.2 and 3.0kb suggesting the 
existence of RNA splicing complexity. The CD1 D gene is not transcribed to the same extent 
as the classical CD1 genes at the mRNA level (Balk et al, 1989). Northern blot analysis of 
thymus tissue using full length CD1 D and CD1A probes revealed the presence of both types 
of transcript but with significantly less signal for the CD1 D probe, suggesting that CD1 D is a 
relatively low abundance thymic transcript. In addition, low or undetectable levels of CD1 D 
gene transcription was observed in several T lymphoblastoid cell lines and no message in a 
series of B cell or myeloid lines. 
The existence of a complex array of alternatively spliced human CD1 transcripts has also been 
suggested by both cDNA sequence analysis and nuclease protection assays (Calabi et al, 
1989c). Cryptic splice sites have been detected in the leader -a1 intron of HCD1A, in the 
leader exon and leader -al intron of HCD1 E, and within the a3 exons of HCD1 B and HCD1 E 
(Calabi et al, 1991). Most of these splicings cause frameshifts leading to chain termination or 
probable destruction of p2m binding and membrane expression. Human CD1 transcription 
has most recently been analysed in mouse myeloma transfectants and thymocytes (Woolfson 
and Milstein, 1994). RT -PCR analysis was performed on the clone 10B3 derived from a mouse 
myeloma cell line transfected with a partially spliced CD1A cDNA. Four PCR products were 
detected using primers derived from the a3 and 3'UT regions. One PCR band was found to 
correspond to an unspliced transcript with a cryptic stop codon in the intron between the a3 
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and TM /CYT domains. Protein sequencing of Cola purified from the transfectant supernatant 
indicated that the unspliced transcript encodes a secretory isoform of CD1 a. A second PCR 
band was found to correspond to an alternatively spliced transcript in which a cryptic splice 
acceptor site within the transmembrane /cytoplasmic exon is utilised in preference to the site 
at the beginning of the exon. The product of this transcript was found to be an intracellular 
component. A third band represented the transcript encoding the correctly spliced 
membrane -bound form of CD1 a, and the fourth band was a heteroduplex derived from two of 
the other bands. A similar analysis of all five HCD1 genes was performed in thymus tissue. A 
single major band, corresponding to the correctly spliced membrane -bound form of CD1, was 
detected following amplification of CD1A and CD1 B cDNA. The single CD1A transcript 
detected in thymus tissue contrasts sharply with the complex splicing pattern observed in the 
CD1A transfectant. CD1 D amplification gave one major band and two additional minor bands. 
In contrast, CD1 C and CD1 E gave complex splicing patterns. The CD1 C pattern was 
comparable to that observed in the CD1A transfectant, with unspliced, alternatively spliced 
and correctly spliced transcripts being detected. Human CD1 gene transcription is thus 
characterised by considerable mRNA splicing complexity which may be tissue specific. 
Analysis of murine cDNA clones derived from total thymus RNA has revealed that the majority 
represent partially spliced RNA transcripts (Bradbury, PhD Thesis, 1987; Bradbury et al, 
1990). RNase mapping experiments with probes containing each of the domains of mouse 
CD1 D with a section of adjacent intron, showed that for mouse CD1 there was a significant 
degree of unspliced message (20 -50% of total) for the al , a2 and a3 regions in the thymus, 
a small degree (1 -5 %) in the spleen, and normal splicing in the liver (Bradbury, PhD Thesis, 
1987). CD1 message was detected by RT -PCR in both mouse and rat IEC (intestinal epithelial 
cells) at an equivalent low intensity (lchimiya et al, 1994), in contrast to previous results using 
mAbs which revealed prominent staining in murine intestinal epithelium (Bleicher et al, 1990). 
However, the RT -PCR results are supported by in situ hybridisation analysis of murine 
intestinal epithelium which demonstrated that only Paneth cells at the bottom of crypts of 
Lieberkuhn express CD1 message and no signal was detected in other IEC (Lacosse and 
Martin, 1992). 
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CD1 gene transcription in the rat was analysed by Northern blot analysis using a TM /CYT /3'UT 
probe (lchimiya et al, 1994). CD1 mRNA transcription was detected in nonlymphoid organs 
(liver, heart, kidney and lungs) as well as in the lymphoid organs of the spleen and, to a lesser 
extent, the thymus. Brain and IEC tissue were negative in this analysis. CD1 transcription was, 
however, detected in the rat intestine, and also in two thymic epithelium cell lines, using the 
more sensitive RT -PCR technique. The level of CD1 transcription in the IEC was comparable 
to that observed in the murine intestine. The level of CD1 transcription was much higher in the 
rat thymus than in the murine thymus- rat CD1 was readily detectable by Northern blot 
compared to CD1 in the murine thymus which was only detectable by S1 nuclease mapping 
(Bradbury et al, 1990). Northern blot analysis with the TM /CYT /3'UT probe gave no indication 
of splicing complexity for rat CD1 RNA in contrast to the variation in splicing of the human CD1 
genes in this region. 
1.6 The CD1 Molecules. 
The first human differentiation antigen to be defined by a monoclonal antibody (mAb) was the 
CD1 a molecule, then called HTA -1 (human thymocyte antigen 1)which was recognised by the 
mAbs NA1 /34 (McMichael et al, 1979) and T6 (Reinherz et al, 1980). Serological and 
biochemical studies on the antigens recognised by these and several other mAbs allowed the 
CD1 mAbs to be clustered into three distinct groups (reviewed by Calabi et al, 1991). The 
mAbs recognise three different CD1 molecules, CD1 a, b and c, characterised by their 
molecular weights, epitopic sites and tissue distributions. In the past few years, a fourth CD1 
molecule, CD1d, has been characterised in humans and mice using specific mAbs ( Bissland 
and Milstein, 1991: Bleicher et al, 1990; Balk et al, 1994). The CD1 molecules have now been 
described in a variety of species including humans, mice, rats, sheep, cattle and pigs. 
1.6.1 Serological And Biochemical Characterisation Of The CD1 Molecules. 
Human CD1a, b and c molecules have been characterised using a panel of mAbs and various 
serological and biochemical techniques, including SDS -PAGE, sequential 
immunoprecipitations, 2D gels and analysis of IEF patterns (Terhorst et al, 1980; van 
Agthoven and Terhorst, 1982; van de Rijn et al, 1983; Lerch et al, 1983; Cotner et al, 1982; 
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Amiot et al, 1986; Knowles and Bodmer, 1982; Small et al, 1987; Calabi et al, 1991). The CD1 
molecules consist of a glycosylated a chain of variable molecular weight in noncovalent 
association with ß2m. The CD1a, b and c a chains have molecular weights of 49kD, 45kD and 
43kD respectively. The more recently characterised human CD1d molecule is also a ß2m 
associated protein and has an a chain of 49kD molecular weight (Bilsland and Milstein, 1991; 
Blumberg et al, 1991). CD1 a and d a chains each have 4 potential N- linked glycosylation 
sites, while CD1b and c each have 3 potential N- linked glycosylation sites. The differences in 
the molecular weights of the a chains are due to variation in the extent of glycosylation. The 
panel of human anti -CD1 Abs have been used to define 7 epitopes on the three CD1 
molecules CD1a, b and c- 4 epitopes are restricted to CD1a, 2 epitopes to CD1b and 1 
epitope to CD1c (Amiot et al, 1987). Recent investigation into human CD1d expression in the 
intestinal epithelium have demonstrated the expression of a non -132m associated 37kD 
protein with no N- linked carbohydrate modifications (Balk et al, 1994). The significance of this 
CD1 isoform in the intestinal epithelium is unclear. A protein product of the human CD1 E 
gene has not yet been defined, although genomic sequence analysis suggests that this 
gene is functional (Calabi et al, 1989). 
A cluster of mAbs have similarly been used to define and characterise the murine CD1d 
molecules (Bleicher et al, 1990; Mosser et al, 1991). A rabbit antiserum raised against the 
murine CD1.2 fusion protein recognised a set of four glycoproteins (49 -55kD) which contain a 
common core protein corresponding to the size predicted by sequence analysis (36kD, 
Bradbury et al, 1988) (Mosser et al, 1991). The multiple molecular weight sizes of the a chain 
appear to reflect varying degrees of glycosylation which may be tissue specific. The murine 
CD1.1 cDNA was transfected into mouse fibroblasts and used to raise the mAbs 3C11 and 
1H1 (Bleicher et al, 1990). Both mAbs immunoprecipitated a 48kD a chain in association with 
ß2m. The molecular wei ght of the a chain is compatible with the accommodation of 5 potential 
N- linked glycosylation sites, as predicted by sequence analysis. The existence of a (32m- 
associated CD1 molecule in the rat has recently been demonstrated using a rabbit anti -rat Ab 
raised against recombinant rat CD1 protein (Ichimiya et al, 1994). The predicted size of the 
polypeptide backbone is similar in both rat and mouse, although the extent of glycosylation at 
the 5 N- linked glycosylation sites may differ, since the rat a chain has a molecular weight of 
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45kD compared to 48kD in the mouse. 
CD1 molecules have also been defined by mAbs in the rabbit (Wang et al, 1987), in cattle 
(MacHugh et al, 1988; Howard et al, 1993a and b), in the pig (Pescovitz et al, 1984; Pescovitz 
et al, 1990) and in the sheep (MacKay et al, 1985; Dutia and Hopkins, 1991; Bujdoso et al, 
1989). Recent investigations of ovine CD1 expression using anti -sheep and anti -cattle mAbs 
have demonstrated that all the mAbs recognise a 46kD a chain in association with (32m (S. 
Rhind, personal communication). 
1.6.2 Cellular And Tissue Distribution Of The CD1 Molecules. 
The patterns of expression of CD1 molecules have been investigated by immunohistology 
and FACS analysis in humans, mice, cattle, pigs and sheep. Expression of the various CD1 
isoforms appears to be differentially regulated in different tissues. In all species, CD1 a, b and c 
expression is predominantly detected on thymocks and antigen presenting cells including 
dendritic cells, Langerhans cells, B cells and monocytes, whereas CD1d expression appears 
to be mainly localised to intestinal cells. 
In humans, CD1 molecules are expressed by virtually all cortical thymocytes, but not by 
medullary thymocytes nor by peripheral T cells (Amiot et al, 1986; Calabi et al, 1991). The 
CD1 a, b and c molecules are coordinately expressed on the same cells with CD1 a levels the 
highest and CD1c levels the lowest ( Calabi and Bradbury, 1991). Expression of CD1a, b and c 
molecules has also been detected on the thymic lymphoma cell line MOLT4 (Cotner et al, 
1981; Kahn -Perles et al, 1985). The significance of CD1 expression in the thymus has been 
investigated by studying CD1 expression in relation to other cell surface markers such as 
CD4, CD8 and CD3 (Lanier et al, 1986; Blue et al, 1987; Blue et al, 1989; Gambon et al, 
1988). The results indicate that thymocyte maturation is accompanied by a loss of CD1 
expression and the simultaneous development of cells into single positive lineages 
expressing a functional TCRiCD3 complex. Thymic CD1 expression is also inversely 
correlated to MHC class I expression and it has been suggested that CD1 plays an active role 
in the developmental processes in the thymus ( Calabi et al, 1991). 
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In addition to cortical thymocytes, human CD1 expression has also been detected on 
dendritic cells (DC's; Cattoretti et al, 1989) and B cells (Small et al, 1987). Dermal DC's are 
CD1a +b -c +, Langerhans cells (LC's) are CD1a +b-c-and B cells express only CD1c. CD1 +DC's 
can be detected in the T cell rich paracortical regions of lymph nodes, and CD1+ B cells have 
been observed in the marginal zone (MZ) surrounding germinal centres of both lymph nodes 
and spleen. 
Several reports in recent years have demonstrated expression of a fourth CD1 molecule, 
CD1d, on the majority of intestinal epithelial cells and low level expression on the thymic 
lymphoma cell line MOLT4 (Bilsland and Milstein, 1991; Balk et al, 1991; Blumberg et al, 1991; 
Balk et al, 1994). CD1d expressed in the gut may be an important ligand for CD8 +T cells 
(Panja et al, 1993). 
The murine CD1d molecules exhibit a similar pattern of expression to that observed in the 
human situation. Bleicher and colleagues (1990) detected prominent expression of CD1 on 
murine intestinal epithelial cells and in the cytoplasm of hepatocytes using a rat mAb raised 
against a murine CD1.1 fibroblast transfectant. This mAb also detected low levels of CD1 
expression on thymocytes and peripheral lymph node cells. A rabbit antiserum raised against 
a recombinant CD1.2 fusion protein detected CD1 expression by Western blot analysis in 
murine thymus, liver and spleen but not in intestine (Mosser et al, 1991). The discrepancies in 
detection of intestinal CD1 expression have been resolved by in situ hybridisation analysis 
which demonstrated that only Paneth cells at the bottom of crypts of Lieberkuhn expressed 
CD1 mRNA at high levels and that no signal was detected in other IEC (Lacasse and Martin, 
1992). 
The pattern of expression of bovine and porcine CD1 resembles the pattern detected in the 
ovine system, as described below for the ovine group I mAbs (MacHugh et al, 1988; Howard 
et al, 1993a; Howard et al, 1993b; Pescovitz et al 1990; Dutia and Hopkins, 1991). Current 
studies in sheep using a panel of mAbs raised against sheep and cattle thymocytes, dendritic 
cells and intestinal epithelial cells have provided further data on the extent of ovine CD1 
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tissue distribution (S. Rhind, personal communication). The mAbs studied cluster into 2 main 
groups which have differential staining patterns. The mAbs in group I are HCD1 b -like and 
detect CD1 expression on cortical thymocytes, afferent lymph DC's, and DC's in the dermis, 
lymph node and spleen. The second group of mAbs, exemplified by SBU -T6 (Mackay et al, 
1985), have a much wider tissue distribution. In addition to recognising the same cell types as 
the group one mAbs, CD1 expression is also detected on LC's in the epidermis, on the 
majority of B cells in the blood, afferent and efferent lymph, on blood monocytes and on cells 
of dendritic morphology in the lamina propria, liver and lungs. 
1.6.3 Molecular Associations Of The CD1 Molecules. 
The CD1 a chains associate noncovalently with 132m. In the case of human CD1a and CD1b 
molecules, but not CD1c, this association is "loose" since free CD1a and b a chains have 
been detected at the cell surface (Ziegler and Milstein, 1979; Amiot et al, 1986). Furthermore, 
extracellular ß2m can exchange with ß2m bound to CD1a a chains but not to CD1c a chains - 
the CD1a molecules detected on MOLT4 cells grown in tissue culture in the presence of 
foetal calf serum are preferentially associated with bovine ß2m (Kefford et al, 1984; Bernabeau 
et al, 1984). It has been suggested that "loose" ß2m association is functionally important and 
may facilitate intermolecular interactions (Calabi et al, 1991). 
It is not known whether association of the classical CD1 a chains with rem is an essential 
requirement for transport to the cell surface, as is the case for MHC class I molecules (Zijlstra et 
al, 1990). However, recent experiments have indicated that this is not the case for the human 
CD1d molecule expressed in the intestinal epithelium (Balk et al, 1994). Immunoprecipitations 
with CD1d- specific mAbs were negative for ß2m, suggesting either cell surface expression in 
the absence of ß2m, or a loose, easily perturbed, association with f32m. Transfection of Cold 
cDNA into a human (32m- negative cell line confirmed that Cold can be expressed at the cell 
surface in the absence of f32m. 
All three classical human CD1 molecules are additionally found at the cell surface in 
association with molecules other than ß2m. In particular, covalently associated CD1 a/CD8 
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complexes have been detected on the surface of cortical, but not medullary, thymocytes 
(Snow et al, 1985; Ledbetter et al, 1985). These disulphide- bonded multimers exist as 
complexes of 120kD and above, with a minimum stoichiometry of CD1a1:CD82. The bond(s) 
occur in the membrane spanning or cytoplasmic domains of both molecules and ß2m is absent 
from the complexes. The CD1 a a chain has also been observed in noncovalent association 
with CD1b, CD1c and MHC class I a chains at the cell surface of thymocytes but not leukemic 
cells (Calabi et al, 1991). 
1.6.4 Influence Of Cytokines On Expression Of CD1 Molecules. 
A series of studies have documented the differential effects of various cytokines on CD1 
expression in different cell types (Forcelli et al, 1993; Kasinrerk et al, 1993; Kolenik et al, 
1990; Ishii et al, 1990). CD1 expression is inducible by IFN --y on the human thymoma cell line 
MOLT4 (Kahn -Perles et al, 1985). Human peripheral blood monocytes, which do not normally 
express significant levels of CD1a, b or c molecules, were cultured for 60 hours in medium 
containing 1000/mí of GM -CSF and IL -4 (Porcelli et al, 1993). High levels of expression of the 
three classical CD1 molecules were detected. Monocytes cultured in the absence of 
cytokines or with IFN -y did not express detectable levels of these molecules. A second study 
of human monocytes found that the expression of CD1a, b, and c molecules was induced by 
treatment with100ng /ml of rGM -CSF alone (Kasinrerk et a1,1993). CD1 expression appeared 
on day 1 of culture and was upregulated until day 3. Recombinant IFN -y, TNFa, IL -1a, IL -1ß 
and IL -6 had no effect on CD1 expression. CD1 mRNA was detected by Northern blot analysis 
in monocytes cultured with rGM -CSF but not in freshly isolated cells. Down regulation of CD1a 
and CD1c occurreá by day 6 of culture but CD1b expression remained stable. The cytokine 
GM -CSF, known to be produced by keratinocytes, had a totally different effect on human 
Langerhans cells ( Kolenik et al 1990). Culture of LC's with 10ng /ml GM -CSF for 5 days caused 
a decrease in CD1 expression and an increase in the ability of the cells to stimulate 
proliferation of allogeneic T cells. The decrease in CD1 expression detected on LC's treated 
with TNF -a and IL -1 resembled the phenotypic changes observed when LC cells are placed 
in culture by themselves. In contrast, the cytokines IL -6 and TNF -a, also known to be 
produced by keratinocytes, induced an upregulation in CD1a expression on gingival LC's 
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when cultured with cells at 5ng /ml (Ishii et al, 1990). GM -CSF had no effect in this system. 
The specific induction of CD1 expression by cytokines on potential antigen presenting cells 
supports the hypothesis that CD1 molecules are involved in the interactions between 
accessory cells and T cells. 
1.6.5 Relationship Between TL and CD1. 
The CD1 molecules were originally considered to be the human equivalent of the mouse TL 
antigens, on the basis of the pattern of expression and preliminary biochemical evidence 
(Terhorst et al, 1980; van Agthoven and Terhorst, 1982). However, differences in the peptide 
backbone sizes of the CD1 molecules compared to the TL molecules gave the first indication 
that these molecules may not be homologous (van de Rijn et al, 1983). Isolation and 
sequencing of CD1 genes in the mouse revealed that the CD1 genes are no more closely 
related to the TL genes than to other class I genes, and RNA transcripts for both TL and CD1 
antigens coexist in the mouse thymus (Bradbury et al, 1988). Furthermore, the very limited 
polymorphism in the mouse does not segregate with MHC haplotype, indicating that the CD1 
genes, in contrast to the TL genes, are not encoded in the murine MHC gene complex on 
chromosome 17. The subsequent mapping of the human CD1 genes to chromosome 1 and 
the murine genes to chromosome 3 confirmed that the CD1 genes are not MHC encoded and 
therefore are not homologous to the murine TL genes (Albertson et al, 1988; Bradbury et al, 
1991). 
1.7. Function(s) Of Class lb Molecules. 
The CD1 molecules are similar in various respects to the nonclassical class I molecules H2Q, T 
and M in the mouse and HLA -E, F and G in humans. These molecules are collectively referred 
to as the class lb proteins, and are characterised by limited polymorphism and restricted tissue 
distribution in comparison to the classical class I molecules (Stroynowski and Fischer Lindahl, 
1994). 
Although the structure and expression of the CD1 molecules has been extensively studied in 
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various species, their function(s) remain ill- defined. That these molecules do have a function 
is suggested by their structural relatedness to MHC class I molecules and their preferential 
expression on cells involved in antigen presentation to T cells i.e. Langerhans cells, dendritic 
cells and B cells. Furthermore, the expression of CD1 in the thymus is tightly regulated during 
thymocyte differentiation, suggesting a role in thymic developmental processes. CD1 is 
expressed exclusively on cortical thymocytes at a time when these cells are subject to the 
selection processes which control MHC restriction and tolerance development. It is striking 
that CD1 expression is inversely correlated to class I expression on thymocytes (Blue et al, 
1989). CD1 has also been shown to be covalently associated with CD8 on thymocytes and 
there is some evidence that CD1 molecules are linked to a cellular activation pathway 
(Theodorou et al, 1990). Several investigators have additionally proposed a role for CD1 
molecules in antigen presentation to T cells, and in particular to yS T cells, as outlined below 
(Strominger, 1989; Calabi et al, 1991; Janeway et al, 1988). However, it has alternatively been 
suggested that the class lb molecules, including CD1, are nonfunctional in comparison to the 
classical class I molecules, and that their genes represent "rotting hulks in an evolutionary 
junkyard" (Klein et al, 1991; Lawlor et al, 1990). The reasons cited in support of this view 
include the fact that nonclassical class I genes in the mouse can be deleted without 
deleterious effect, the lack of polymorphism which is essential for classical class I function, and 
the inability to demonstrate an antigen presentation function for these molecules. This view 
has been challenged in recent years by growing evidence that class lb molecules can present 
peptides to both aß and y6 T cells, as outlined in the following sections. 
1.7.1 Class lb Molecules As Ligands For T Cell Receptors. 
A role for class lb molecules in antigen presentation to y6 T cells was originally proposed on 
the basis that the limited germline diversity of y6 TCR's suggested recognition of relatively 
nonpolymorphic ligands (Janeway et al, 1988; Strominger, 1989). However, this view has 
been modified since it is now known that the y6 TCR repertoire is actually larger than the aß 
TCR repertoire due to the great potential for junctional diversity (see section 1.3.2), although 
the murine -y6 TCR repertoire ¡s, in fact, highly restricted at particular epithelial sites (Allison 
and Havran, 1991). In recent years there has been increasing evidence to suggest that CD4- 
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CD8- (DN) T cells, irrrespective of whether they express aß or y6 TCR's, predominantly 
recognise nonclassical presentational elements including the class lb molecules Qa,TL, Blast - 
1 (TCT.1 or CD48), as well as CD1 molecules themselves. Several studies have reported the 
involvement of the murine nonclassical class I molecules Qa, TL and HMT in eliciting T cell 
responses. Three TL- specific murine T cell clones have been characterised in detail. The 
target ligand for the DN 76+ clone G8 has been mapped to the TL region of the MHC using a 
panel of APC's derived from various inbred mouse strains (Bluestone et al, 1988; Houlden et 
al, 1989; Matis and Bluestone, 1991). The pattern of reactivity was observed to correlate with 
a novel polymorphism in the TL locus. The TL- specificity of the DN y6+ clone KN6 has been 
similarly characterised (Bonneville et al, 1989; Matis and Bluestone, 1991; van Kaer et al, 
1991) and the gene encoding the specific TLmolecule (127b, now called T22b) has been 
cloned (Ito et al, 1990). Milligan and colleagues demonstrated that a short peptide from the 
influenza virus haemagglutinin protein is recognised by CD8+ aß+ cytotoxic T cells in 
association with a TL- encoded molecule (Milligan et al, 1991). In addition, the TL molecule 
encoded by the T3b gene in mice has recently been shown to mediate a transplantation 
response and elicit CD8+ aß+ cytotoxic T cells (Morita et al, 1994). The DN y6+ helper T cell 
clone DGT3, generated by fusion of poly -GT primed lymph node cells with a thymoma cell line, 
recognises the synthetic copolymer Glu50Tyr50 in a Qa -1 dependent manner, and the 
response is abolished by addition of anti -Qa -1 antibodies (Vidovic et al, 1989). The murine 
HMT molecules are probably the best defined nonclassical presentational elements (see 
section 1.3.2) and it has been demonstrated that they can present bacterial peptides to CTL 
during Listeria monocytogenes infection (Pamer et al, 1992; Kurlander et a1,1992). 
The CD1 molecules themselves have also been implicated in antigen presentation to T cells. 
The specific recognition of CD1a by the human DN aß +T cell clone BK6 and of CD1c by the 
human DN yS +T cell clone IDP2 has been demonstrated using CD1 transfected cell lines and 
blocking antibodies (Porcelli et al, 1989). The J2B7 human DN yS +T cell clone, isolated from 
the blood of a healthy donor, was found to lyse target cells in a CD1c- dependent manner 
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(Faure et al, 1992). A human CD8 +aj3 +intestinal epithelial cell line was found to exhibit CD1 
specific cytotoxicity and a dominant clone was CD1c specific (Balk et al, 1991 b). Similarly, a 
report by Panja and colleagues has provided evidence that human CD1d is functionally 
important in CD8 +T cell activation by intestinal epithelial. cells (Panja et al, 1993). More 
recently, Porcelli and coworkers have reported that the proliferative and cytotoxic responses 
of a DN aß +T cell line specific for Mycobacterium tuberculosis are restricted by the CD1b 
molecule (Porcelli et al, 1992). Finally, a DN y6+ cytotoxic T cell recognising the TCT.1 (Blast - 
1/CD48) molecule, encoded by a gene in the CD1 region of chromosome 1 in humans, has 
been described (Mami- Chouaib et al, 1990; Mami- Chouaib et al, 1991; Del Porto et al, 1991). 
The studies described above clearly demonstrate that class lb molecules can be recognised 
by T cells. However, the majority of the responses actually occur in the absence of any 
apparent exogenous antigen, and even though most responses are classified as 
"alloreactive ", the clones may be considered to possess autoreactivity due to the 
nonpolymorphic nature of the class lb molecules (Porcelli et al, 1991). The requirement for 
antigen has only been directly demonstrated in four cases- recognition of a synthetic 
copolymer in the context of Qa -1 (Vidovic et al, 1989), presentation of the influenza peptide 
by a TL- encoded molecule (Milligan et al, 1991), CD1- dependent T cell responses to 
mycobacterial peptides (Porcelli et al, 1992), and presentation of bacterial peptides by HMT 
molecules during Listeria monocytogenes infection (Pamer et al, 1992; Kurlander et al, 
1992). However, additional evidence has accumulated in recent years to support the idea that 
class lb molecules can, in fact, present peptides, as outlined in the following section. 
1.7.2 Peptide Presentation By Class lb Molecules. 
Several lines of evidence support the hypothesis that class lb molecules are able to present 
peptides (Stroynowski and Fischer Lindahl, 1994). Three types of class lb molecules have so 
far been found to depend on the TAP pathway for peptide loading- Qa -1, H2M3 and Qa -2 
(Stroynowski and Fischer Lindahl, 1994; Shawar et al, 1994; Aldrich et al, 1992). However, 
TAP -independent pathways of peptide loading also exist as demonstrated by the fact that 
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KN6 cells interact with the T22b molecule on cells deficient in the TAP transporters (Moriwaki 
et al, 1993). Interaction of class lb molecules with peptides is further suggested by the ability 
of a tryptic digest of Mycobacterium bovis HSP65 to stabilise cell surface expression of Qa -1 
molecules Omani and Soloski, 1991). Furthermore, mutations in the floor of the putative 
peptide -binding groove of the T22b molecule affect recognition by the y6 +T cell clone KN6, 
implicating peptides in this interaction (Moriwaki et al, 1993). Direct interaction of the class lb 
molecule Qa- 2 with peptides has recently been demonstrated by analysis of peptides eluted 
from these molecules. Pool sequencing has indicated that Qa -2 molecules have a more 
stringent specificity for peptide binding than other class I molecules and that "only a few 
different peptides are presented" (Rotzschke et al, 1993). However, a more refined analysis 
of individual eluted peptide sequences revealed that Qa -2 molecules can bind a diverse array 
of structurally similar peptides in a quantitatively similar manner to the classical class I 
molecules (Joyce et al, 1994). 
1.8 Thesis Objectives. 
The ovine CD1 family has previously been investigated only at the protein level using a limited 
panel of anti- bovine and anti -ovine CD1 mAbs (Hopkins et al, 1989; Bujdoso et al, 1989; Dutia 
and Hopkins, 1991). The information gained from these studies has not been extensive and 
all mAbs were found to detect a 46 kD a chain in association with (32- microglobulin. In order to 
gain a better understanding of these molecules it was necessary to characterise the ovine 
CD1 family at the molecular level and correlate the results with biochemical and serological 
analyses. The primary objective of this study was therefore to characterise the CD1 gene 
family using well- defined molecular biology techniques, including isolation of CD1 cDNA 
clones by library screening, and determination of the number of CD1 genes by Southern blot 
analysis. The ovine CD1 gene probes produced could then be utilised to investigate CD1 
expression at the mRNA level in various cells and tissues by Northern blot analysis and in situ 
hybridisation. The availability of gene specific probes would enable the differential expression 
of different CD1 subtypes in different tissues to be investigated. Characterisation of the CD1 
genes and production of a panel of CD1 transfectants would permit correlations to be drawn 
with the serological data. Overall, definition of the ovine CD1 genes would complement the 
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existing information from mAb studies and would prove useful in the design of future 
experiments into CD1 function. The sheep is a particularly suitable experimental animal for this 
purpose in that CD1 molecules have been implicated in antigen presentation to y T cells, 
which are a prominent cell type in this species (Mackay and Hein, 1991). 
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2. Materials and Methods. 
2.1 Materials. 
The chemicals used during research for this thesis were supplied by Sigma Chemical Co., 
Poole, Dorset, England, or Fisons Scientific Equipment, Loughborough, England, unless 
stated otherwise. Radiolabelled compounds were supplied by Amersham International PLC, 
Amersham, England. Restriction endonuclease enzymes and other DNA modifying 
enzymes, were purchased from Northumbria Biologicals Ltd. (NBL), Cramlington, U.K., New 
England Biolabs. (NEB), Hitchin, England, or Boehringer Mannheim, BCL, Lewes, U.K., 
unless stated otherwise. Recipes for solutions used during this project are given in 
Appendix 1. 
2.2 Bacterial Cultures. 
2.2.1 Bacterial Growth Media and Plates. 
The basic bacterial growth medium was Luria Bertani (LB) broth. This medium was 
supplemented with the antibiotic ampicillin for selection of transformed cells, since all plasmid 
vectors used during this project contained the gene which conferred ampicillin resistance. 
For blue /white selection (Sambrook et a1,1989) of bacteria transformed with pTZ or 
pBluescript plasmids, LB /agar plates were made with LB /1.5% (w /v) bacteriological agar 
(Oxoid, Basingstoke,England), supplemented with 1004/ml ampicillin, and 0.75 %(w /v) top 
agar supplemented with 1004/ml ampicillin, 170µg /ml isopropylthio -j3 -D- galactoside (IPTG- 
Melford Laboratories Ltd., Ipswich, England), and 2004/m1 5 bromo 4 chloro 3 indolyl (3 D 
galactoside (Xgal -Melford Laboratories Ltd.).The plasmid pCRThll from the TA Cloning kit 
(Invitrogen Corporation, San Diego, California) was transformed into INVaF' competent 
E.coli. In this system, transformed cells were selected on plates containing ampicillin and X- 
gal only. 
2.2.2 Bacterial Strains, Stocks and Culture. 
E.coli strain JM101 (F' traD36 laclq A[lacz]M15 proAB /supE thi A[lac- proAB]) (Yannish- 
Perron et al, 1985)was used for bacterial transformations involving pTZ or pBluescript 
41 
plasmids. The E.coli strain Y1090 (F A[lac]U169 Ion -100 araD139 rpsL[Strr] supF mcrA 
trpC22::Tr10 [pMC9;TetrAmpr] (Huynh et al, 1985) was used as the host for plating out X.gt 11 
cDNA libraries. Single colonies of untransformed E.coli were grown by streaking out cells 
from frozen stocks onto agar plates made with M9 minimal medium for JM101 cells, and 
LB /Amp for Y1090 cells. Transformed JM101 cells were grown on LB /Amp plates. Bacterial 
stocks were frozen in 20 %(v /v) glycerol and stored at -70 °C. 
2.2.3 Preparation of Competent Bacteria. 
Competent E.coli cells, ready for transformation with recombinant plasmid, were prepared by 
two slightly different modifications of the method of Hanahan (1983), as follows. 
Method 1 
0.2ml of a saturated overnight culture of E.coligrown in LB medium, was diluted into 20m1 of 
Psi broth and grown with shaking at 37 °C until the optical density at 550 nm (OD550) was 0.3. 
5ml of this culture was made up to 100m1 in Psi broth and grown until the OD550 was 0.48. 
Cells were briefly cooled on ice and pelleted by centrifugation at 2,000xg, 4 °C for 5 minutes. 
The cell pellet was resuspended in 33ml ice cold transformation buffer I (TfBI) and placed on 
ice for 15 minutes. The cells were pelleted as before, resuspended in 4ml transformation 
buffer 11 (TfBll), and placed on ice for 20 minutes. Aliquots (0.2m1) were then transferred to 
eppendorf tubes, snap frozen in liquid nitrogen and stored at -70 °C until required. 
Method 2 
1ml of a saturated overnight culture of E.coligrown in LB medium was diluted into 100m1 of 
fresh LB medium, and grown at 37 °C with shaking until the OD550 was - 0.5. Cells were 
pelleted from 10m1 of this culture by centrifugation at 1 ,300xg, 4 °C, for 5 minutes, 
resuspended in 800m1 transforming buffer (TFB) solution and placed on ice for 5 minutes. 
Cells were maintained on ice while all further solutions were added- dimethylsulphoxide 
(DMSO) to 3.5% for 5 minutes, dithiothreitol (DU) to 75mM for 5 minutes, and a final addition 
42 
of DMSO to 7.0 %. The competent cells were kept on ice and used as soon as possible, 
100µI per transformation reaction. 
2.2.4 Transformation Procedure. 
Competent bacteria were thawed, or maintained, on ice, and incubated with the ligated DNA 
(10µI) on ice for 30 -60 minutes. Cells were heat shocked for 90 seconds at 42 °C. LB medium 
(80041) was then added and the cells incubated at 37 °C for - 60 minutes, to allow 
expression of the ampicillin resistance gene. Cells were then gently pelleted (10 second spin 
in microfuge, 11,000xg), resuspended in 100µI of LB medium, and plated out onto plates 
containing appropriate antibiotic and chemicals for blue /white colour selection. Plates were 
incubated at 37 °C for 16 hours, and single white colonies picked for plasmid preparations. 
2.3 Preparation of Plasmid Vectors and Inserts for Cloning. 
2.3.1 Preparation of Plasmid Vector for Cloning. 
2 -5µg of pBluescript plasmid vector (Stratagene, La Jolla, California) was digested with 5 -20 
Units of enzyme(s) in a total volume of 20µI, using the manufacturer's buffer. Single enzyme 
digest controls were included where double enzyme digests were carried out. Following 
digestion, the 5' end of the linearised plasmid was dephosphorylated to help prevent 
religation by addition of 1 -2 Units of calf intestinal phosphatase (CIP) (Boehringer Mannheim), 
and the manufacturer's buffer. Reactions were incubated at 37 °C for 30 minutes followed by 
addition of 1 Unit of CIP for further 5 minutes at 37 °C. Inactivation of CIP was achieved by 
addition of 1/20 volume of 0.5M EDTA pH8.0, and heating to 65 °C for 10 minutes. CIP 
inactivation was completed by extraction with phenol /chloroform and chloroform. Following 
ethanol precipitation, the DNA pellet was resuspended in 10µl SDW or TE and analysed by 
gel electrophoresis. 
2.3.2 Preparation of DNA Fragments for Blunt Ended Cloning. 
DNA fragments for blunt ended cloning were prepared using the Klenow fragment of E.coli 
DNA polymerase I (Stratagene, La Jolla, California) to " fill in " recessed 3' ends, and T4 
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polynucleotide kinase (NEB) to phosphorylate the 5' ends. The DNA fragments were 
incubated at 37 °C for 30 minutes with ATP and 10 Units of kinase in the manufacturer's 
buffer in a total volume of 501.1.I. Approximately 10 -20 Units of Klenow were then added along 
with 1004M of each dNTP and a further 1µl of 10xbuffer (total volume 60µI), and the 
incubation continued for a further 30 minutes. Phenol /chloroform and chloroform extractions 
were performed, followed by ethanol precipitation, and the DNA fragments resuspended in 
10 -20µI SDW in preparation for cloning. 
2.4 Ligation of DNA Fragments. 
Ligations were generally carried out using 70 -100ng of vector DNA with the insert DNA 
present at threefold molar excess. Ligations were performed in 1041 volumes containing 5 
Units of T4 DNA ligase (NBL, Cramlington, U.K.) and the manufacturer's buffer, and 
incubated at 4 °C for 16 hours. Appropriate controls were included to assess ligase, CIP and 
transformation efficiency. 
2.5 Restriction Endonuclease Digestion of DNA Samples. 
Restriction endonuclease digests of DNA, for example X bacteriophage DNA or pBluescript 
plasmid DNA, were carried out in a total volume of 20µI using the manufacturer's buffer. 
Typically, 5µI of DNA from X minipreps., or 3µI DNA from plasmid minipreps., were digested 
with 5 -20 Units of enzyme(s) for 1 -2 hours at 37 °C. Digested samples, along with uncut or 
singly cut controls, were analysed by gel electrophoresis. 
2.6 Purification and Quantitation of DNA. 
DNA samples were routinely extracted with equal volumes of phenol /chloroform 
and 
chloroform, and precipitated in a dry ice /ethanol bath with 1 /10th volume 0.3M sodium 
acetate and 2 volumes of 100% ethanol. Precipitated DNA was pelleted at 11,000xg 
for 10 
minutes at 4 °C, washed with 70% ethanol, briefly air- dried, and resuspended 
in TE or SDW 
prior to further manipulation. Alternatively, ammonium acetate, pH7.5 (final concentration 
2- 
2.5M), was used in the precipitation step when it was necessary to purify 
the DNA from high 
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concentrations of excess nucleotides in the sample. 
Following plasmid DNA isolation and restriction endonuclease digestion to obtain insert 
fragments or linearised vector, DNA was analysed on a 0.8 -1.5% (w /v) agarose gel containing 
1µg /ml ethidium bromide. TAE buffer was used when it was necessary to subsequently purify 
DNA from the gel, since TBE buffers inhibit efficient DNA recovery from gels using the 
Geneclean II system (Stratech Sci.).TBE buffer was used on all other occassions. Before 
loading, samples were mixed with 1/6 volume of x6 DNA sample buffer. Gels were run at 85- 
100V for 60 -90 minutes, at constant voltage. EcoRl /Hindlll digested lambda DNA molecular 
weight markers (NBL, Cramlington, U.K.) were included on every gel. 
Two methods for isolating DNA fragments from agarose gels were employed. Fragments 
greater than 0.5kb in size were extracted using the Geneclean II kit (Stratech Sci.) according 
to manufacturer's instructions. Fragments less than 0.5kb in size are not recovered at optimal 
efficiency using this kit. Spinbind DNA extraction units (FMC Bioproducts, Rockland, Maine, 
USA) were used to extract DNA fragments less than 0.5kb, according to the manufacturer 
protocol. 
The concentration of DNA in a purified sample was generally estimated by running a 10% 
aliquot on a 0.8 -1.5% (w /v) agarose gel, and examining the intensity of fluorescence under 
UV illumination. The concentration of DNA in larger preparations was measured 
spectrophotometrically'by determining the absorbance at a wavelength of 260 nm 
(OD260) An OD260 of 1.0 is equivalent to 5014/ml double stranded DNA, or 404g /ml single 
stranded DNA or RNA. The OD 260/280 ratio gave an estimate of the purity of the sample, 
where a ratio of 1.8 indicated a sample free from protein or phenol contamination (Sambrook 
et al, 1989). 
2.7 Preparation of 32P-labelled Probe. 
DNA fragments to be used as probes were gel purified and the DNA extracted from gel slices 
using Spinbind DNA extraction units (FMC Bioproducts) as previously described (section 
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2.6). The probes were labelled with a32P -dCTP (Amersham, specific activity 400Ci /mmol.) 
using the Pharmacia oligolabelling kit (Pharmacia LKB Biotech.) according to the 
manufacturer's protocol. This method, based on that of Feinberg and Vogelstein 
(1983,1984), routinely labelled 50ng quantities of DNA to 108- 109cpm /µg DNA, as 
determined by acid precipitation on glass fibre discs with 5% trichloroacetic acid (TCA) 
(Sambrook et al, 1989). Dried discs were placed in 2ml Optiphase Scintillant (Pharmacia LKB 
Biotech.), activity measured in an LKB Rackbeta Liquid Scintillation Counter, and the specific 
activity calculated. Only probes with a specific activity greater than 108cpm 4tg DNA were 
used in hybridisations. Spinbind DNA extraction units were used to purify the labelled probe 
from excess nucleotides and free label. Immediately prior to use, probe DNA was denatured 
by boiling for 10 minutes and quenching on ice. 
2.8 Preparation of M13 Replicative Form DNA. 
The human CD1 probes were provided as M13 DNA at 20ng /4l in TE buffer. Double stranded 
DNA for use as a probe in library screening was obtained by preparation of M13 'phage stock 
and large scale preparation of M13 replicative form DNA, as described below. 
2.8.1 Preparation of M13 ' Phage Stock. 
A titration of the M13 DNA was carried out as follows. Competent JM101 E. coli were 
prepared (2.2.3), and a series of dilutions of the M13 DNA made up in TE, such that 1µl 
volumes contained 2ng, 0.2ng and 0.02ng of the M13 DNA. The competent bacteria were 
transformed with 1µl, 2µI and 50 volumes of each M13 dilution (2.2.4), mixed with 0.9ml 
LB /20mM glucose and incubated for 30 minutes at 37 °C. Transfected cells were mixed with 
3m1 top agar, IPTG added to 170µg /ml, X -gal added to 200µg /ml and the cells plated out onto 
LB plates. The plates were incubated overnight at 37 °C. This procedure is estimated to 
produce -1000 plaques per ng of DNA transfected (Sambrook et al, 1989). 
One plaque was picked from a plate containing well separated plaques, deposited into 1m1 of 
SM buffer, and left at room temperature for 1 -2 hours to allow the ' phage to diffuse out of the 
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agar plug. 100µI of the ` phage suspension was mixed with 2m1 of plating bacteria (one JM101 
colony grown in 50m1 LB for 6 -8 hours, but not to saturation) and incubated at 37 °C for 5 -6 
hours with agitation. 1m1 of this culture was centrifuged in an eppendorf at 11,000xg for 5 
minutes at room temperature. The supernatant containing the ss form of the ' phage was 
retained as the M13 ' phage stock. 
2.8.2 Large Scale Preparation of M13 Replicative Form DNA. 
2.5ml of plating bacteria (JM101) were inoculated with 0.5ml of ' phage stock, mixed by 
tapping the tube, and incubated at room temperature for 5 minutes. This culture was diluted 
into 250m1 prewarmed LB in 2 litre flasks and incubated at 37 °C for 15 minutes with agitation. 
Chloramphenicol was added to a final concentration ofl514/ml and the culture incubated for 
a further 2 hours at 37 °C. Chloramphenicol inhibits bacterial replication and allows the 
replicative form of the 'phage to accumulate inside the cells (Sambrook et a1,1989). Cells 
were harvested by centrifugation at 4000xg for 15 minutes at 4 °C, the supernatant removed 
and the pellet resuspended in 100m1 ice -cold STE. The cells were harvested as before and 
the M13 circular replicative form DNA isolated by alkaline lysis (see 2.10.1 and Sambrook et 
a1,1989). 
2.9 Screening of cDNA Bacteriophage Libraries By Colony Hybridisation 
2.9.1 Library Plating and Nitrocellulose Lifts. 
Approximately 2.4x105 plaques were screened from each cDNA library, at -3x104 pfu per 
plate. The titre of each library had previously been determined by serial dilution of the library 
' phage stock and plating out in exactly the same manner as outlined here. An appropriate 
number of 'phage were added to a mixture of 3ml adsorption buffer (10mM CaC12 /10mM 
MgCl2) and 2ml of host Y1090 E.coli grown to saturation, usually overnight, in LB broth 
supplemented with 0.4% (v /v) maltose. This mixture was incubated for 10 -15 minutes at 
37 °C to allow the bacteriophage to adsorb to host cells. The adsorbed ' phage mix 
was added 
to an appropriate volume of LB /agar (0.75 %, w /v) supplemented with 
10mM magnesium 
sulphate and 0.6% glucose, and plated out onto LB /agar (1.5% w /v) plates 
containing) OmM 
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magnesium sulphate. Plates were incubated at 37 °C for 16 hours. 
After incubation, the ' phage plates were cooled at 4 °C for 30 minutes. Nitrocellulose filters 
(Immobilon -NC membrane, Millipore,UK) were numbered and labelled using pencil, and 
carefully placed, numbers down, onto the cooled plates. Filters were left in place for 5 
minutes, and alignment holes made using a sterile 18 -gauge needle. Meanwhile, four pads 
of Whatman 3MM paper were prepared, each three layers thick. Two pads were soaked with 
alkaline solution (0.2M NaOH) and two with neutralizing solution (0.5M Tris pH 7.5, 1.5M 
NaCI), and excess fluid was poured off. Filters were removed from the plates and sequentially 
placed, numbers up, on each alkaline and neutralizing pad for 2 minutes each. Filters were 
dried at 37 °C, then baked for 2 hours under vacuum at 80 °C to fix the DNA to the filters. 
2.9.2 Hybridisation of DNA Probes to Nitrocellulose Lifts 
Baked nitrocellulose filters were prehybridised for 4 -6 hours in a minimum volume of 
hybridisation solution, but ensuring that the filters could move independently of each other. 
After prehybridisation, the denatured radioactively labelled probe was added to the 
hybridisation solution. Heterologous hybridisation reactions were performed at 58 °C for 16 
hours and homologous hybridisations at 65 °C for 16 hours. 
Following overnight hybridisation, the filters were washed as follows. For both heterologous 
and homologous hybridisations, an initial rinse with 2xSSC/0.1%SDS was carried out for 2 -3 
minutes at room temperature. Filters used for heterologous hybridisations were then washed 
for 30 -60 minutes in 0.5% SSC /0.1 %SDS at 58 °C. Filters used for homologous 
hybidisations were successively washed for 30 -60 minutes in 0.5xSSCX /0.1 %SDS at 65 °C 
and 20 -60 minutes in 0.2xSSC /0.1 %SDS at 65 °C. In each case the radioactivity coming off in 
the wash solution and that remaining on the filters was monitored at regular intervals, and 
washing stopped when very little radioactivity appeared to be coming off the filters. Filters 
were air -dried and then exposed to Kodak X -OMAT R or S film, with a phosphotungstate 
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intensifying screen, at -70 °C for 1 -3 days. 
2.9.3 Secondary Screening of Bacteriophage Libraries. 
Positive plaques from primary screens were picked into 1 ml SM buffer and 3 drops of 
chloroform to form a 'phage stock. A 1/500 dilution of these ' phage stocks was used to infect 
host cells for secondary screening, and plated out essentially as described for primary 
screening. Plates which grew dense plaques or too few plaques at this dilution were not 
screened. Rather, alterations were made to the ' phage dilution to give an appropriate density 
of plaques for secondary screening. Nitrocellulose lifts were taken and hybridisations and 
washes carried out as previously described. Positive plaques were picked for preparation of 
A. DNA, as follows. 
2.9.4 Preparation of Bacteriophage Lambda (X) DNA 
Following identification of CD1 positive plaques in secondary screens of various Xgt11 cDNA 
libraries, small scale preparations of X DNA were carried out. Positive plaques were picked 
into a mixture of 0.3ml adsorption buffer (10mM CaCl2 /10mM MgCl2) and 0.2m1 of dense 
overnight culture of host Y1090 E.coli grown in LB /0.5% maltose. This mixture was 
incubated at 37 °C for 10 -15 minutes to allow phage adsorption to host cells. 10m1 of 
LB /10mM MgSO4 /0.6 %(v /v) glucose was added, and the cultures incubated with shaking at 
37 °C for 16 hours. The cells were then pelleted by centrifugation at 1,300xg for 5 minutes, 
The supernatant containing the X 'phage was then centrifuged at 150,000xg for 30 minutes 
at 4 °C, and the ' phage pellets resuspended in 10141I SM buffer. Proteinase K (Sigma), made 
up in SM buffer, was added to a final concentration of 0.5mg /ml and the mixtures incubated at 
37 °C for 2 hours. The samples were extracted with equal volumes of phenol /chloroform and 
chloroform, followed by ethanol precipitation. The DNA was pelleted (10 minutes, 11 ,000xg), 
washed in 70% ethanol, briefly dried,and resuspended in 500 TE. 511I of each sample was 
digested with the appropriate enzyme and examined by gel electrophoresis for the presence 
of excisable inserts. 
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2.10 DNA Sequencing. 
Both double stranded and single stranded DNA sequencing were carried out based on the 
dideoxy chain termination method of Sanger et al (1977). 
2.10.1 Small Scale Preparation of Plasmid DNA for Double Stranded Sequencing. 
Transformed E.coli were grown at 37 °C for 16 hours with shaking in 12 -25ml LB broth 
containing 10mM MgSO4 and 0.6% (w /v) glucose. Plasmid DNA was isolated by a 
modification of the methods of lsh- Horowicz and Burke (1981) and Birnboim and Doly (1979). 
Bacterial cells were pelleted (1,300xg, 4 °C, 10 minutes), resuspended in 2000s of GTE 
(solution I), and lysed by the addition of 4000 of freshly made alkaline /SDS solution (solution 
11). Addition of 3000 potassium acetate solution (solution Ill) precipitated chromosomal DNA. 
This was removed, along with protein /SDS complexes and high molecular weight RNA by 
pelleting in a microfuge (11,000xg, 5 minutes, room temperature). The remaining RNA was 
removed by incubation in 50µg /ml DNAase free RNAase A (Pharmacia) at 37 °C for 1 -2 hours. 
Phenol /chloroform and chloroform extractions were performed, and the DNA precipitated by 
addition of 500µI (0.6 volumes) isopropanol. The precipitated DNA was pelleted (11,000xg, 
room temperature, 10 minutes), washed with 70 % ethanol, dried briefly,and resuspended in 
500 TE. 30 of this sample was used for restriction endonuclease digestion and gel 
electrophoresis, and 50 ( -.3 -5µg DNA) for sequencing. The plasmid DNA isolated by this 
method is sufficiently pure for double stranded DNA sequencing to be carried out. Typical 
DNA yields from these preparations were in the range 3 -54 plasmid DNA per ml of original 
culture (Sambrook et al, 1989). 
2.10.2 Large Scale Preparation of Plasmid DNA for Double Stranded Sequencing. 
The method used for preparation of plasmid DNA from 100m1 cultures was essentially the 
same as described for 12ml preparations, but using proportionately larger solution volumes. 
For 500m1 cultures, plasmid DNA was prepared using pZ523 columns (5 Prime -3 Prime Inc., 
West Chester, USA), according to the manufacturers protocol. The plasmid DNA isolated by 
this method was sufficiently pure to allow double stranded sequencing to be carried out. The 
initial part of this protocol (bacterial cell lysis) was essentially a scaled up version of the alkaline 
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lysis method described above (section 2.10.1). RNA was then removed by incubation with 
RNAase at 50µg /m1 for 1 -2 hours at 37 °C. Phenol/chloroform and chloroform extractions 
were performed. The aqueous layer was removed, 360µI of 5M NaCI added, and the volume 
adjusted to precisely 1.8m1, using TE. The pZ523 column was spun at 1100xg for 1 minute in 
a swinging bucket rotor to remove the storage buffer. The 1.8ml sample was carefully loaded 
onto the column, and the column spun at 1100xg for 12 minutes in the swinging bucket rotor. 
The volume of collected effluent was measured, and 0.6 volumes of 100% isopropanol 
added to precipitate the DNA. The DNA was pelleted at 16,000xg for 20 minutes at room 
temperature and the pellet washed three times with 70% ethanol. The pellet was 
resuspended in 250µI of TE or SDW prior to sequencing, and analysed by restriction 
endonuclease digestion and gel electrophoresis to estimate the quantity and purity of the 
DNA sarrple. 
2.10.3 Preparation of Plasmid DNA for Single Stranded Sequencing. 
Single stranded plasmid DNA for sequencing was basically prepared according to the 
Pharmacia protocol. Transformed E.coli were grown at 37 °C with shaking in 2xYT broth 
supplemented with ampicillin (1504/m1), until the OD660 was -0.5 -0.7. 40041 of this culture 
was infected with the helper 'phage M13K07, at a multiplicity of infection (MOI) of 10, and 
cultured at 37 °C with shaking for 1 hour. The culture was then made up to 10mi with 2xYT 
supplemented with ampicillin (1504g/m1) and kanamycin (7049/m1), and grown at 37 °C with 
shaking for 16 hours. Bacterial cells were pelleted by centrifugation (2,000xg, 4 °C, 10 
minutes) and ' phage were precipitated from the supernatant by the addition of 2.5ml 
polyethylene glycol solution (20 %PEG, 3.5M NaCI) on ice for 30 minutes. Precipitated 
'phage were pelleted at 11,000xg for 40 minutes at 4 °C, and the pellet resuspended in 
50041 STE solution. This solution was extracted twice with phenol /chloroform, once with 
chloroform, and the DNA ethanol precipitated. The single stranded DNA was resuspended in 
30µI SDW, and -7p.1 used for each sequencing reaction. 
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2.10.4 Sequencing Reactions. 
Both double and single stranded sequencing were carried out using the Sequenase Version 
2.0 kit (USB Corporation) with the supplied Sequenase Version 2.0 T7 DNA polymerase, 
and a -35S -dATP (Amersham: specific activity 400Ci /mmol.) according to the manufacturer's 
protocol. Prior to double stranded sequencing, the DNA template was denatured by 
treatment with alkali. Approximately 3 -5µg of plasmid (5pI from miniprep. DNA) was placed in 
an eppendorf tube and the volume raised to 20µI with SDW. 2µI of denaturing solution (2M 
NaOH/ 5mM EDTA) was added, mixed well, and the solution left at room temperature for 5 
minutes. Denatured DNA was precipitated in a dry ice /ethanol bath by addition of 6.2413M 
sodium acetate, 7µI SDW and 75µI 100% ethanol. The precipitated DNA was pelleted by 
centrifugation (11,000xg, 10 minutes, 4 °C), washed with 70% ethanol, and resuspended in 
7µI SDW. The majority of sequencing reactions were carried out in the presence of 10% 
dimethylsulphoxide (labelling mix diluted 1/5 in 50% DMSO), to help overcome problems 
with compressions. 
2.10.5 Sequencing Gel Electrophoresis. 
DNA sequencing gels were composed of 6% or 8% (w /v) acrylamide (29:1 ratio of 
acrylamide:N -N methylene bisacrylamide [Biorad]), 8M urea (Sigma; molecular biology grade), 
and 1xTBE -A buffer. Deionised formamide (10% v /v) was sometimes added to the gel mix, as 
this chemical helps to destabilise any secondary structures in the DNA template which may 
cause compressions (USB,1990). The sequencing plates were sealed at the base using the 
casting tray with 60m1 acrylamide, 20011I TEMED and 4004I of 25 %(w /v) AP (Biorad). The 
acrylamide solution (120m1) was degassed and filtered through a 0.45µm filter prior to adding 
100p1 TEMED, 400µI of 25% AP, and casting the gel. The gel casting plates and sequencing 
tank equipment were either from Hybaid Ltd.,U.K. or Biorad Sequi -Gen. The running buffer 
used in the upper and lower reservoirs was 1xTBE-M. 
Just prior to sample loading, urea was washed out of the wells using a needle 
and syringe. 
The sequencing samples were heated to 75 °C for 2 minutes, and 1.5 -3.0µI of 
each sample 
was quickly loaded onto the gel. For short runs (3 -4 hours), the gels were 
prerun for 30 
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minutes to 1 hour until the temperature reached 45 -50 °C. Gels were run for 3 -10 hours at 60 
Watts. Sequencing gels were dried down on Whatman no.3 paper at 80 °C under vacuum on 
a Biorad model 583 gel drier. Gels were exposed to Kodak X -OMAT R or S film for 1 -3 days at 
room temperature. 
2.10.6 Analysis of Sequence Data. 
Sequence data was analysed using version 7.3 of the University of Wisconsin Genetics 
Computer Group Sequence Analysis software ( UWGCG 7.3; Devereux et a1,1984). 
2.11 Southern Blot Analysis 
2.11.1 Preparation of Genomic DNA. 
Genomic DNA was prepared according to the methods of Enrietto (1983)° and Gross Bellard 
et al (1972). Efferent lymph cells were used as a readily available source of tissue for genomic 
DNA preparation. Cells from 12 samples, each containing 1.5x107 cells, were pelleted by 
centrifugation at 500xg for 5 minutes, and washed twice in ice -cold PBS. Pelleted cells were 
resuspended in 400µI per sample of lysis buffer and incubated at room temperature for 15 
minutes. Proteinase K was added to a final concentration of 100mg /ml, and incubated at 
68 °C for 1 hour. Lysed, digested cells were extracted once with an equal volume of 
phenol /chloroform pH8.0 at 68 °C, once with phenol /chloroform at room temperature, and 
once with chloroform only at room temperature. Nucleic acids were precipitated in a dry 
ice /ethanol bath by addition of sodium acetate (0.15M final concentration) and 2 volumes of 
100% ethanol. Precipitated nucleic acids were pelleted at 1700xg for 10 minutes, washed in 
70% ethanol, dried briefly and resuspended in 400µI TE containing 50mg /m1 RNAase. 
Digestion of RNA was carried out at 37 °C for 1 hour. Genomic DNA was extracted once with 
phenol pH8.0, twice with phenol /chloroform and twice with chloroform /IAA. DNA was 
precipitated with sodium acetate and 100% ethanol as before. Pellets were washed in 70% 
ethanol, briefly airdried, and resuspended in 200µI TE. To facilitate solubilization, the DNA 
was stirred gently at 4 °C for 16 hours. The final concentration of DNA was determined 
spectrophotometrically. 
53 
2.11.2 Southern hybridisation. 
Approximately 1014 samples of genomic DNA were digested with 15 -45 Units of a variety of 
restriction endonucleases in the manufacturer's buffer, for 16 hours at 37 °C. A further 5 -15 
Units of enzyme was added to each sample, mixed thoroughly and incubated for 6 more 
hours at 37 °C. Digested DNA was run on a 0.8% (w /v) agarose gel in TAE buffer for 16 -18 
hours at 40V, constant voltage. The gel was examined under UV light to check for completion 
of digestion, and a photograph taken. 
Following electrophoresis, DNA was transferred to a nylon membrane (Hybond N, 
Amersham) according to a modification of the protocol of Southern (1975). After 
electrophoresis, the DNA was first depurinated by soaking the gel with gentle shaking in 
0.25M HCI for 15 minutes, and denatured /neutralised by soaking in 1.5M NaCI /0.5M NaOH 
for 30 minutes. Blotting of DNA onto the nylon membrane was carried out overnight as 
described by Sambrook et al (1989) using alkaline transfer buffer (0.4 M NaOH). After 
blotting, the gel was examined under UV light to check the efficiency of DNA transfer to the 
filter. The nylon filter was rinsed in 2xSSC for 5 minutes, and allowed to airdry. 
2.11.4 Hybridisation of Nylon Filters. 
Nylon filters were prehybridised for 2 -4 hours at 42 °C in a formamide containing 
prehybridisation solution. The 32 -P labelled DNA probe (see section 2.7 for labelling 
procedure) was denatured by boiling for 5 -10 minutes, added to a minimum volume of 
prehybridisation solution, and the incubation continued for a further 16 -18 hours at 42 °C. 
Nylon filters were then rinsed in 2xSSC /0.1 %SDS for 5 minutes at room temperature 
with 
gentle agitation, followed by 20 -30 minutes at 42 °C in 0.2xSSC /0.1 %SDS 
and 20 -30 
minutes at 42 °C in 0.1xSSC /0.1 %SDS. Filters were air -dried at room 
temperature, and 
exposed to Kodak X -OMAT S film in a casette with an intensifying screen, 
at -70 °C for 5 -15 
days. 
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2.12 RNA Isolation. 
Both total RNA and polyA+ RNA were isolated for use as templates in cDNA synthesis 
reactions. The precautions taken to minimise RNase contamination included treatment of 
SDW for making up solutions with 0.2% diethylpyrocarbonate (DEPC) followed by 
autoclaving, baking glassware at 120 °C overnight, and wearing gloves at all times (Sambrook 
et a1,1989). 
2.12.1 Isolation of PolyA+ RNA. 
The FastTrack mRNA Isolation kit (Invitrogen Corporation, San Diego, California) was used to 
isolate polyA+ RNA. Tissue removed at postmortem was immediately snap frozen in liquid 
nitrogen, and stored at -70 °C for a short time before use. Approximately 1g of frozen tissue 
was cut into small pieces and ground in a pestle and mortar with a little dry ice. The crushed 
tissue was placed in a sterile, baked Dounce homogenizer and the polyA+ RNA isolation 
continued according to the manufacturer's protocol. Briefly, the tissue was lysed in a 
detergent -based buffer containing RNase and protein degraders for 60 minutes at 45 °C. 
High molecular weight DNA was thoroughly sheared by passing the lysate through a sterile 
plastic syringe fitted with a 21 -gauge needle until it became relatively easy to do this. The salt 
concentration was adjusted and the lysate applied to oligo(dT) cellulose for adsorption. The 
DNA, proteins and cell debris were washed off in low salt buffer, the mRNA eluted in elution 
buffer and polyA+ RNA precipitated from the eluate by ethanol precipitation with sodium 
acetate. The RNA pellet was resuspended in 20 -500 elution buffer, and the yield 
determined by spectrophotometry (an 00260 of 1.0 is equivalent to 40p.giml of RNA). 
2.12.2 Isolation of Total RNA. 
Total RNA was isolated by single step extraction according to the method of Chomczynski 
and Sacchi (1987). 
Small pieces of tissue removed at postmortem were immediately snap frozen 
in liquid 
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nitrogen and stored briefly at -70 °C until use. Approximately 200mg of frozen tissue was cut 
into small pieces and placed in a Dounce homogenizer. 2ml of GTC (guanidinium 
isothiocyanate) buffer was added and the tissue quickly homogenized. The lysate was mixed 
well with 20011I sodium acetate (pH 4.0), 400pI chloroform and 2ml water -equilibrated phenol, 
aliquoted into eppendorf tubes and placed on ice for at least 15 minutes. The mixture was 
then centrifuged at 11,000xg for 10 minutes at 4 °C. 400µI of aqueous supernatant was 
removed, mixed with an equal volume of isopropanol and placed on ice for 10 minutes. 
Precipitated RNA was pelleted by centrifugation (11,000xg, 10 minutes, 4 °C).The 
supernatant was discarded and the pellet washed twice in 75% ethanol. The RNA pellet was 
air -dried and resuspended in 100µI of DEPC treated sterile water. 
2.12.3 Gel electrophoresis of Total RNA. 
Small aliquots of total RNA were separated by electrophoresis through a formaldehyde - 
containing gel to check the integrity of the samples prior to further manipulation. The 
1.5 %(w /v) denaturing agarose gel was prepared as follows. 4.5g of agarose was mixed with 
214m1 sterile DEPC- treated water and 30m1 10xMOPS (3 -[N- morpholino] -propanesulfonic 
acid) buffer. This was boiled to dissolve the agarose, cooled to 60 °C, and 54ml formaldehyde 
added in a fume hood just prior to pouring the gel. RNA samples were prepared by mixing 5111 
of sample with 15µI of RNA loading buffer, and heating to 70 °C for 15 minutes. One fifth 
volume (4µI) of RNA dye mix was added, and the samples loaded onto the gel. The gel was 
run at 65V constant voltage in a cold room for 1.5 -2 hours. The gel was examined under UV 
light to check the samples. Samples containing degraded RNA were visible as smears lacking 
clear 28S and 18S ribosomal RNA bands, and were discarded. 
2.13 cDNA Synthesis and Tailing Reactions. 
2.13.1 cDNA Synthesis 
First -strand cDNA synthesis from either total RNA or poly A+ RNA was carried out using the 
Amersham cDNA Synthesis Kit (cat.no. RPN1256Z) and random hexanucleotide primers 
according to the manufacturer's protocol. The reverse transcriptase enzyme in this kit was 
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derived from the Rous associated virus 2 (RAV2). The efficiency of the synthesis reaction 
was estimated by inclusion of a -32P dCTP in the reaction mix and measurement of the 
specific activity of the TCA precipitable fraction, as described previously (see section 2.7). 
Oligonucleotide primers and excess dNTP's were removed by ammonium acetate 
precipitation of the cDNA (carried out twice), and the cDNA pellet resuspended in either 
30.641 of TE for subsequent tailing reactions, or 40411 of TE for use as a PCR template (10- 
1541 used per PCR reaction). 
A similar protocol was used to synthesis cDNA for the PCR investigations of gut CD1 
expression. Briefly, cDNA was synthesised from total RNA in a 2041 reaction mix composed of 
Superscript buffer (Gibco BRL), dNTP's, random hexanucleotide primers, DTT and 
Superscript enzyme (Gibco BRL). This enzyme is derived from a cloned Moloney Murine 
Leukemia virus (M -MLV) gene. The reaction was carried out at 45 °C for 45 minutes and 
terminated by heating to 95 °C for 5 minutes. The cDNA mixture was cooled on ice, diluted to 
40µI inTE, and 341 used as template in each PCR reaction. 
2.13.2 Tailing Reactions. 
The enzyme terminal deoxynucleotidyl transferase (Boehringer Mannheim) was used to tail 
the cDNA's with either poly G or poly A, according to the manufacturer's protocol and the 
method outlined by Thiessen et al (1990). This protocol resulted in addition of 15 -25 residue 
tails on the cDNA at the 3' end. The enzyme was inactivated by heating to 65 °C for 5 -10 
minutes. The cDNA pool was diluted into a final volume of 200 -40041 with TE, and 10 -1541 
used as a DNA template in each PCR reaction. 
2.14 Polymerase Chain Reaction (PCR). 
PCR reactions were carried out in 50 or 10041 volumes in sterile 0.5mi eppendorf tubes. The 
basic PCR reaction components were assembled as follows- 1 xPCR reaction buffer (50mM 
KCI, 10mM Tris.Cl pH8.3, 1.5mM MgCl2), 1004M each dNTP (Pharmacia) 0.17mg /mi bovine 
serum albumin (BSA), DNA template, 25- 50pmoles of each primer and 2 units of Thermus 
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aquaticus (Taq) polymerase enzyme. Ohara's buffer contained 3mM DTT in addition to the 
basic reaction buffer components (Ohara et a1,1989). The various PCR reaction mixes and 
cycling parameters used during this project are detailed in Table 1. When all the reaction 
components were assembled, a mineral oil overlay was added and cycling carried out as 
described, using either a Techne Programmmable Driblock PHC -1 or a Hybaid Omnigene 
thermal cycler. Following completion of PCR amplification, 10% of the product was analysed 
by gel electrophoresis, as described previously (2.6). 
In some instances, additional components were added to the reaction mix, as indicated in the 
table. DMSO is a denaturant and is thought to contribute to PCR amplification success by 
reducing the secondary structure of the DNA template, when used at concentrations of 10% 
(v /v) or less (Pomp and Medrano,1991: Rolfs et al, 1992). The addition of the detergent w1 is 
thought to contribute to the maintenance of enzyme stability during amplification, and its 
inclusion depended on the source of the enzyme used. For some PCR reactions, the 
reaction tubes were heated to 94 °C for 4 minutes and cooled to 80 °C prior to addition of the 
Taq. polymerase enzyme ( "hot- start "), as this has been shown to improve the yield and 
specificity of the PCR product (D'Aquila et al, 1991). 
The primers used for POR were synthesised by Oswel DNA services (Dept. of Chemistry, 
Kings Buildings, West Mains Road, Edinburgh, EH9 3JJ) and their sequences are given in 
Appendix 2. Typically, PCR primers werel8 -34 nucleotides in length and -50% GC rich so 
that both primers in a reaction had similar optimal annealing temperatures. Ideal primers 
contained a random distribution of bases. Primer sequences were selected to avoid those 
which could potentially form hairpin loops. It was particularly important to avoid 3° end 
complementarity which would lead to the formation of primer -dimers (Rolfs et a1,1992; 
Clontech Labs. Inc., 1991). The majority of primers were designed with a G or C residue at the 
3' end. Primer sequences were checked for specificity against other ovine CD1 sequences 
using the GAP programme of UWGCG version 7.3 (Devereux et al, 1984). 
Various precautions were taken to avoid contamination of the PCR reactions, including 
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Table 1: PCR Reaction Details and Cycling Parameters. 
The reaction buffers, template DNA, primers and cycling parameters used in the various PCR 
amplifications carried out during this project are summarised in the table. Details of the primer 
sequences are given in Appendix 2. 
1 . The PCR cycling parameters show the denaturation, annealing and extension 
temperatures, as well the time taken (in minutes) for these phases during each PCR cycle. 
The single temperature of 72 °C quoted in several of the PCR's is the final extension 
temperature, generally held for 10 minutes. 
2. PCR amplification of the human CD1 C probe required the use of sterile toothpicks to "stab" 
M13 plaques. The plaques were then deposited in the PCR solution by rolling the toothpicks 
between thumb and first finger with the plaque end immersed in the PCR mix. 
3. Amplification of the 5' ends of the A25 and B -42 sequences required nested PCR 
reactions. The primers used in the first round of PCR are given after the 1. and primers used in 
the nested reaction are given after the 2. Two different PCR approaches were employed for 5' 
end amplification - (A) the RACE -PCR protocol and (B) the PCR protocol involving the 5' 
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54 °C -0.6' 55 °C -1.0' 55 °C -3.0' 
72 °C -1.5' 72 °C -1.5' 72 °C -4.0' 94 °C -3.0' 94 °C -0.7' 
1 cycle 55 °C -2.0' 55 °C -1.0' 
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94 °C -0.7' 1 cycle 
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wearing gloves at all times and changing them frequently, assembling reaction components 
in a laminar flow hood or setting up PCR reactions in a laboratory where no CD1 cloning had 
previously been carried out, and using positive displacement pipettes to reduce aerosol 
contamination. 
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3.1 Library Screening and Identification of Ovine CD1 cDNA 
Clones. 
3.1.1 Introduction 
The initial objective of the work outlined in this thesis was to identify and sequence 
complementary DNA encoding the individual ovine CD1 molecules. Previous molecular 
studies of CD1 had been carried out in humans, mice and rabbits, with broadly similar 
strategies employed in each case. The first human CD1 cDNA clone was identified by isolating 
a cell line (NH17) expressing high levels of HTA -1 (CD1A molecule), enrichment of HTA -1 
mRNA by immunoselection of polysomes, synthesis of cDNA, and screening of cDNA clones 
by mRNA selection followed by in vitro translation and immunoprecipitation (Calabi and 
Milstein, 1986). One clone (FCB6) was found to select a mRNA encoding an HTA -1 a chain 
like polypeptide according to relative molecular mass and recognition by a specific rabbit 
antiserum. Clone FCB1 was subsequently identified from a total NH17 cDNA library using 
FCB6 as a probe. Each clone encodes the HCD1A molecule. There are three single base 
differences between the two clones which are probably cloning artefacts, with FCB1 
extending 180 nucleotides further in the 5' direction.The FCB1 clone begins approximately 
30 nucleotides upstream from the start of the a2 domain. A Southern blot of human Molt4 
DNA digested with EcoR I and probed with the insert from FCB6 identified five hybridising 
bands (Martin et al, 1986). These were found to correspond by size to the EcoR I fragments of 
five different clones isolated from a genomic library (R4B3, R1 L5, R7L4, R3G1 and R2G4), 
and represent the five different human CD1 genes (HCD1A, B, C, D and E). The a3 domains 
of the genomic clones were sequenced and the FCB6 cDNA clone was matched with the 
XR4B3 /CD1A clone. In 1989, Balk et al reported the isolation of a cDNA clone corresponding 
to HCD1 D (Balk et al, 1989a). This clone was isolated by screening a thymus cDNA library with 
a mixture of full length cDNA CD1A,B and C probes. They used the same probes, followed by 
probes corresponding to the CD1 D 5'UT, al and 3'UT domains, to identify the equivalent 
genomic clone. 
In the mouse, the first CD1 gene ( MCD1.1) was identified by screening a genomic library with 
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the insert from FCB6 (Bradbury et a1,1988). The second gene was identified by screening a 
genomic library with a subclone of MCD1.1 which spans the a3 region, to yield MCD1.2. The 
insert from clone FCB1 was used to screen a thymus cDNA library and nine positive clones 
were identified (Bradbury et a1,1990). None of these clones !s' correctly spliced, as 
discussed in 3.1.5. Balk et al (1991a) also identified several identical murine CD1 cDNA 
clones, by screening a thymus cDNA library with a probe derived from the gene encoding the 
a2 and a3 domains of HCD1 D. Partial sequencing showed that this CD1 is identical to the 
MCD1.1 previously identified by Bradbury et al. The mouse CD1 genes are most homologous 
to HCD1 D. The sequence of another rodent CD1 gene, rat CD1, has recently been reported 
(Ichimiya et al, 1994). The cDNA encoding rat CD1 was isolated from a thymic lymphoma cDNA 
library using a PCR- derived rat a3 region probe. The rat CD1 sequence is highly homologous 
to both murine sequences in the 5'UT region and in the coding domains. Sequence 
divergence in the 3'UT region indicates that rat CD1 is equivalent to the murine CD1.1 gene 
(80% identity) and not to the CD1.2 gene (52% identity). In the rabbit, screening of cottontail 
and domestic rabbit genomic libraries with the insert from FCB1 and rescreening of positive 
clones with a synthetic oligonucleotide mixture corresponding to all sequences which could 
possibly encode residues 10 -15 of the known rabbit CD1 polypeptide sequences, identified 
one clone from each library (Calabi et al, 1989b). The cottontail rabbit clone encodes the a1 , 
a2 and a3 domains and is most related to the human and mouse CD1 D genes.The domestic 
rabbit clone encodes the 5'UT and a1 domains only, and is most similar to HCD1 B. 
All of the known CD1 sequences except for clone FCB6 have been identified by library 
screening techniques. An alternative approach for identifying the individual ovine CD1 
cDNA's would be to use the potentially faster PCR technique to amplify the required 
sequences (Mullis and Faloona,1987). However, in practice, the use of PCR can itself prove 
rather laborious, due to the necessity of sequencing multiple clones derived from a single 
PCR product. The sequencing of multiple clones is required to produce a consensus 
sequence because of the relatively high error rate of the Taq polymerase enzyme (Eckert and 
Kunkel, 1991; Tindell and Kunkell, 1988). PCR also requires areas of well conserved 
sequence across species barriers in order to generate appropriate primers for the PCR. If 
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these regions lie within the coding sequence this generates the additional problem of 
obtaining sequence information for the 3' and 5' ends. 
The strategy I chose to follow for identification of the ovine CD1 DNA sequences was to 
screen a variety of sheep thymocyte cDNA libraries with heterologous human probes. 
Previous monoclonal antibody studies of sheep tissues had confirmed the expression of CD1 
molecules in the thymus cortex (Dutia and Hopkins,1991), and several thymocyte libraries 
were provided for screening by Dr. Wayne Hein, Basel. A foetal liver library was also screened, 
since several reports had provided evidence for expression of various human and murine 
non -classical class I and CD1 molecules in the liver, particularly during foetal development 
(Houlihan et a1,1992; Balk et a1,1991a; Bleicher et a1,1990; Bradbury et al, 1988). The foetal 
liver cDNA library screened was derived from lambs at day 40 -42 of gestation. It is around this 
time that the first identifiable lymphocytes are found in the thymus of the foetal sheep. Liver 
CD1 expression has also recently been observed in the sheep (S.Rhind, personal 
communication). 
3.1.2 Libraries, Probes and Preparation For Use. 
Two human CD1 probes were a kind gift of Dr. Cesar Milstein, MRC Laboratory of Molecular 
Biology, Cambridge, one a CD1A probe and the other a CD1C probe. The CD1A genomic 
clone B353.88 contains a -0.6 kb insert comprising the coding sequence for the human 
CD1A exon 41a3 domain (0.28kb) as well as some flanking intron sequence (Martin et al, 
1986). This had been prepared from a random shotgun library and blunt end cloned into the 
Sma I site of M13tg130. The CD1C genomic clone L4R.J4 contains a -0.6 kb insert 
comprising the coding region of the human CD1C exon 4/a3 domain (0.28kb) as well as some 
flanking intron sequence (Martin et a1,1986). The insert had been isolated and cloned in an 
identical manner to the CD1A clone. 
Four different sheep cDNA libraries were screened during this project- a foetal thymocyte 
library (termed SFT for sheep foetal thymocyte; Hein et a1,1989), two lamb thymocyte libraries 
(termed ST -1 and ST -2; Hein et al, 1989; Grossberger et a1,1990), and a foetal liver library 
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(termed SFL). The thymocyte libraries were generated by isolation of RNA from the thymus of 
two single eight week old lambs (ST -1 and ST -2) and from the pooled thymi of three 67day old 
foetal lambs (SFT). The SFL library was generated from the pooled livers of twelve 40 -42 day 
old foetal lambs (SFL). Poly (A) + RNA was isolated, cDNA synthesised and a poly C tail added. 
Oligo (dG) was used to prime second strand synthesis, and the dsDNA cloned into the Eco RI 
site of the vector X.gt11. All libraries were a kind gift from Dr. Wayne Hein, Basel Institute for 
Immunology, Basel, Switzerland. 
In order to use the human probes for screening the cDNA libraries, double- stranded DNA 
(dsDNA) from the M13 human clones was required. The initial approach taken was an attempt 
to isolate the double stranded replicative form (RF) of M13 from which insert DNA could be 
isolated. However, despite several attempts, isolation of the RF form was never achieved, 
although it was relatively easy to isolate single stranded ` phage DNA from the culture 
supernatants. An alternative approach was then taken. This involved the use of the PCR 
reaction and M13 forward and reverse sequencing primers (see Appendix 2) to amplify insert 
DNA taken from "plaque stabs" (DNA Cloning vol.1). 
A titration of the provided M13 human CD1C clone DNA was performed in order to determine 
the dilution of M13 DNA which would provide well- separated plaques to stab for PCR. 
Essentially, 50µI PCR solutions were set up as described in Methods, 2.14. Figure 1A 
illustrates the result of a set of plaque stab PCR's, showing that fragments of the expected 
size were obtained. The PCR fragments were subsequently excised from the gel, pooled, 
and purified by phenol /chloroform and chloroform extractions and sodium acetate 
precipitation. The insert DNA was prepared for cloning using the Klenow fragment of E. coli 
DNA polymerase Ito blunt end the DNA and T4 polynucleotide kinase to phosphorylate the 5' 
ends, and cloned into the vector pTZ19R (FIG. 1B). A large scale plasmid preparation of 
dsDNA from sample number 6 was carried out as described in 2.10.2. This yielded -3.5mg of 
plasmid DNA from a 1 litre culture. The identity of the insert as human CD1 C was confirmed by 
sequence analysis of the recombinant dsDNA with the M13 forward and reverse primers. A 
sample of the recombinant dsDNA was digested with the enzymes EcoR I and Hind Ill, yielding 
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Figure 1: Preparation of CD1 Probes From M13 Human Genomic CD1 Clones. 
Photographs A, B and C illustrate the results of PCR amplification of the HCD1C insert from 
the L4R.J4 M13 clone analysed by gel electrophoresis. 
A. Results from seven plaque stab PCR's, as outlined in the text. 25% of each PCR reaction 
was analysed by gel electrophoresis, and five of the seven samples contained inserts of the 
expected size (0.6kb). 
B. The remaining PCR mixes from the five positive samples shown in A were purified by 
phenol /chloroform extraction, blunt ended with Klenow and phosphorylated with kinase, gel 
purified, and the inserts ligated into Sma I cut pTZ19R. ssDNA was prepared from six samples 
and 3µI from a total of 30µI were digested with EcoR I and Hind Ill. The results from three 
samples are shown, with insert bands of 600bp apparent in lanes 2, 4 and 6. Lanes 1,3 and 5 
show equivalent amounts of undigested samples. 
C . A largescale dsDNA plasmid preparation from sample six (B, lane 4) was carried out. 30µg 
of DNA was digested with EcoR I and Hind Ill and separated on a gel over four lanes (2 -5). 
Lane 1 shows undigested pTZ plasmid. Results of the digest show bands of the expected 
size (0.6kb). The four bands were pooled and purified prior to use as a probe in library 
screening. 
Photographs D, E and F illustrate preparation of the HCD1A probe analysed by gel 
electrophoresis. 
D .15µI of a 1 /10 dilution of the provided M13 CD1A clone DNA (B3S3.88) was digested in a 
total volume of 30µI with Barn HI and EcoR I, and separated by electrophoresis over two lanes, 
yielding an insert of the expected size (0.6kb). 
E. The two faint insert bands from 10 were excised, purified and ligated into EcoR I /Bam HI 
digested pBluescript. Four white colonies of transformed E.coliwere picked for DNA isolation, 
1µl from a total of 500 of the dsDNA was digested with EcoR I and Barn HI and analysed by gel 
electrophoresis. All four clones yielded insert bands of the expected size (0.6kb), although 
there was much less DNA in samples 3 and 4. 
F. A further Barn HI /EcoR I digest was carried out on 20µI from the 50µI total of dsDNA from 
sample 1 and analysed by electrophoresis over three lanes. This provided sufficient insert 
DNA for purification and use as a probe for library screening. 
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sufficient insert for purification and use as a probe (FIG. 1C). The four insert bands were 
excised from the TAE gel, pooled, purified and labelled with 32P as described in sections 2.6 
and 2.7. 
In order to obtain dsDNA of the human CD1A fragment as a probe, an attempt was made to 
excise the insert band from the M13 DNA and clone it directly. The restriction enzymes EcoR I 
and Barn HI were used to digest a sample of the M13 DNA, as shown in Figure 1D. The single 
insert bands in each track were excised from the TAE gel, pooled, purified and ligated into the 
pBluescript plasmid vector. Plasmid DNA from four white colonies was prepared, and digested 
with EcoR I and Barn HI (Fig. 1E). Insert bands from preparations 1 and 2 were excised, pooled 
and purified (Fig.1 F) prior to labelling with 32P for use as a probe. 
3.1.3 Library Screening and Isolation of Ovine CD1 cDNA Clones. 
Library screening was carried out as described in the Methods, section 2.8. A primary screen 
of the Xgt 11 foetal thymocyte library (SFT) was carried out using the human CD1C probe. 
Approximately 240,000 plaques were screened at reduced stringency (final wash of 0.5xSSC 
at 58 °C for 1 hour). Forty positive plaques were picked for secondary screening. These 
included plaques which gave weak as well as strong positive signals. Using duplicate filters 
from the same primary plates, this library was also screened with the human CD1A probe, as 
detailed in a later section of 3.1.3. Positive plaques from the SFT library screened with the 
CD1C probe were called series A, while positive plaques identified with the CD1A probe were 
called series B. The primary screening results with each probe were directly compared by 
aligning the filters over a light box. Very few plaques were identified by both probes. This 
result was rather unexpected since it was presumed that the CD1A probe would identify most 
if not all of the ovine CD1 clones, generating a major overlap with plaques identified by the 
CD1C probe. 
Lambda DNA (see 2.8.4) was prepared from the positive plaques identified in the secondary 
screens, followed by digestion of the DNA to determine if any EcoR I excisable inserts were 
present. Details of the results of screening the various libraries are given below. 
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Screening the SFT Library With HCD1C (series A). 
Forty positive plaques were picked for secondary screening, of which thirty -one were initially 
plated at a suitable density for secondary screening. Seventeen of the thirty -one samples in 
the secondary screen gave positive signals, and lambda DNA was prepared from all of these. 
Four samples yielded EcoR I excisable inserts- A9, A16, A25 and A31. The insert band sizes 
were approximately 750, 950, 1000, and 1100 nucleotides respectively. The insert bands 
were excised from the TAE gel, purified, and ligated into the EcoR I -cut pBluescript plasmid 
vector. Transformed E.coliwere plated out on the appropriate selective media and colonies 
picked for DNA isolation on the basis of blue /white colour selection (2.2.1). 
Double stranded plasmid DNA was prepared from four transformants derived from each 
sample, followed by EcoR I restriction enzyme digests to check the inserts, and the cleanest 
preparations chosen for sequencing (2.10). Of the four secondary screen positive clones, 
A16, A9 and A31 were found to be negative for CD1 by initial sequencing with the primers 
392 and 393. However, the A25 clone (insert size -1000 bp's)was identified as an ovine CD1 
by comparison of the initial sequence data with the known human sequences. This 
comparison showed A25 to be most homologous to human CD1 B. Figure 2 illustrates the 
A25 insert excised from the lambda DNA (2A) and excised from the pBluescript plasmid after 
subcloning (2B). 
At this point it seemed appropriate to carry out further secondary screens on three samples 
which had been plated too densely for secondary screening using the initial dilution of the 
'phage stock, as well as five other samples which had not given positive hybridisation signals 
on the initial secondary screening. All eight samples gave positive signals this time, and 
preparation of lambda DNA followed by EcoR I digestion yielded inserts from two further 
samples, A23 and Al2, with insert sizes of approximately 1000 and 2000 nucleotides. The 
inserts were isolated and subcloned into pBluescript, so that dsDNA could be generated for 
sequencing analysis. The initial sequencing results indicated that Al2 is not homologous to 
the human CD1 sequences, and that A23 is identical to the previously cloned A25 ovine 
CD1. 
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Figure 2: Isolation and Subcloning of SCD1A25 
Panel A shows Eco RI digests of lambda DNA from four positive clones analysed by gel 
electrophoresis. The clones were isolated from the SFT library by screening with the human 
CD1 C probe. The -1000bp insert excised from clone A25 is visible in lane 2, flanked by three 
Eco RI insert negative clones. 
Panel B shows Eco RI digests from three transformants analysed by gel electrophoresis 
after subcloning of the A25 insert into the pBluescript plasmid. 
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Since thirteen of the seventeen clones which gave positive signals after secondary screening 
did not yield EcoR I excisable inserts, a different approach was applied. The enzyme Mlu I cuts 
lambda vector 
at several points in the pgibiaser-ipt-ii4a&mid, including at either side of the polylinker site, so 
lambda vector 
that approximately two kilobases of pteesc -kpt DNA flanks any insert at this site. Therefore, 
lambda vector 
an MIu I digest of pl3lues pt-wnich contains an insert would yield, among others, a band of 
x +2kb, where x is the actual size of the insert in kb. Thirteen samples were digested with Mlu 
I, and seven samples yielded "insert" band sizes of 3000 -3200 bases. These were excised, 
purified, blunt ended (see 2.3.2) and subcloned into the EcoR V site of pBluescript. Since 
the EcoR V site is not reconstituted after ligation of the insert DNA into the plasmid, other 
enzymes which cut in the polylinker site on either side of the insert were used in order to 
excise it from the plasmid DNA. The enzymes Sac I I and Hinc I I were chosen as they both work 
equally well in a particular restriction enzyme buffer. However, digests of ds plasmid DNA with 
these enzymes gave some unexpected results. It was expected that either single bands of 
approximately 3 kb in size, or multiple insert bands totalling approximately 3 kb, would be 
observed following digestion and gel electrophoresis, depending on the existence of internal 
Sac II or Hinc II sites within the insert. In fact, a variety of insert sizes were observed, few of 
which corresponded to the expected results. Four clones derived from different samples 
were checked by dsDNA sequencing with the primers 392 and 393, and initial results 
indicated that none are homologous to the human CD1 sequences. 
Screening The SFT Library with HCD1A (series B). 
The SFT library was also screened with the human CD1 A probe to give series B samples. 
Again, approximately 240,000 plaques were screened at reduced stringency (final wash of 
0.5xSSC, at 58 °C for 1 hour). Forty positive plaques were picked, of which thirty -two samples 
were plated at a suitable density for secondary screening using the initial dilution of the 
'phage stock. Of the thirty -two samples in the secondary screen, eighteen produced positive 
plaques. Twelve samples yielded EcoR I excisable inserts, although the results were a little 
unexpected. Two of the samples contained double inserts of approximately 1 and 3 kb in 
each case. For each sample, both bands were isolated for subcloning (B8U and L, B34U and 
L). Eight of the other ten insert- positive samples contained inserts of approximately 3000 
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bases. The remaining two samples, B16 and B21, contained inserts of approximately 4000 
and 6000 bases respectively. These inserts seemed too large given that the expected full 
length coding region size of CD1 molecules is approximately 1 kb, although mRNA transcript 
sizes ranging from 1.2 to a maximum of 3kb have been observed in humans and mice (Calabi 
et al, 1988; Calabi et al, 1989c). Inserts from B11 and B21 were isolated and purified for 
subcloning, in addition to the B8 and B34 inserts. Sequencing reactions were carried out on 
plasmid samples from BBL, B11, B34U and B34L, and initial sequencing results indicated that 
none of the samples are homologous to human CD1 sequence. 
Due to the problems with Mlu I digests and subsequent cloning of inserts from the series A 
samples, it was decided not to pursue this approach for the B series. However, it was possible 
to carry out a further secondary screen on five samples which had previously been plated too 
densely for rescreening, and on five samples which had previously been negative on 
secondary screening. A further seven EcoR I excisable inserts were identified. Of these, 
three samples contained inserts of 4000 bases or more (B2, B6 and B22), and four contained 
inserts of approximately 3000 bases (B30, B4, B13 and B36). Again, these insert sizes were 
unexpectedly large considering the coding region size of CD1 molecules. Initial sequence 
analysis of selected clones from B30,B4, B13 and B22 indicated that none are homologous 
to human CD1. 
The A25 clone (renamed SCD1A25 for subsequent use- for sheep CD1, A25 clone) had 
been completely sequenced by this point, allowing a homologous sheep probe to be derived 
by PCR amplification of the a3 /TM /CYT domain for use in further library screening (Figure 3A). 
A 1 pi sample of a 1/100 dilution of the SCD1A25 ds clone DNA was used as a template for 
the primers 5801 and 5802, with cycling carried out as described in Table 1 (section 2.14). Gel 
electrophoresis of the resultant PCR product showed that a band of the expected size (-450 
nucleotides) had been amplified (Fig.3B, Lane 1), as well as two less prominent higher 
molecular weight bands. The 450 bp band was purified using a Spinbind column (Fig.3B, lane 
2). However, as the two upper bands were as efficiently recovered as the required band, the 
remainder of the purified sample was run on a TAE gel, and the main band excised from the 
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Figure 3: Preparation of the PCR Derived A25 a3 /TM /CYT Region Probe. 
Panel A shows a partial sequence of the insert from the SCD1A25 cDNA clone, with the 
borders of the a3 region indicated by vertical dashed lines. The stop codon is denoted by a 
line under the trimer sequence TGA. The primers 5801 (derived from the sense strand) and 
5802 (derived from the antisense strand), as indicated in bold type, were used to amplify the 
a3 /TM /CYT region by PCR, using 111I of a 1/100 dilution of dsDNA from the SCD1A25 clone 
as a template. 
Panel B shows a photograph of the PCR product analysed by gel electrophoresis. 
Lane 1: 2µI of PCR product from a total of 30µI amplified. 
Lane 2: The remaining 28µI of PCR product was purified on a Spinbind column, eluted in 2011I 
and 1µI analysed by gel electrophoresis. 
Molecular weight markers are indicated in base pairs. 
A 
5801 
239 ATATTTCCTG AGTGTCCTTG ATGCAGGCAA AGCAGAACTG CAGAGGCAAG 
Alpha 3 domain 
289 ITGAAGCCTGA GGCCTGGCTG TCCAGCGGCC CCACTCCTGG GCCTGGCCGC 
339 CTACTGCTGG TGTGCCATGT CTCAGGATTC TACCCAAAAC CTGTGTGGGT 
389 GATGTGGATG AGGGGTGAGC AGGAAGAGCC TGGCACTCAG CAAGGGGACA 
439 TCATGCCCAA TGCAAATTGG ACTTGGCATC TGCGAGCAAC CCTAGATGTG 
489 GCAGCTGGAG AGGCGGCTGG TCTGAGTTGC CGAGTGAAGC ACAGCAGTCT 
ITM/CYT domain 
539 AGGAGACCAG GACATCGTCC TGTACTGGGIG ACACCCCACC TCCACTGGCC 
589 TGATATTTGT GGCAATAATA GTGTCCTCCC TCATCCTTTT GATCTGTCTT 
639 GCATTATGGT TTTGGAGGCG CTGGTCATAT CTGACTATCT TGTGAGCCCA 







gel prior to further purification using a Spinbind column (see section 2.6). This removed the 
two higher molecular weight bands, eliminating the possibility of them interfering with library 
screening. 
Screening The ST -1 and ST -2 Libraries With The Homologous Probe (series A- and B -1. 
The homologous sheep probe was subsequently used to screen two lamb thymocyte 
libraries, ST -1 and ST -2. Approximately 120,000 plaques were screened from each library, 
using stringency conditions of 0.2xSSC at 65 °C for the final wash. Positive plaques from the 
ST -1 library were called series A -, while positive plaques identified from the ST -2 library were 
called series B -. 
Nineteen positive plaques were identified from the ST -1 library after primary screening, of 
which fourteen were plated at a suitable density for secondary screening. All fourteen 
samples gave positive signals in the secondary screen, and lambda DNA was prepared from 
each. Three EcoR I excisable inserts were identified, in samples A -14, A -64 and A -81, with 
insert sizes of approximately 1000, 2000 and 2000 bases respectively. For the ST -2 library, six 
positive plaques were identified in the primary screen, of which four were initially plated at an 
appropriate density for rescreening. All gave positive signals after the rescreen, and lambda 
DNA was prepared from each one. Two EcoR I excisable inserts were identified, in samples B- 
42 and B -52, with insert sizes of approximately 1000 and 1200 bases respectively. Inserts 
from the five positive samples (A -14, A -64, A -81, B -42, B- 52)were subcloned into the 
pBluescript plasmid, and dsDNA prepared for sequencing. Initial sequencing showed that two 
of the inserts are identical in size and sequence (A -14 and B -52), and are ovine CD1 
equivalents. B -52 was arbitrarily retained for further study and renamed SCD1 B -52. B -42 was 
also retained for further sequencing, and was renamed SCD1 B -42. Figure 4A shows the B -42. 
and B- 52inserts excised from the lambda DNA and Figure 4B shows the same inserts excised 
from the pBluescript plasmid after subcloning. 
Initial sequencing of clones A -64 and A -81 revealed poly A tracts at both ends of each clone. 
It thus appeared that two inserts had originally been cloned in a head to head orientation into 
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Figure 4: Isolation and Subcloning of SCD1B-42 and SCD1B-52. 
Panel A shows Eco RI digests of lambda DNA from four positive clones analysed by gel 
electrophoresis, with B -42 in lane 3 ( -950 base pairs) and B -52 in lane 4 (-1100 base 
pairs).The samples analysed in lanes 1 and 2 did not yield Eco RI excisable inserts.The clones 
were isolated from the ST-2 library by screening with the homologous a3 /TM /CYT region 
probe. 
Panel B shows Eco RI digests from three transformants each of B -42 (lanes 1 -3) and B -52 
(lanes 4 -6) analysed by gel electrophoresis after subcloning the lambda inserts into the 
pBluescript plasmid. 
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the EcoR I site of the lambda DNA when the cDNA library was generated. The EcoR I site 
between the two inserts appears to have been lost, since only a single insert of approximately 
2000 nucleotides was isolated from each lambda clone. The sequence from A -64 and A -81 
also revealed that one of the two presumed inserts in each clone is virtually identical to the 3' 
end of the B -42 clone. The other inserts in A -64 and A -81 are identical but show no homology 
at all to the known CD1 sequences. No further sequence analysis was pursued for these two 
clones. 
Screening The SFT and SFL Libraries With The Homologous Probe SCD1A25 a3/TM /CYT. 
The PCR generated homologous a3 /TM /CYT probe was used to screen the SFL library and 
rescreen the SFT library. Approximately 150,000 plaques were screened from each library. 
The hybridised filters were washed with 0.5xSSC at 65 °C for forty minutes, with a final 
stringent wash of five to ten minutes in 0.2xSSC at 65 °C. No positive plaques were identified 
from the foetal liver library, although this may have been due partly to the stringency of the 
washing conditions. Twenty positive plaques were isolated from the foetal thymocyte library. 
Of these, four were initially plated too densely for secondary screening. Of the remaining 
sixteen, twelve gave positive signals after secondary screening. Lambda DNA was prepared 
from all of these and enzyme digestion yielded one EcoR I excisable insert (T10) of 
approximately 1200 nucleotides (Fig. 5A). The insert was excised from the TAE gel, purified, 
and ligated into the pBluescript plasmid for sequencing (Fig. 5B). Initial sequence analysis 
confirmed that the insert was homologous to human CD1. The sample was renamed 
SCD1T10 for further analysis. 
3.1.4 Presentation of cDNA Clone Sequence Data. 
The four ovine cDNA clones, SCD1A25, SCD1 B -42, SCD1 B -52 and SCD1 T10, were fully 
sequenced on each strand by dsDNA sequencing using the dideoxy chain termination 
technique (Sanger et a1,1977). The complete sequence of each cloned insert was 
determined by primer walking, rather than subcloning. Primer walking involves the synthesis 
of an oligonucleotide which hybridises near the 3' end of the newly obtained sequence, and 
which primes synthesis in a subsequent set of dideoxy reactions (Strauss et el, 1986). The 
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Figure 5: Isolation and Subcloning of SCD1T10. 
Panel A shows Eco RI digests from five positive clones analysed by gel electrophoresis. 
The clones were isolated from the SFT library by screening with the homologous a3/TM /CYT 
probe. The 1400 base pair insert from T10 is visible in lane 1, followed by four clones from 
which no Eco RI inserts were obtained (lanes 2 -5). 
Panel B shows Eco RI digests from three transformants analysed by gel electrophoresis 
after subcloning of the T10 insert into the pBluescript plasmid. 
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sites chosen for the sequencing primers were located at 80 -100 nucleotides upstream from 
the 3' end of the most recently obtained sequence in order to generate some overlap 
between sequences derived from different primers. The primer sequences chosen were 
generally 18 -20 nucleotides in length and care was taken to avoid the potential for hairpin 
loop formation within each primer. The sequences obtained for the sense and antisense 
strands of each clone were compared and any ambiguities resolved by referring back to the 
original sequencing autoradiographs. The sequencing strategy employed for each of the 
cDNA clones, illustrating the position of the sequencing primers, is presented in Figure 7. 
The complete sequence of each primer is given in Appendix 2. The sequences generated 
were assembled using the University of Wisconsin Genetics Computer Group (UWGCG) 
version 7.3 sequence analysis software package (Devereux et al, 1984). The ccrJ:çliefe 
nucleotide sequence of each clone is shown in Figure 6, A -D. 
A summary of the domain structure of each clone, as well as the sequencing strategy used, is 
outlined in Figure 7. Comparison of the sequence of each of the four ovine CD1 clones to the 
known human, mouse and rabbit sequences revealed that all were most homologous to the 
human CD1B gene (a detailed analysis of these comparisons is provided in section 3.3). The 
positions of the domain boundaries in the ovine cDNA clones were therefore assigned by 
comparison to the known genomic exon /intron boundaries of the human CD1B gene (Martin 
et al, 1987; Aruffo and Seed,1989), as exon / intron boundaries tend to be highly conserved 
across species barriers. 
As outlined in Figure 7, both SCD1A25 and SCD1 B -42 were isolated as truncated versions of 
the CD1 sequence. The SCD1A25 sequence begins towards the end of the al region. and 
the SCD1 B -42 sequence begins fifty -eight nucleotides into the a2 region. Section 3.2 
outlines the approach taken to determine the sequence of the 5' untranslated (5'UT) and a1 
regions of these two clones. The SCD1 T10 clone was also isolated as a truncated form, with 
the sequence beginning towards the end of the al domain. However. attempts to isolate the 
5' region of this CD1 subtype were unsuccessful (see section 3.2). The SCD1 B -52 clone is 
the only clone which contains the 5'UT and al regions, but it lacks an a3 domain. This 
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Figure 6: Sequences of The Four Ovine CD1 cDNA Clones. 
The four sequences illustrated in A -D represent the sequence information obtained by 
dsDNA sequencing of each of the four ovine cDNA clones. Each clone was fully sequenced 





The domain boundaries of each clone are indicated by vertical dashed lines. 
Long sequences ( -20 nucleotides) marked in bold type represent primers derived from the 
sense strand, while long sequences which are underlined denote primers derived from the 
antisense strand. 
Trimer sequences marked in bold type represent either the start codon (ATG) or the stop 
codon (TGA). 
The six -mer sequences marked in bold type in the SCD1A25, SCD1 B -42 and SCD1B-52 
sequences denote the location of the polyadenylation signal in each sequence. 
Fig.6A: SCD1 A25 
Alpha 1 Domain (Alpha 2 Domain 
1 CAGCTGGA ATIACCCCTTT GTGATCCAGG ACATAGCAGG 
39 TTGTGAGCTG CATCCTGGGA AGGCCGTAGA AAGCTTCTTG AAGGGAGCTT 
G5784 
89 TTGGAGGATT GGATTTCGTG AGCATCAAGA ATGATTCATG TGCACCTGTC 
139 CCAGGAGGCG GCAGCATGGC CCAGCGTTTC TATGAACTCA TCATTCAGAC 
189 CATGCTATCT GTGATACTAT AGCTAAGCTC CTCTTAGAAA CCTGCCCTCG 
5801 
239 ATATTTCCTG AGTGTCCTTG ATGCAGGCAA AGCAGAACTG CAGAGGCAAG 
IAlpha 3 Domain 
289 ITGAAGCCTGA GGCCTGGCTG TCCAGCGGCC CCACTCCTGG GCCTGGCCGC 
339 CTACTGCTGG TGTGCCATGT CTCAGGATTC TACCCAAAAC CTGTGTGGGT 
389 GATGTGGATG AGGGGTGAGC 
439 TCATGCCCAA TGC 
489 GCAGCTGGAG AGGCGGCTGG 
539 AGGAGACCAG GACATCGTCC 
AGGAAGAGCC TGGCACTCAG CAAGGGGACA 
B200 
AAATTGG ACTTGGCATC TGCGAGCAAC CCTAGATGTG 
B201 
TCTGAGTTGC CGAGTGAAGC ACAGCAGTCT 
ITM/CYT Domain 
TGTACTGGGIG ACACCCCACC TCCACTGGCC 
589 TGATATTTGT GGCAATAATA 
639 GCATTATGGT TTTGGAGGCG 
5802 
689 TCACTGTCTC CTTTTCCATT TGGAATAAGT ACCCACGAAC CCAGAAACTC 
739 AAGCGGTCAG CCCAGTAGCC AATTTCATCA TATTTCATCA AATAATCATC 
789 TGATCAAATC AAGTTCCTGT AGATTGCAAG ATCAGAAACA GAATTAAAGG 
839 TGTTCATATA TTATGAGACA ATACTAATAT TAGGATCTGC TCAGATTTCT 
889 TGGATGTGGG ATGCGGGAAA GAATGTACCT TGTAATAAAT GAAATGATGT 
939 ACACAAAAAA AAAAAAAAAA AAAAAAA 
GTGTCCTCCC TCATCCTTTT GATCTGTCTT 
CTGGTCATAT CTGACTATCT TGTGAGCCCA 
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Fig.6B: SCD1 B-42 
1 AAAGCTCT TTGAGAGGAGC 
Alpha 2 Domain 
20 CTTTAGGAGG ACTGGATGTT TTGAGGATCC AGAATCATTC CTGCATGCCT 
70 GCACCAGACA GCGGCAACAG GGGGCAGAAG CTTTGTGCAC TCCTGAGTCA 
120 GTATCAAGGC ACCTCCGATA TCATTGAGAG ACTCGTCTCA GAAACCTGTC 
170 CTCGATATCT CCTGGGTGTC CTCGATGCAG GGAAGGCAGA ACTGCAGAGG 
IAlpha 3 Domain 6088 
220 CAAGITGAAAC CTGAAGCCTG GCTTTCCAGT GGCCCCACTC CTGGGCCTGG 
B204 
270 CCGCCTACTG CTGGTGTGCC ATGTCTCAGG ATTCTACCCA AAACCTGTGC 
320 AGGTGATATG GATGAGGGGC AAGCAGGAGC AGCCTGGCAC TCAGCAAGGA 
B205 
370 GACATCATGC CCAATGCTGA CTGGACTTGG TATCTCCGAG TAACCCTAAA 
420 TGTGGCAGCT GGGGAGGCGG CTGGCCTGAG TTGCCGAGTG AAGCACAGCA 
ITM/CYT Domain 





















































Fig.6C: SCD1 B-52 
I 
Leader Domain 
1 CTCCGAGAGT CAGAAGTTCT ACTTCCCAGT GAAIATGCTGC TTCTACCACT 
'Alpha 1 Domain 
51 TCTGTTACTT GGAGTTATCC TCCCAGGTGG TGACIAATGAG GATGTGTTCC 
101 AGGGGCCAAC CTCCTTCCAT CTCAAGCAGA TTTCAACCTT TGTCAACAGC 
151 ACATGGGCTC AAAATCAAGG CTCAGGCTGG TTGGATGACT TGAAGATTCA 
G3540 6087 
201 TGGCTGGGAG AGTGACTCGG GCACTGCCAT TTTCCTGAAG CCCTGGTCCA 
251 AGGGCAACTT TACTGATGAG GAGATGACTG AGCTGGAGGA CATCTTCCGA 
301 GCCTACTTCA TTTTCTTCAC TCAGGAAGTG CAGGATCGAG TCAATGAGTT 
Alpha 2 Domain 
351 CCAGTTAGAA TIACCCCTTTG TGATCCAGGT CACAGCAGGC TGTGAGCTGC 
A410 
401 ATTCTGGGGA GGCCATAGAA AGCTCTTTGA GAGGTGCTTT AGGAGGACTG 






TACGAGGGGG CAGAATTTTT GTGCACTCAT 
A411 
CCGATATCCT TGAGAGACTC CTCTCAGAAA 
GGTGTCCTCG ATGCAGGGAA GGCAGAACTG 
TM/CYT Domain 
ATCCATTGGC TTGATACTTG TGGCAATAAT 
G3539 






751 TTGTGAGCAC TGACCGTGTC TCCTTTTCCA TTTTGGAATA AGTATCCAGG 
6086 
801 TACCCTGAAA CTCAAGTTGT CAGCCTAGGA GTCAGTCTCA TCATATTTCA 
851 TCAAATAATC ATCACATTTG ATCAAACATT GTTCCTGTAG GTTGTAAGAT 
901 AGATCATAAT TTATACCCTA GCAGAAACAA AAATGAAAAT TGTTATTATG 
951 AGACCATATC ACTAGCAGGA TCCACTCAGA TTTCATAGAT GTGATTTGTG 
1001 AGAAAGAATA TACCTTGGAA TAAATGAAAT GATGTACACA AAAAAAAAAA 
1051 AAAAAAAAAA AAAAAAA 
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Fig.6D: SCD1T10 
Alpha 1 Domain 1 Alpha 2 Domain 
1 CGGGCTGCAG GAATTCCAGT TTGAATIACCC ATTTGTGATT CAGGGCATAG 
51 CAGGTTGTGA GCTGCATTCT GGGAAGGCCA TACAAAGCTT CTTGAGAGCA 
101 GGTTTTGAAG GACTGGATTT CGTGAGCATC GAGAATCACT CATGTGTGCC 
G3537 
151 TGAGCCAGAG GGAGGCAGTG AAGCACAGTG GTTTTGTGTT TTCATTACTC 
201 AGTACCAAGG CATCTTGGCT ATCATAGACA GGCTCCTCTC AAAAACCTGC 
251 CCCCGATATC TCCTGGGTGT CCTCGATGCA GGGAAGGCGG AACTGCACAG 
I Alpha 3 Domain 
301 GCAAGITGAAG CCTGAAGCCT GGCTGTCCAG TGGCCCCACT CCTGGGCCTG 
351 GCCGCCTATT GCTGGTCTGC CATGTCTCAG GATTCTATCC AAAACCTGTA 
G4252 
401 CGGGTGATGT GGATGAGGGG TGAGCAGGAG CAGCCTGGTA CTCAGCAAGG 
451 AAACATCATA CTCAATGCTG ATTGGACTTG GTATCTCCGA GTAACCCTGG 
G3774 
501 ATGTGGCGGC TGGGGAGGCA GCTGGCCTGA GTTGTCGAGT GAAGCACAGC 
ITM/CYT Domain 
551 AGTCTAGGAG ACCAGGATAT CATCCTGTAC TGGGIGACACC CCATGTACAT 





















































































Figure 7: Sequencing Strategy and Domain Structure of The Four Ovine 
cDNA Clones. 
The top line in the diagram is a linear representation of a CD1 molecule, with the domain 
structure indicated by vertical lines. The domain structure of each clone was assigned as 
outlined in the text. The sequencing strategy for each of the four ovine cDNA clones is 
shown, with the approximate annealing positions of the sequencing primers indicated with 
respect to the overall domain structure. 
The position of each sequencing primer is shown by an arrowhead: right- facing arrows above 
each clone represent primer sequences derived from the sense strand, while left- facing 
arrows below each clone represent primer sequences derived from the antisense strand. 
The sequences of primers 392 and 393 were derived from pBluescript plasmid sequence in 
the regions immediately adjacent to the polylinker site. 
The thick black lines represent sequences which were subsequently derived by PCR. These were 





















































































































































































































deletion corresponds exactly to the a3 domain borders of the human CD1 B nucleotide 
sequence, so that the deletion does not cause a frameshift to occur. It is therefore possible to 
derive a predicted amino acid sequence for SCD1 B -52, as illustrated in section 3.3. 
Three of the four ovine cDNA's contain 3'UT regions of comparable length to that observed in 
the HCD1B sequence (-250 nucleotides), the exception being SCD1T10 which has a 3' UT 
region of 641 nucleotides. No consensus polyadenylation signal (AATAAA) is found in the 
3'UT of SCD1T10 and the sequence lacks a poly A tail. 
The final point to note regarding sequencing of the four cDNA clones is that the comparison 
of the SCD1A25 sequence to the HCD1B sequence for assignment of domain boundaries 
reveals an apparent one nucleotide deletion at position 187. This causes a frameshift and 
introduction of premature stop codons in the derived amino acid sequence. Comparison of 
the SCD1A25 sequence to the other three ovine sequences (see section 3.3) indicates that 
the other clones possess a T residue at this position. The approach taken to confirm the T 
deletion was two -fold. Firstly, a sequencing primer was designed from the sense strand 
sequence (G5784) which would anneal to A25 approximately 100 nucleotides upstream of 
the apparent deletion site. This enabled a short sequencing run to be carried out so that the 
nucleotides surrounding the deletion site ran close to the bottom of the sequencing gel and 
were widely spaced for ease of reading. Sequencing with primer G5784 confirmed the 
absence of T residue at position 187 (Figure 8A). The second approach taken to investigate 
the deletion was to map the cDNA clone using the enzyme Rsa I which cuts in the GTAC 
sequence. This strategy is outlined in Figure 9. It was possible to predict the number of bands 
resulting from an Rsa I digest of the SCD1A25 clone using the MAP programme on GCG 7.3, 
since the number and position of Rsa I cut sites in the pBluescript plasmid alone were already 
known (Stratagene Literature,1992). Sequence analysis of the SCD1A25 clone predicts that 
if there is a T at position 187, digestion with Rsa I will yield seven fragments, 2013, 1090, 375, 
197, 156, 69 and 25bp in size (Fig. 9B). If SCD1A25 lacks a T residue at position 187, then 
digestion with Rsa I will yield six fragments, 2088, 1090, 197, 156, 69 and 25bp in size Fig. 
9B). As a control, the clone SCD1T10, which has a T residue at a position equivalent to 
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Figure 8: Analysis of the SCD1A25 Clone to Determine the Presence or 
Absence of a T Residue at Position 187. 
A . The primer G5784 was used to sequence the SCD1 A25 clone, in order to verify the 
absence of a T residue at position 187. The sequence shown here reads from the bottom as 
follows, with the dot indicating the position where the T residue is missing: 
CATCATTCAG.ACCATGCTATCTGTGATACT 
B. The photographs show the results of Rsa I digests of various plasmid DNA samples 
analysed by gel electrophoresis. 
Lane 1. undigested pBluescript plasmid DNA. 
Lane 2. Rsa I digested pBluescript DNA. 
Lane 3. Rsa I digested DNA from clone A23 (identical to clone A25 by initial sequencing). 
Lane 4. Rsa I digested DNA from clone A25. 
Lane 5. Rsa I digested DNA from clone T10. 
Molecular weight markers are indicated in base pairs. 
A 
2 3 
A C G T 
3054 2036 
1584 1635 2036 
1635 1375 1018 
516/506 516/506 
394 394 516/506 
44 ¡ 344 I,'; 394 
298 298 
398 220 ` 220 




nucleotide 187 in SCD1A25, was also digested with Rsa I. Sequence analysis predicts that 
digestion of SCD1T10 with Rsa I will yield eight fragments, 2028, 1090, 504, 285, 198, 140, 
40 and 20bp in size (Fig. 9C). In all the digests, fragments of -100bp and less were not visible 
in the gel. Undigested and digested pBluescript DNA samples were analysed as controls (Fig. 
8B, lanes 1 and 2). The lack of a band of 375bp confirmed the absence of a T residue at 
position 187 in the A25 sequence (Fig. 8B, lane 4). Similarly, the A23 clone, which is identical 
to SCD1A25 according to the initial sequencing data, also lacked the definitive 375bp band 
(Fig. 8B, lane 3). However, the 2388bp fragment present in the SCD1A25 digest is absent in 
the digest of A23 DNA. Instead, two bands of -1800bp and 600óp are present which appear 
to have been derived from the 2388bp fragment i.e. there is an internal Rsa I site somewhere 
within this 2388bp fragment. This fragment is composed of 1826bp of pBluescript sequence 
(between positions 700 and 2526) and 562bp of insert sequence (Fig. 9B). The Rsa I 
digestion results for A23 indicate that the extra cut site is located either within the pBluescript 
sequence or near the start of the insert sequence. Given that the initial sequence data for 
A23 was unambiguous, the extra Rsa I site appears to be located somewhere within the 
pBluescript segment of the 2388bp fragment. Such a site is probably the result of a rare point 
mutation event which occurred during the various DNA manipulation procedures. Since the 
A23 result supported the absence of a T residue at position 187 in the A25 sequence, no 
further experiments were performed to investigate the extra Rsa I digestion site in A23. The 
result of the SCD1T10 digestion was as expected (Fig.8B, lanes). 
3.1.5 Discussion. 
Studies have been carried out to investigate the ovine CD1 family at the molecular level. A 
human CD1C a3 domain probe was used to screen several sheep thymocyte cDNA libraries 
and the ovine HCD1 B -like clone SCD1A25 was isolated from the foetal thymocyte library. A 
homologous a3 /TM /CYT probe derived from this clone identified a further three ovine clones - 
SCD1 B -42, SCD1 B -52 and SCD1T10, all of which are most homologous to the human CD1 B 
gene. Three of the four clones are truncated at the 5' end with sequences beginning around 
the end of the a1 domain or start of the a2 domain. The identification of 5' truncated clones is 
generally considered to be a feature of poor reverse transcriptase activity during library 
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Figure 9: Rsa I Restriction Enzyme Maps of pBluescript, SCD1A25 and 
SCD1T10. 
The three diagrams illustrate the second approach taken to verify the absence of a T 
nucleotide at position 187 of the SCD1A25 sequence, by mapping the clone with the 
restriction enzyme Rsa I, which cuts at the sequence GTAC. The diagrams show linearised 
versions of circular plasmids. 
Diagram A illustrates the positions of the Rsa I sites in the pBluescript plasmid vector alone, 
as well as the location of the EcoR I site into which the lambda inserts were subcloned. 
Figures in plain type above the line represent distances in base pairs. Figures in alternative 
type below the line indicate the position of enzyme digestion sites or the termini of the 
plasmid sequence. Diagrams B and C are annotated in a similar manner. 
Diagrams B and C illustrate the orientation of the A25 and T10 inserts after subcloning, as 
revealed by initial sequencing with the primers 392 and 393. The positions of the Rsa I sites 
are marked by arrowheads as in digram A, and the predicted number and sizes of bands 
obtained following Rsa I digestion are shown. The SCD1T10 clone was analysed as a 
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preparation. The fourth clone, SCD1 B -52, represents an a3 deletion transcript. 
An interesting point to note concerning the library screening data is that the first ovine CD1 
cDNA identified (SCD1A25) was selected by the human CD1C probe, and is a homologue of 
the human CD1 B gene. The other three ovine CD1 cDNA clones, identified with the 
homologous probe, are also most homologous to HCD1 B. The fact that all four of the ovine 
cDNA's are HCD1 B homologues is rather unexpected given the existence of five different 
CD1 subtypes in humans (Martin et al, 1986). Subsequent Southern blot analysis (see 
section 3.4) has revealed the existence of up to seven ovine CD1 genes, and it may be that 
the four cDNA's identified here do not represent the complete range of expressed ovine CD1 
genes. However, several pieces of information suggest that the homologous probe is 
capable of recognising all possible variants of the ovine CD1 antigens. Comparison of the 
SCD1A25 a3 region to the a3 domains of the human, mouse and rabbit genes indicates that 
the a3 domain is highly conserved across species barriers (76 -87% nucleotide identity). This 
suggests that the A25 a3 /TM /CYT probe is capable of identifying all possible ovine CD1 
subtypes, assuming the use of appropriate stringency conditions. In fact the ovine a3 
regions are more similar to each other than to the a3 regions in the CD1 genes of other 
species (90 -92% nucleotide sequence identity among the ovine a3 domains compared to 
76 -87% nucleotide sequence identity between ovine a3 domains and the a3 domains of 
human, rabbit and mouse genes). In a similar situation, the first human CD1 cDNA clone 
identified (FCB6 /FCB1 -two HCD1A sequences but with FCB1 extending a further 180 
nucleotides into the a1 domain; Calabi and Milstein, 1986), which contains the a3 domain as 
well as part of the a2, the TM /CYT and the 3'UT domains, was used to identify all five of the 
human genomic clones (Martin et al, 1986), the two mouse genomic clones (Bradbury et al, 
1988), several mouse cDNA clones (Bradbury et al, 1990) and the rabbit genomic clones 
( Calabi et al, 1989b). The FCB1 probe, in addition to the a3 domain, contains the TM /CYT 
domain, the a2 domain and part of the a1 domain. These regions are considerably less 
homologous across species barriers than the a3 region, yet the FCB1 probe was still able to 
identify other human, mouse and rabbit CD1 sequences. It is particularly notable that the 
FCB1 CD1 A probe was capable of identifying the CD1 D -type murine genomic and cDNA 
86 
clones, given that the nucleotide identity between the human and murine sequences for the 
a1 /a2 /a3 /TM /CYT /3'UT regions, as in the FCB1 probe, is only -55 %. It seems reasonable to 
conclude that the A25 a3 /TM /CYT probe is potentially capable of identifying all possible 
variants of the ovine CD1 molecules. Likewise, the human probes are probably capable of 
identifying the transcribed ovine genes, since comparison of the HCD1A and HCD1C a3 
domains with the ovine a3 domains gives an identity of 78 -84 %. 
For the initial library screen of the SFT library, duplicate filters were taken from the eight primary 
screen plates. One set of filters was probed with the human CD1 A a3 probe and the second 
identical set screened with the human CD1C a3 probe. In view of the fact that there is 79% 
nucleotide sequence identity between the a3 domains of HCD1A and HCD1C (Calabi et al, 
1991), it was expected that a significant overlap of plaques identified by each probe in the 
separate screenings would be observed. However, alignment of the duplicate filters revealed 
that few, if any, plaques were identified by both probes. This result gave the first indication of 
the problems which followed in screening the sheep libraries with the human probes. 
A direct comparison of the results from the SFT library screen with the heterologous HCD1A 
and HCD1C probes and the homologous A25 a3/TM /CYT probe provides a concise overview 
of the problems encountered during the screening work. When the SFT library was screened 
with the HCD1C probe (series A), thirty to fifty plaques were identified per 30,000 plaques 
screened. A similar frequency of positive clones was observed when the same library was 
screened with the HCD1A probe (series B). However, of the six EcoR I excisable inserts 
obtained from twenty -five positive plaques isolated from the secondary screen of the A series 
(1.0 -1.2kb in size), only two were CD1 equivalents, and these were identical. SCD1A25 was 
retained for further analysis. Following Mlu I digestions of the positive clones which did not 
yield Eco RI excisible inserts, several inserts were subcloned and four were sequenced, 
although none were found to be homologous to CD1. For the series B clones, seventeen 
EcoR I excisable inserts were obtained from a total of twenty -eight positive plaques isolated 
from the secondary screen. In contrast to the series A clones, several of the series B clones 
contained double inserts, and most bands were in the size range 3 -4kb. The size of these 
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inserts gave some cause for concern, since 3kb is the maximum size of any CD1 transcript 
observed so far (Calabi et al, 1988). None of the inserts turned out to be CD1 homologues. 
Screening of the SFT library with the A25 a3 /TM /CYT probe, although not a direct contrast to 
the results obtained by screening with the heterologous human probes because of the 
differences in stringency conditions, gave a frequency of twenty positive plaques per 
150,000 plaques screened. One EcoR I excisable insert (T10, -1.3kb) was obtained from 
twelve positive plaques identified in the secondary screen, and initial sequence analysis 
confirmed that it was a CD1 homologue. 
There are two main points to note regarding the screening results outlined above. Clearly, the 
heterologous probes were much less specific than the homologous probe at identifying 
ovine CD1 clones, as indicated by the numbers of positive plaques identified. This was 
confirmed by screening the ST -1 and ST -2 libraries with the homologous probe. Although not 
a direct comparison with the SFT library results, these screenings gave a similar frequency of 
positive plaques. Given the high percentage nucleotide identity between the a3 domains of 
the human, mouse, rabbit and ovine sequences (76 -86 %), the results seem to suggest that 
the flanking regions contained within the M13 human clones ( -0.3kb of flanking intron 
sequence from a total insert size of 0.6kb) may have significantly contributed to the screening 
difficulties encountered. With hindsight it appears that the initial library screens might have 
been more successful had most of the flanking region sequence been removed. For 
example, the PCR technique could have been used to amplify the a3 region from the M13 
DNA using primers based on the terminal sequences of the a3 domain. 
The second point to note is that library screening with the two human probes gave very 
different results. The human CD1 C probe was derived by PCR amplification from the original 
M13 clone, and was confirmed as CD1C by sequencing analysis. The human CD1A probe 
was obtained by directly subcloning the original M13 insert without FOR amplification. Since 
this probe was not confirmed as CD1A by sequence analysis, it is possible, though unlikely, 
that something other than a CD1 sequence was subcloned and subsequently used for library 
screening. An alternative explanation for the differences observed in screening with the two 
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human probes would be that the flanking intron sequences for the two probes differentially 
contributed to the identification of false positives. 
A third minor point to note regarding the screening results is that, with hindsight, the PCR 
technique could have been used to amplify inserts identified as positive in secondary screens 
but which did not yield Eco RI excisable inserts. This would have enabled subcloning and 
sequencing of all positive samples to be completed. 
Sequence analysis of the SCD1A25 clone revealed an apparent one nucleotide deletion at 
position 187 in the sequence, introducing premature stop codons in the deduced amino acid 
sequence (see section 3.3). This was initially considered to be due to error in reading the 
sequence, but further experiments ruled out this possibility. The deletion was verified by 
sequencing with the primer G5784 and by Rsa I digestion of the cloned DNA, as described 
previously. It is possible that the deletion represents a cloning artefact which could have 
arisen during synthesis of the cDNA used to prepare the library. This possibility could be 
investigated by isolation and sequencing of a genomic clone equivalent to SCD1A25, or by 
in vitro translation of A25 mRNA isolated using the cloned cDNA. In the latter case, the 
translation product is analysed by gel electrophoresis to determine its size and thus confirm 
the presence or absence of premature stop codons in the nucleotide sequence. 
The two clones SCD1 B -42 and SCD1 B -52 were both isolated from the ST -2 library. SCD1 B- 
42 contains a truncated CD1, while the SCD1 B -52 insert lacks the region which corresponds 
exactly to the a3 domain. Comparisons of these two sequences at the nucleotide level 
showed that they are -96% identical. A more detailed discussion of the implications of this 
high percentage sequence identity between SCD1 B -42 and SCD1 B -52 is presented in 
section 3.3.5. The SCD1 B -52 a3 deletion clone was presumably identified by the A25 
a3 /TM /CYT probe as a result of interaction between the TM /CYT domains of the probe and 
the SCD1 B -52 sequence. Comparison of the TM /CYT region of SCD1 B -52 and SCD1A25 
gives 88.5% identity over 113 nucleotides. No comparable deletion to that observed in 
SCD1 B -52 has been detected among any of the other known CD1 mRNA splice variants in 
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humans and mice (Calabi et al, 1989c; Bradbury et al, 1990; Woolfson and Milstein, 1994), 
although Kirszenbaum et al (1994) have recently reported an alternatively spliced form of the 
human nonclassical class I molecule HLA -G which lacks exon 4 (corresponding to the a3 
domain). 
Both cDNA sequence analysis and nuclease protection assays suggest the existence of a 
complex array of alternatively spliced human CD1 transcripts (Calabi et al, 1989c). Cryptic 
splice sites have been detected in the leader -a1 intron of HCD1 A, in the leader exon and the 
leader -a1 intron of HCD1 E, and within the a3 exons of HCD1B and HCD1 E (Calabi et al, 
1991). Most of these splicings cause frameshifts leading to chain termination or probable 
destruction of 132m binding and membrane expression, whereas the SCD1 B -52 sequence 
appears to be translatable. A recent analysis of human CD1 expression in mouse myeloma 
transfectants and in human thymocytes has revealed further mRNA splicing complexity 
(Woolfson and Milstein, 1994). Mouse myeloma cells were transfected with a partially spliced 
CD1A cDNA and the 10B3 clone selected for further analysis. Total 10B3 mRNA was copied 
into cDNA and used as a template in PCR reactions with CD1A primers from the a3 and 3' 
untranslated regions. Four bands were detected, cloned and sequenced. One PCR band was 
found to correspond to an unspliced transcript with a cryptic stop codon in the intron between 
the a3 and TM /CYT domains. Protein sequencing of CD1 a purified from the transfectant 
supernatant indicated that the unspliced transcript was a secretory isoform of CD1 a. A second 
PCR band was found to correspond to an alternatively spliced transcript in which a cryptic 
splice acceptor site within the transmembrane /cytoplasmic exon is utilised in preference to 
the site at the beginning of the exon. The product of this transcript was found to be an 
intracellular component. A third band represented the correctly spliced membrane -bound 
form of CD1 a and the fourth band was a heteroduplex derived from two of the other bands. A 
similar analysis of all five HCD1 genes was performed in thymus tissue. A single major band 
was detected following amplification of CD1A and CD1B cDNA, of a size consistent with the 
correctly spliced membrane -bound form of CD1. The single CD1A transcript detected in 
thymus tissue contrasts sharply with the complex splicing pattern observed in the CD1 A 
transfectant which was possibly due to overproduction. CD1 D amplification gave a major band 
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but in addition gave two minor bands. In contrast, CD1 C and CD1 E gave complex splicing 
patterns. The pattern for CD1C was comparable to that observed in the CD1A transfectant, 
with unspliced, alternatively spliced and correctly spliced transcripts being detected. Human 
CD1 gene expression is thus characterised by considerable mRNA splicing complexity which 
may be tissue specific. 
In the mouse, analysis of cDNA clones from total thymus RNA has revealed that the majority 
derive from partially spliced transcripts (Bradbury et al, 1990; Bradbury, A. PhD Thesis). The 
problems and implications of alternative splicing of mouse CD1 transcripts from thymus tissue 
have been fully discussed by Bradbury et al (1990). These authors highlight the fact that 
alternative splicing is not unique to the CD1 genes in the thymus and neither is it unique for 
thymus tissue. Introns of different genes have been found to be removed with different 
efficiency in different tissues. In fact, RNase mapping experiments with probes containing 
each of the domains of mouse CD1 D with a section of adjacent intron, showed that for mouse 
CD1 there was a significant degree of unspliced message (20 -50% of total) for the al , a2 and 
a3 regions in the thymus, a small degree in the spleen (1 -5 %) and normal splicing in the liver 
(Bradbury, A. PhD Thesis). The significance of the predominance of alternatively spliced CD1 
isoforms in the thymus is unclear, although it is of interest that thymic CD1 expression is 
confined to immature cortical thymocytes and is negatively correlated with MHC class I 
expression (Calabi et al, 1991). Heterogeneity of mRNA transcripts has been detected by 
Northern blot analysis for the mouse class lb gene TLa, with transcript sizes ranging from 1.3- 
3.5 kb (Flavell et al, 1986). Alternative splicing events have also been detected for the Qa -2 
class lb gene (Tabaczewski et a1,1994), for ovine and other classical class I molecules 
(Grossberger et al, 1990; Guillemot et al, 1988), and for a wide variety of other mammalian 
genes (Breitbart et al, 1987). Alternative splicing of CD1 mRNA may provide a mechanism for 
regulating gene expression (Calabi et al, 1991). 
Many of the known alternative splicing events for the CD1 molecules represent the use of 
alternative donor and acceptor sites for splicing which lie within potential coding sequence, 
and result in mRNA species which cannot be translated. In contrast to this, the a3 deletion of 
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SCD1 B -52 represents exclusion of a discrete exon of genetic information, which would result 
in the inability of the translated product to interact with ß2m. The biological significance of such 
a molecule is unclear, and it may be functionally unimportant. However, when alternatively 
spliced message has been identified from MHC class I genes, the cognate protein has often 
been subsequently found (Rodgers et al, 1986; McCluskey et al, 1986; Lew et al, 1987). The 
potential for membrane expression of an SCD1B-52 protein product remains to be 
established, since it is unclear whether interaction with ß2m, which is necessary for the correct 
folding and membrane expression of MHC class I a chains (Zijlstra et al, 1990), is an absolute 
requirement for surface expression of all CD1 molecules (Calabi et al, 1991). Although the a 
chains of HCD1 a and HCD1 b can be expressed on the cell surface independently of 132m, this 
appears to be the result of dissociation from ß2m at the cell surface (Calabi et al, 1991). 
Interestingly, Balk et al (1994) have recently reported the expression of HCD1d on human 
intestinal epithelial cells as a 37kD, non -(32m associated protein with no N- linked carbohydrate. 
Transfection into a ß2m- negative cell line confirmed that HCD1d (and the murine equivalent, 
CD1.1) can be expressed at the cell surface in the absence of ß2m. It is not known whether 
such 132m- independent CD1d molecules are functionally significant or not. The authors 
suggest that the lack of association with ß2m may be dictated by the conformation of the non - 
glycosylated CD1d a chain, indicating that a conventional site for peptide binding may not be 
present. Similarly, the protein encoded by SCD1 B -52 may be conformationally different 
compared to typical CD1 molecules, and may therefore not possess a conventional class I -like 
peptide binding groove. The question of structural differences between an SCD1B -52 
translation product and conventional CD1 molecules could be resolved by elucidation of their 
crystal structures and comparison to the known crystal structures of MHC class I molecules. 
A clone (A -14) identified by initial sequencing to be identical to SCD1 B -52, was also isolated 
from the adult ST -1 library. However, it was unlikely that A -14 contained the a3 region either, 
since the original lambda insert was identical in size and by initial sequencing data to that 
observed for the SCD1 B -52 clone. The identification of an a3 deletion cDNA clone 
from two 




Several potential experiments could be performed in order to further define the nature of 
SCD1 B -52 transcription and expression. The transcription of SCD1 B -52 could be 
investigated using a sensitive hot -start PCR technique, as employed in the investigation of 
HLA -G transcription (Kirszenbaum et al, 1994), using primers specific for the a2 and 3'UT 
regions of SCD1 B -52. Alternatively, Northern hybridisation using a probe based on the 
sequence of the a2 /TM border would enable the transcription of SCD1 B -52 to be 
investigated in a variety of tissues. This probe could also be used to confirm the specificity of 
any products amplified by PCR. It may also be possible to study SCD1B-52 membrane 
expression by generating an antipeptide antiserum against an epitope encoded by the 
junction of the a2 and TM nucleotide sequences. This latter method has recently been 
successfully employed to study the alternatively spliced transcripts of the nonclassical murine 
class I molecule Qa -2 (Tabaczewski et al, 1994). An antipeptide antiserum was generated 
against an epitope encoded by the junction of exon 4 and exon 6 in Qa -2 which was able to 
distinguish soluble Qa -2 molecules produced from exon 5 (TM domain) deletion transcripts 
and those derived from membrane -bound antigens. 
The SCD1T10 clone contained a truncated CD1 with a long 3'UT region of 641 nucleotides as 
compared to 260 -280 nucleotides for the 3'UT's of the other clones. The insert lacked a poly 
A tail and no polyadenylation signal (AATAAA) was observed. This is a similar situation to that 
observed after the cloning of HCD1 D cDNA, which has a 3'UT of 705 base pairs with no poly A 
tail or polyadenylation signal (Balk et al, 1989). In the latter case, sequencing of the 
corresponding genomic clone revealed a probable polyadenylation signal 21 base pairs 
downstream from the end of the cDNA sequence. It was noted that the cDNA library from 
which SCD1T10 was isolated (SFT), had been generated by isolation of messenger RNA on a 
poly dT column, followed by cDNA synthesis (Hein et al, 1989). It was therefore assumed that 
the SCD1T10 sequence, by virtue of being present in the cDNA library, had possessed a poly 
A tail at least until the point of being selected on the poly dT column. Messenger RNA 
transcripts lacking poly A tails are very unstable (Wickens et a1,1990; Wahle and Keller,1992), 
and it is unlikely that such a transcript would have survived selection on the poly dT column 
and cDNA synthesis. Careful examination of the region by alignment of all the ovine 
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sequences revealed a potential polyadenylation signal in an equivalent site to those 
observed in the other clones, although in this case the sequence read ACTAAA. The 3' UT 
for SCD1T10 extended a further 379 nucleotides downstream of this site, whereas the poly A 
tail in the other clones is located just 15 nucleotides downstream of the polyadenylation 
signal. Comparison of the nucleotide sequences preceding the polyadenylation sites in a 
wide variety of other eukaryotic mRNA's has revealed the presence of the ubiquitous 
hexanucleotide sequence AAUAAA (Wahle and Keller,1992). Mutagenesis experiments 
have since confirmed that this consensus sequence, typically located 10 -35 nucleotides 
upstream of the polyadenylation site, is essential for 3' -end formation of polyadenylated 
mRNA. The only common natural variant is AUUAAA. Comparison of the efficiency of 
polyadenylation of a variety of mutant polyadenylation sites has shown that the sequence 
AAUAAA is 100% efficient, and the most common variant, AUUAAA is 80% efficient (Wickens 
et al, 1990). The sequence found in SCD1T10 (ACUAAA for the RNA equivalent) was shown 
to be only 10% efficient for polyadenylation of the mRNA. It is apparent that the ACTAAA 
sequence in SCD1T10 was not used as a polyadenylation signal particularly since isolation by 
library screening from a cDNA library indicates that the transcript must be quite abundant in 
thymus tissue in vivo. This does not however rule out the possibility that some naturally 
occurring T10 transcripts may be able to use the ACTAAA sequence for induction of 
polyadenylation. It seems that the polyadenylation signal and poly A tail of SCD1T10 have 
been lost at somepoint during library generation. Isolation and sequencing of the genomic 
clone equivalent to SCD1T10 cDNA, as for HCD1 D, would confirm the use of an alternative 
polyadenylation signal downstream to that used by the other ovine sequences. 
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3.2 PCR Amplification of 5'UT/al Regions. 
3.2.1 Introduction 
Of the four ovine CD1 cDNA clones isolated by library screening, three were found to contain 
inserts truncated at the 5' end. The SCD1A25, SCD1T10 and SCD1B -42 inserts lack the 5'UT 
and a1 domains. The isolation of 5' truncated sequences from cDNA libraries is a relatively 
common phenomenon and is considered to reflect poor reverse transcriptase activity during 
cDNA synthesis for library preparation. The PCR technique was employed to isolate part of 
the 5' untranslated region as well as the al domain of the truncated clones in order to obtain 
full length sequence data encoding the ovine CD1 molecules. The region amplified is 
referred to as the "5'UT /a1 region" throughout this section. 
3.2.2 Experimental Rationale for PCR Of The 5'UT /cr.1 Regions. 
Two main PCR approaches were employed to amplify the unknown 5'UT /a1 regions of the 
ovine CD1 sequences. The first approach involved a modification of the anchored PCR or 
RACE (Rapid Amplification of cDNA Ends) PCR technique (Loh et al, 1989; Fig.1). In 
essence, the 5' RACE protocol generates cDNA molecules by performing reverse 
transcription using a gene specific primer (GSP). The specific first strand cDNA is 
polyadenylated using terminal deoxy nucleotidyl transferase (TdT) and dATP. The poly A tract 
serves as the target sequence for a hybrid poly T containing primer in the subsequent 
amplification process. The hybrid primer consists of oligo (dT) linked to a unique 17 -base 
oligonucleotide "adaptor" primer. One advantage of using a poly A tail concerns the fact that 
A -T binding is weaker than G -C binding, so that longer stretches of A residues in the cDNA are 
required for efficient nonspecific binding of the hybrid primer (Rolfs et al. 1992). The 
unknown 5'UT/al region is amplified using the hybrid primer and a second GSP upstream of 
the first one. One drawback of this approach is that specifically primed first strand cDNA must 
be synthesised for each transcript under study. A second problem with RACE is that specific 
primers may sometimes anneal inefficiently to the transcript of interest as a result of mRNA 
secondary structure. Random primed cDNA synthesis in conjunction with RACE can be 
employed to overcome such difficulties (Harvey and Darlinson, 1991) and was used in this 
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Figure 1: RACE -PCR of 5'UT /a1 Regions. 
Schematic representation of the RACE protocol for PCR amplification of 5'UT /a1 regions. 
The diagram is simplified at each stage to illlustrate only how the new product formed during 
the previous step is utilised. 
The diagram illustrates cDNA synthesis and the first round of PCR utilising the hybrid T17- 
adaptor primer (B186), the adaptor primer (B185) and the external gene specific primer 
(GSP2). The subsequent nested PCR reaction (not shown) utilised the adaptor primer and 
the internal gene specific primer (GSP1) only. All primer sequences are listed in Appendix 2B, 
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case. The use of nested antisense 3' GSP's is known to greatly increase the specificity of the 
RACE technique (Rolfs et al, 1992) and was also employed in this case. The antisense 3' 
primer sequences were carefully selected from maximally diverse regions of the SCD1A25 
and SCD1 B -42 clones in order to decrease the likelihood of nonspecific amplification of CD1 
sequences other than the target sequence. 
The second PCR approach for amplification of the 5'UT /a1 regions involved the use of a 5' 
degenerate primer in conjunction with nested 3' antisense GSP's (Fig. 2A). The 5' primer 
sequence (B199) was based on a conserved hexamer sequence located in the 5' UT region 
approximately100 nucleotides upstream of the translational start site (Fig. 2B). This 
conserved sequence is present in four of the five human CD1 genes, in the domestic rabbit 
gene and in both mouse genes (Calabi et al, 1989a; Balk et al, 1991a). The hexamer 
sequence is flanked by further regions of homology enabling a degenerate primer to be 
designed which could theoretically anneal to all the known sequences in this region. 
3.2.3 PCR Amplification of 5'UT /a1 Regions. 
Total RNA or poly A+ RNA was isolated from sheep thymus as described in section 2.12. 
cDNA was synthesised using random hexanucleotide primers, and the cDNA polyadenylated 
(see 2.13). This poly A tailed cDNA was used as a template for all 5' end PCR reactions. The 
PCR primers used for amplification of the 5'UT /a1 regions are listed in Appendix 2B. The anti - 
sense gene specific primers at the 3' end were located such that a 15 -20 nucleotide overlap 
was generated between the PCR product and the main clone sequence. All of the primers 
used in these PCR reactions contained additional sequences leading to incorporation of 
restriction enzyme sites in the resultant PCR products. Details of the PCR reactions are given 
in section 2.14. Control PCR reactions were included where appropriate. 
Amplification of the missing 5'UT /a1 regions of SCD1A25 and SCD1 B -42 was achieved 
using both PCR strategies described above (Fig. 3). The PCR products generated were of 
the expected size ( -450 -500 nucleotides). The attempted amplification of the 5'UT /a1 region 
of the SCD1 T10 sequence was unsuccessful. 
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Figure 2: PCR of The 5'UT /a1 Regions Utilising The Degenerate 5' Primer 
B199. 
A. The top line in thediagramis a linear representation of a CD1 molecule with the domain 
structure indicated by vertical lines. The lower part of the diagram shows a basic outline of the 
5'UT /a1 PCR technique utilising the degenerate 5' primer B199 and the nested 3' gene 
specific primers. 
B. The aligned sequences illustrate the derivation of the 5' degenerate primer B199. The 
conserved hexamer sequence GAAGTC is located -100 nucleotides upstream of the 
translation initiation codon in the 5' UT region, and is flanked by semiconserved regions of 
sequence. Outwith the hexamer sequence, nucleotides were preferentially selected from the 
HCD1A, B, C and DomRab sequences, since the HCD1 E, MCD1.1 and MCD1.2 sequences 
belong to a different class of CD1 molecules (Calabi et al, 1991). 
A 
5' UT ALPHA 1 , ALPHA 2 




1st round of PCR: B199 + GSP2 (external gene specific primer) 
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Figure 3: Results of PCR Amplification of 5' UT/al Regions. 
The photograph shows the results of PCR amplification of the 5'UT /a1 regions of SCD1A25 
and SCD1 B -42. 20% of the PCR products from the nested reaction were analysed by gel 
electrophoresis in a 1.5% agarose gel. 
Lane 1: 5'UT /a1 of SCD1A25 amplified using the 5' degenerate primer B199 in conjunction 
with the nested 3' GSP's. 
Lane 3: 5'UT /a1 of SCD1 B -42 amplified using the 5' degenerate primer B199 in conjunction 
with the nested 3' GSP's. 
Lane 5: 5'UT /a1 of SCD1A25 amplified using the RACE -PCR protocol. 
Lane 7: 5'UT /a1 of SCD1 B -42 amplified using the RACE -PCR protocol. 
Lane 9: positive control PCR (amplification of the first 936 nucleotides of the env gene of 
Maedi Visna virus strain EV1, using primers 240X and 767F and -5ng of plasmid pA46 DNA: 
Carey and Dalziel,1994) to show that all PCR reaction components were working effectively. 
Lane 10: as for lane 1, but using an alternative first round PCR sample as template. 
Lanes 2, 4, 6, 8 and 11: negative control PCR reactions where the DNA template was 
substituted by an equal volume of SDW. 
Molecular weight markers are indicated in base pairs. 




1375 ' 947 
831 - 564 
Initial attempts at cloning the purified PCR products by restriction enzyme digestion and 
ligation into appropriately cut pBluescript were not successful for unknown reasons. The 
remainder of the PCR products were finally cloned using the TA cloning kit (Invitrogen). 
However, the small number of clones derived from the RACE PCR products were found to be 
false positives, probably reflecting the small amount of amplified DNA which was then available 
for cloning. Cloning of the PCR products resulting from the reactions using the degenerate 5' 
primer was much more successful, yielding several insert- positive clones for sequencing. 
3.2.4 Presentation of 5'UT /a1 Sequence Data. 
The inserts from five SCD1 A25 5'UT /a1 region clones and three SCD1 B -42 5'UT /a1 region 
clones were essentially fully sequenced on each strand by dsDNA sequencing using the 
dideoxy chain termination technique (Sanger et a1,1977) and M13 forward and reverse 
sequencing primers (see Appendix 2A).The sequences obtained for the sense and 
antisense strands of each clone were compared and any ambiguities resolved by referring 
back to the original sequencing autoradiographs. The multiple sequences for the 5'UT /a1 
regions of SCD1A25 (Fig.4A) and SCD1B -42 (Fig.4B) were aligned using the PILEUP 
programme of the UWGCG version 7.3 sequence analysis software package (Devereux et al, 
1984). Pairwise comparisons between the SCD1A25 and SCD1B -42 sequences were 
performed using the GAP programme of UWGCG 7.3. 
The 1A25, 3A25 and 5A25 5'UT /a 1 region sequences are identical outwith the degenerate 
5' primer site except for two single base differences over 1347 (449x3) nucleotides (Fig. 4A). 
The 3A25 sequence contains an A residue at position 331 compared to a G residue present 
in the other two sequences. The 5A25 sequence contains a G residue at position 378 as 
opposed to an A residue at the same position in the other two sequences. There are sixteen 
nucleotide differences outwith the degenerate 5' primer site between the final two clones, 
2A25 and 4A25, as well as a four nucleotide deletion in the 5' UT region of 4A25. The single 
nucleotide differences are located at positions 33, 34, 76, 79, 101, 102, 110, 111, 165, 210, 
273, 280, 287, 370, 383 and 387. 
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Figure 4: Sequences of The 5'UT /alRegions of SCD1A25 and SCD1B -42. 
The sequences illustrated in Figure 4 represent the sequence information derived by dsDNA 
sequencing of each strand of the five SCD1A25 5'UT /a1 clones (Fig. 4A) and the three 
SCD1 B -42 5'UT /a1 clones (Fig.4B). 
Domain boundaries are indicated by vertical dashed lines. 
Long sequences ( -20 nucleotides) marked in italic bold type represent the primers used in 
the nested PCR reaction. 
The trimer sequence marked in bold type (ATG) is the translation initiation codon. 
Differences between the sequences are indicated by a single underline beneath the 
sequence alignment. 
The overlap of the PCR sequences with the main clone sequence begins at nucleotide 415 
for the SCD1A25 5' ends and at nucleotide 483 for the SCD1 B -42 5' ends. 
The horizontal line dividing the first three virtually identical SCD1A25 5' sequences from the 
other two=ilustrates the clear division of the first three sequences from the other two similar but 































































101 Leader Domain 1150 
1A25 TGCTTCTGCC ACTTCTATTG CTAGCAGTTA TTGTGCCAGG TGGTGACIAAT 
3A25 TGCTTCTGCC ACTTCTATTG CTAGCAGTTA TTGTGCCAGG TGGTGACIAAT 
5A25 TGCTTCTGCC ACTTCTATTG CTAGCAGTTA TTGTGCCAGG TGGTGACIAAT 
2A25 TGCTTCTACC GCTTCTGTTA CTTGGAGTTA TCCTCCCAGG TGGTGACIAAT 


































































Alpha 1 Domain 
TCCAGGGGCC AACCTCCTTC CATGTCATCC 
TCCAGGGGCC AACCTCCTTC CATGTCATCC 
TCCAGGGGCC AACCTCCTTC CATGTCATCC 
TCCAGGGGCC AACCTCCTTC CATCTCAAGC 
































































ATTCCAGCTG GAATIACCCCT TTGTGATCCA 
ATTCCAGCTG GAATIACCCCT TTGTGATCCA 
ATTCCAGCTG GAATIACCCCT TTGTGATCCA 
GTTCCAGTTA GAATIACCCCT TTGTGATCCA 






































1 B199 50 
1B-42 AAAGGAAGTC AGTACAGAGT ACTG...AAA AAAAAAAAAG CTGAAATTAG 
3B-42 GAAGGAAGTC AGTACAGAGT ACTGAAAAAA AAAAAAAAAG CTGAAATTAG 
2B-42 GGAAGAAGTC ACAACAGAGT ACTG....AA AAAAAAMAG CTGAAATTAG 
51 5'UT Domain 100 
1B -42 AGATCAAATA CCAGCTCCGA GAGTCAGAAA TTCTACTTTC CAGTGAAATG 
3B -42 AGATCAAATA CCAGCTCCGA GAGTCAGAAA TTCTACTTTC CAGTGAAATG 
2B -42 AGATCAAATA CCAGCTCCGA GAGTCAGAA TTCTACTTÇC CAGTGAAATG 
101 1150 
1B -42 CTGCTTCTAC CGCTTCTGTT ACTTGGAGTT ATCCTCCCAG GTGGTGACIAA 
3B -42 CTGCTTCTAC CGCTTCTGTT ACTTGGAGTT ATCCTCCCAG GTGGTGACIAA 
2B -42 CTGCTTCTAC CACTTCTGTT ACTTGGAGTT ATCCTCCCAG GTGGTGACIAA 
151 Alpha 1 Domain 200 
1B -42 TGAGGATGTG TTCCAGGGGC CAACCTCCTT CCATCTCAAG CAGATTTCAA 
3B -42 TGAGGATGTG TTCCAGGGGC CAACCTCCTT CCATCTCAAG CAGATTTCAA 
2B -42 TGAGGATGTG TTCCAGGGGC CAACCTCCTT CCATCTCAAG CAGATTTCAA 
201 250 
1B -42 CCTTTGTCAA CAGCACATGG GCTCAAAATC TAGGCTCAGG CTGGTTGGAT 
3B -42 CCTTTGTCAA CAGCACATGG GCTCAAAATC TAGGCTCAGG CTGGTTGGAT 
2B -42 CCTTTGTCAA CAGCACATGG GCTCAAAATC AAGGCTCAGG CTGGTTGGAT 
251 300 
1B -42 GACTTGCAGA TTCATGGCTG GGAGAGTGAC TCGGGCACTG CCATTTTCCT 
3B -42 GACTTGCAGA TTCATGGCTG GGAGAGTGAC TCGGGCACTG CCATTTTCCT 
2B -42 GACTTGAAGA TTCATGGCTG GGAGAGTGAC TCGGGCACTG CCATTTTCCT 
301 350 
1B -42 GAAGCCCTGG TCCAAGGGCA ACTTTAGTGA TGAGGAGATA ACTGAGCTGG 
3B -42 GAAGCCCTGG TCCAAGGGCA ACTTTAGTGA TGAGGAGATA ACTGAGCTGG 
2B -42 GAAGCCCTGG TCCAAGGGCA ACTTTAGTGA TGAGGAGATG ACTGAGCTGG 
351 400 
1B-42 TGGACCTCTT CCGAGTCTAC CTCATTGGAT TCATTCGGGA AGTGCAGGAT 
3B-42 TGGACCTCTT CCGAGTCTAC CTCATTGGAT TCATTCGGGA AGTGCAGGAT 
2B-42 AGGACATCTT CCGAGÇCTAC TTCATTTTCT TCAÇTCAGGA AGTGCAGGAT 
401 Alpha 2 Domain 450 
1B -42 CGAGTCAATG AGTTCCAGTT AGAATI GTCATAGA 
3B -42 CGAGTCAATG AGTTCCAGTT AGAATIACCCC TTTGTGATCC AGGTCATAGA 
2B -42 CGAGTCAATG AGTTCCAGTT AGAATIACCCC TTTGTGATCC AGGTCAçAGÇ 
451 500 
1B -42 AGGCTGTGAG CTGCATTCTG GGGAGGCCAT TGAAAGCTCT TTGAGAGGAG 
3B -42 AGGCTGTGAG CTGCATTCTG GGGAGGCCAT AGAAAGCTCT TTGAGAGGAG 
2B -42 AGGCTGTGAG CTGCATTCTG GGGAGGCCAT AGAAAGCTCT TTGAGAGGAG 
501 B203 518 
1B -42 CTTTAGGAGG ACTGGATG 
3B -42 CTTTAGGAGG ACTGGATG 
2B -42 CTTTAGGAGG ACTGGATG 
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Two of the three SCD1B-42 5'UT /a1 region clones (1B-42 and 3B -42) are highly 
homologous outwith the degenerate 5' primer site with only one single nucleotide difference 
at position 481, as well as a three nucleotide deletion in the 5'UT region and a seventeen 
nucleotide deletion at the beginning of the a2 domain (Fig. 4B). The third clone, 2B -42, 
contains eighteen nucleotide differences outwith the degenerate 5' primer site compared to 
the other two clones as well as a four nucleotide deletion in the 5'UT region. The nucleotide 
differences are located at positions 37, 38, 80, 89, 112, 231, 257, 351, 356, 366, 371. 377, 
378, 389, 384, 387, 447 and 450. The 2B -42 clone is 99.4% identical to the known 5' end of 
the SCD1 B -52 sequence. 
3.2.5 Discussion. 
The PCR technique was used to amplify the missing 5'UT /a1 regions of the truncated clones 
SCD1A25 and SCD1 B -42. The amplification products from the reactions involving the 5' 
degenerate primer B199 and nested 3' GSP's were cloned and dsDNA isolated for 
sequencing. The inserts from five SCD1A25 5'UT /a1 region clones and three SCD1 B -42 
5'UT /a1 region clones were fully sequenced on each strand. The sequences within each 
group were aligned enabling consensus sequences to be derived for completion of the 
SCD1A25 and SCD1B -42 clone sequences. 
Several points worthy of discussion arose during the course of this work. Thymus tissue was 
selected for preparation of the mRNA as the main ovine clones had been isolated from 
thymocyte cDNA libraries. The template cDNA for the 5'UT /a1 region PCR reactions was 
synthesised using random hexanucleotide primers rather than a gene specific primer or oligo 
(dT) primer. Use of a GSP is preferable to use of an oligo (dT) primer for isolation of 5' ends, for 
obvious reasons. However, it is often more advantageous to use random primed cDNA for 5' 
end isolation. This is because use of random primers for cDNA synthesis overcomes potential 
problems with inefficient binding of the GSP to the target transcript due to mRNA secondary 
structure. In addition, a random primed cDNA pool can be used for PCR amplification of 
numerous different target sequences, obviating the requirement for generation of specifically 
primed cDNA for each transcript of interest. 
103 
The random primed cDNA was polyadenylated for use in the RACE -PCR protocol. In theory, 
any nucleotide can be used in the tailing reaction. However, in practice, poly A tailing is 
preferred, since use of either dC or dG is more likely to lead to truncation of products due to 
nonspecific primer annealing during amplification. This is because homopolymers of C or G 
anneal with much higher affinity than do homopolymers of A or T, and 5' UT and coding 
sequences are naturally GC rich ( Rolfs et al, 1992). 
Four of the five SCD1A25 5'UT /a1 clones and two of the three SCD1 B -42 5'UT /a1 clones 
contain small gap regions in the 5'UT domains (Fig.4A and 4B). These deletions are located 
within a poly A stretch of sequence which varies between seven and fifteen nucleotides in 
length. The location of the deletions within a poly A region in each clone suggests that they 
are FOR artefacts, probably produced by slippage or stuttering of the Taq pol enzyme during 
DNA amplification. This phenomenon of small deletions occuring in PCR products within a 
region of poly N (where N is A, C, G or T) sequence has also been observed during the 
cloning and isolation of the ovine IL -1 a and (3 genes (C. Fiskerstrand, personal 
communication). 
Five 5'UT /a1 region SCD1A25 clones were obtained for sequencing, three of which are 
identical except for two nucleotide differences from a total of 1347 nucleotides. Differences 
occurring within the 5' primer (B199) site were disregarded due to the degenerate nature of 
the primer sequence itself. Two of the three clones (1A25, 3A25 and 5A25) contain a G at 
position 331 and an A at position 378. Sequence 1A25 was therefore selected as the 
representative consensus sequence of the three clones, as it contains the appropriate 
nucleotides at these positions. 
It is assumed that the two nucleotide differences between the 1A25, 3A25 and 5A25 
sequences are the result of Taq polymerase infidelity. In vitro use of polymerase enzymes 
leads to misincorporation of nucleotides due to the lack of the cellular error correcting 
apparatus and because polymerisation conditions are often less than optimal. Cloning 
strategies involving the PCR are particularly error prone because the polymerisation 
reaction is 
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repeated many times in vitro. One study by Saiki et al (1988) estimated an error rate of 0.25% 
(or 1 in 400) following thirty cycles of amplification of a particular fragment. The estimated error 
frequency in a recent study of sequence variation in the gp135 gene of Maedi Visna Virus 
strain EV1 was 1 in 800 or 0.125% (N. Carey, PhD Thesis, University of Edinburgh, 1993). 
Observed error frequencies can vary more than ten fold, from 2 per 10,000 nucleotides to 
less than 1 per 100,000 nucleotides, depending on the target sequence and the conditions 
of DNA synthesis (Eckert and Kunkel, 1991). Several parameters of the PCR reaction can 
influence the fidelity of the polymerase enzyme, including dNTP concentrations, enzyme 
concentration, reaction conditions, MgCl2 concentration and pH. The concept that conditions 
generating the greatest amount of DNA product are also optimal for fidelity of the polymerase 
enzyme is not necessarily true. The frequency of nucleotide differences observed for the 
1A25, 3A25 and 5A25 PCR generated 5'UT /a1 regions is 1 per 675 nucleotides. This figure 
is comparable to the data discussed above, particularly since seventy rounds of amplification 
were performed prior to cloning. The two nucleotide differences detected between 1A25, 
3A25 and 5A25 are both single base purine to purine transitions, one a G -A transition at 
position 331 and the second an A -G transition at position 378 (Fig. 4A). Ennis et al (1990) 
analysed the nature and frequency of PCR- derived errors produced during the amplification 
and cloning of full -length class I HLA cDNA. Purine to purine transitions were the most 
common single base substitutions detected (fourteen out of twenty -eight substitutions were 
purine to purine transitions). 
The representative 1A25 sequence was compared to the known 5'UT /a 1 region of SCD1B- 
52 and to the representative 3B -42 sequence, giving -85% sequence identity in each case. 
This supports the view that the 1A25 sequence does not represent inadvertent amplification 
of the 5'UT /a1 region of either SCD1B-42 or SCD1 B -52. However, it was not possible to 
determine the percentage identity of 1A25 compared to the 5'UT /a1 region of SCD1T10, as 
attempts to amplify the SCD1T10 5'UT /a1 region were unsuccessful. Consequently, the 
possibility that 1A25 corresponds to the 5'UT /a1 region of SCD1T10 could not be eliminated, 
although this possibility was minimised by careful selection of 3'GSP primer sequences. 
Similarly, it is possible that 1A25 corresponds to the 5'UT /a1 region of an, as yet uncloned, 
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ovine CD1 transcript. Given the difficulties in selecting clone specific 3' primers, it is fortuitous 
that three virtually identical 5'UT /a1 region clones were obtained in order to derive a 
consensus sequence for completion of the SCD1A25 sequence. 
The two other SCD1A25 5'UT/al region sequences (2A25 and 4A25) are different from the 
representative 1A25 sequence. This is indicated by pairwise comparison of the 2A25 and 
4A25 sequences to 1A25 each giving -86% nucleotide sequence identity Oomparison of 
2A25 and 4A25 sequences to SCD1B -52 each gave -95% nucleotide sequence identity. 
Comparison of the 2A25 and 4A25 sequences to the representative 3B -42 5'UT /a1 region 
sequence (see a later paragraph) gave -99% and 95% nucleotide sequence identity 
respectively. Hence it appears that the 2A25 sequence has actually been amplified from the 
5'UT /a1 region of SCD1 B -42. The 4A25 sequence is likely to represent inadvertent 
amplification of the 5'UT /a1 region of SCD1 T10 or an, as yet uncloned, ovine CD1 transcript 
as discussed above. 
Three 5'UT /a1 region SCD1 B -42 clones were obtained for sequencing. Two of these clones, 
1B-42 and 3B -42, are identical outwith the degenerate 5' primer site, except for a single 
nucleotide difference (an A -T point substitution) and two deletion sites. It is highly likely that 
the single nucleotide difference between 1B-42 and 3B -42 was generated during PCR 
amplification. The 3B -42 sequence was selected as representative of these two clones as it 
did not contain any gap regions. The larger of the two gap regions in 1B-42 is a splice junction 
deletion of seventeen nucleotides beginning at the start of the a2 domain. This deletion is 
highly unlikely to be a PCR artefact and may represent the use of a cryptic splice acceptor site 
with +h the a2 domain. Similarly, a human CD1 transcript has been detected in which a cryptic 
splice acceptor site within the transmembrane /cytoplasmic exon is utilised in preference to 
the site at the beginning of the exon (Woolfson and Milstein, 1994). The second deletion is 
three nucleotides long and located near the start of the sequence in the 5'UT region. This 
deletion is likely to be a PCR artefact, as discussed previously. 
Comparison of 3B -42 to the 5'UT /a1 region of SCD1B -52 and the representative 1A25 
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sequence gave less than 96% and -85% nucleotide sequence identities respectively. This 
supports the view that the 3B -42 sequence does not represent inadvertent amplification of 
the 5'UT /a1 region of either SCD1 B -52 or SCD1A25. It was not possible to eliminate the 
possibility that 3B -42 corresponds to the 5'UT /a1 region of SCD1 T10 or to the 5'UT /a1 
regions of other as yet uncloned ovine CD1 transcripts, as discussed for the SCD1 A25 
5'UT /a1 regions. The 2B -42 sequence was found to be 99.5% identical to the 5'UT /a1 
region of SCD1B -52 and hence appears to represent an inadvertent amplification during the 
PCR step. The high percentage sequence identity between the SCD1 B -42 and SCD1B-52 
sequences in the a2 domain ( -93 %- see section 3.3) rendered it particularly difficult to select 
3' primer sequences which would preferentially anneal to SCD1 B -42 during PCR 
amplification. 
In view of the 5'UT /a1 region clone sequence data discussed above, the 1A25 sequence 
was selected for addition to the main SCD1A25 clone sequence in order to obtain full length 
sequence information. Similarly, the 3B -42 sequence was used to complete the sequence 
obtained from the main SCD1 B -42 clone. The full length nucleotide sequences for both 
ovine CD1 molecules are presented and analysed in section 3.3. 
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3.3 Analysis Of The Ovine CD1 Sequences. 
3.3.1 Introduction. 
Four ovine CD1 clones have been isolated by library screening. Three of the clones 
(SCD1 A25, SCD1 B -42 and SCD1 T10) contain inserts truncated at the 5' end. The fourth 
clone (SCD1 B -52) contains an insert which is intact at the 5' end but has a precise deletion of 
the a3 domain. The missing 5' sequences for the SCD1A25 and SCD1 B -42 clone inserts 
were obtained by PCR amplification, as detailed in section 3.2. Analyses of the SCD1A25 
and SCD1 B -42 sequences were therefore performed on composite sequences derived from 
both the main clones and from PCR 5'UT /a1 clones. This section of the thesis details the 
analyses performed on the ovine CD1 sequences and includes comparisons with the human, 
murine and rabbit CD1 sequences. 
The various alignments presented in this section were generated using the PILEUP 
programme of UWGCG 7.3. This programme creates a multiple sequence alignment using 
progressive pairwise alignments, and is based on a simplification of the method of Feng and 
Doolittle (1987). Amino acid sequences were derived from nucleotide sequences using the 
TRANSLATE programme. The SCD1A25 sequence appears to contain a one nucleotide 
deletion at position 602 (see Fig.1) which introduces frameshifts and premature stop codons 
in the deduced amino acid sequence. For the purpose of this analysis, a single nucleotide (N, 
representing A, C, T or G) was inserted at position 602 which enabled a full -length in -frame 
amino acid sequence of SCD1A25 to be derived. Pairwise identity comparisons of the CD1 
sequences were calculated using the GAP programme for both nucleotide and derived amino 
acid sequences. This programme uses the algorithm of Needleman and Munsch (1970) to 
find the alignment of two sequences, maximising the number of matches and minimising the 
number of gaps. The programme was executed using the default settings for gap weight and 
gap length (5.0 and 3.0 respectively for nucleotide comparisons, and 0.3 and 0.1 respectively 
for amino acid comparisons). 
The domain boundaries for both the ovine nucleotide and amino acid sequences were 
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Figure 1: Aligment Of The Four Ovine CD1 Nucleotide Sequences. 
The four ovine CD1 nucleotide sequences were aligned using the PILEUP programme of 
UWGCG 7.3. 
Domain boundaries were defined by comparison to the most closely related human gene, 
HCD1B. 
The translation initiation codon (ATG) is indicated in bold type at position 98. The translation 
termination codon (TGA) is indicated in bold type at position 109T. 
Dashes indicate identity to the SCD1B-42 nucleotide sequence. Dots indicate gaps 
introduced to maintain sequence aligment. 
The nucleotide numbering is based on the SCD1 B -42 sequence. 
The hexamer sequences underlined in the 3'UT domains denote the polyadenylation signals. 
5'UT Domain 
1 50 
SCD1B-42 GAAGGAAGTC AGTACAGAGT ACTGAAAAAA AAAAAAAAAG CTGAAATTAG 
SCD1A25 -G C--T ...G- ----GGTTT- 
51 97 
SCD1B-42 AGATCAAATA CCAGCTCCGA GAGTCAGAAA TTCTACTTTC CAGTGAA 
SCD1B-52 G C- 
SCD1A25 AT--T G C C- --T---G 
Leader Domain 
98 147 
SCD1B-42 ATGCTGCTTC TACCGCTTCT GTTACTTGGA GTTATCCTCC CAGGTGGTGA 
SCD1B-52 A 





Alpha 1 Domain 
149 198 
SCD1B-42 AATGAGGATG TGTTCCAGGG GCCAACCTCC TTCCATCTCA AGCAGATTTC 
SCD1B-52 
SCD1A25 A G--- TC 
199 248 
SCD1B-42 AACCTTTGTC AACAGCACAT GGGCTCAAAA TCTAGGCTCA GGCTGGTTGG 
SCD1B-52 A 
SCD1A25 G--A----C- T- A 
249 298 
SCD1B-42 ATGACTTGCA GATTCATGGC TGGGAGAGTG ACTCGGGCAC TGCCATTTTC 
SCD1B-52 A- 
SCD1A25 -CA-T C--T C---- --C-A A----C-- 
299 348 
SCD1B-42 CTGAAGCCCT GGTCCAAGGG CAACTTTAGT GATGAGGAGA TAACTGAGCT 
SCD1B-52 C- G 
SCD1A25 T C G -G 
349 398 
SCD1B-42 GGTGGACCTC TTCCGAGTCT ACCTCATTGG ATTCATTCGG GAAGTGCAGG 
SCD1B-52 --A----A C-- --T TT C----C--A- 
SCD1A25 --A---A--A --TA T-C--TA 
399 425 
SCD1B-42 ATCGAGTCAA TGAGTTCCAG TTAGAAT 
SCD1B-52 
SCD1T10 .CG-GC-GC- G--A T 
SCD1A25 -C-AT----G ---A C-G 
1 09 
Alpha 2 Domain 
426 475 
SCD1B-42 ACCCCTTTGT GATCCAGGTC ATAGAAGGCT GTGAGCTGCA TTCTGGGGAG 
SCD1B-52 C--C 
SCD1T10 T----G- ----C---T- A-- 
SCD1A25 A- ----C---T- C A-- 
476 525 
SCD1B-42 GCCATAGAAA GCTCTTTGAG AGGAGCTTTA GGAGGACTGG ATGTTTTGAG 
SCD1B-52 T 
SCD1T10 C--- ---TC C--G---T -A T-CG---- 
SCD1A25 ---G TC- -A G 
526 575 
SCD1B-42 GATCCAGAAT CATTCCTGCA TGCCTGCACC AGACAGCGGC AACAGGGGGC 
SCD1B-52 TG C T -CG 
SCD1T10 ----G C--A--TG AG-- ----G-A--- -GTGAA-CA- 
SCD1A25 C---A G----A--TG CA TC --GAG G--T--CC- 
576 625 
SCD1B-42 AGAAGCTTTG TGCACTCCTG AGTCAGTATC AAGGCACCTC CGATATCATT 
SCD1B-52 ----TT A-- -C T C-- 
SCD1T10 --TG-T---- --TTT--A-T -C C- T--T G-C A 
SCD1A25 --CGTT-C-A --A----A-C -T----.-C- -T-CT-T--G T----CT A 
626 675 
SCD1B-42 GAGAGACTCG TCTCAGAAAC CTGTCCTCGA TATCTCCTGG GTGTCCTCGA 
SCD1B-52 C G--A-, 
SCD1T10 --C--G---C A---- -C -C 
SCD1A25 -CT-AG---C ---T C T A T-- 
676 704 
SCD1B-42 TGCAGGGAAG GCAGAACTGC AGAGGCAAG 
SCD1B-52 
SCD1T10 G C 
SCD1A25 C--A 
Alpha 3 Domain 
705 754 
SCD1B-42 TGAAACCTGA AGCCTGGCTT TCCAGTGGCC CCACTCCTGG GCCTGGCCGC 
SCD1B-52 
SCD1T10 ----G G 
SCD1A25 ----G G G C 
755 804 
SCD1B-42 CTACTGCTGG TGTGCCATGT CTCAGGATTC TACCCAAAAC CTGTGCAGGT 
SCD1B-52 
SCD1T10 ---T C T A-G--- 
SCD1A25 TG--- 
805 854 
SCD1B-42 GATATGGATG AGGGGCAAGC AGGAGCAGCC TGGCACTCAG CAAGGAGACA 
SCD1B-52 
SCD1T10 ---G TG T A--- 
SCD1A25 ---G TG--- ----AG G---- 
855 904 
SCD1B-42 TCATGCCCAA TGCTGACTGG ACTTGGTATC TCCGAGTAAC CCTAAATGTG 
SCD1B-52 
SCD1T10 T GG 
SCD1A25 AA-T C--- -G----C--- ----G 
905 954 
SCD1B-42 GCAGCTGGGG AGGCGGCTGG CCTGAGTTGC CGAGTGAAGC ACAGCAGTCT 
SCD1B-52 
SCD1T10 --G A T 
SCD1A25 A- T 
955 983 
SCD1B-42 AGGAGACCAG GACATCATCC TCTACTGGG 
SCD1B-52 
SCD1T10 T G 




SCD1B-42 GACACCCCAC ATCCATTGGC 
SCD1B-52 
SCD1T10 T G-A 
SCD1A25 
1033 





SCD1B-42 TTGATCCTTT CGATATGCCT TGCATTATGG TTTTGGAGAC GCTGGTCATA 
SCD1B-52 T C- 
SCD1T10 C- T T 












SCD1B-42 GCCCTGACCA TGTCTCCTTT TC.ATTTGG 





SCD1T10 C-G- ---A 











GAAACTTAAG TTGTCAGCCT AGGAGTCAAT CTCATTATAT TTCATCAAAT 
C G- C 
SCD1B-42 
SCD1B-52 
SCD1T10 --C T- 
SCD1A25 TG- -CAAA 
C T---C 
C --T--C T----C 
1197 1246 













TA-- G -TG -- 
- AGRA -C- 
1297 
ATATCACTAG CAGGATCCAC 














-CT-A -T T TG- 
A-G . .--G A G 
T -G GG A--C-G---- 
1347 1379 
SCD1B-42 G.ATATACCT TGGAATAAAT GAAATGATGT ACAC 
SCD1B-52 -A 
SCD1T10 -A--G--T-- CA--C 
SCD1A25 -A--G T 
G--GGACTAA ATTGTGACAT 
SCD1T10 TCCTTTGGCT TCTTATTTTA 
SCD1T10 ATTTGTCAAA ATGAGCTAAT 
SCD1T10 GCAGAGATGA CCAGCATTTT 
SCD1T10 TCTATCTTGG AGAAACTGAG 
SCD1T10 TCCTACAGTA GAAGTAACCA 
SCD1T10 TTTCCTCTTT ACTCAGAACA 























defined by comparison to the most homologous human gene. This is the HCD1 B gene for 
each of the ovine sequences isolated (see Table 3 later in this section). The domain borders 
for the human, murine and rabbit sequences had been defined previously (human 
sequences- Martin et al, 1987; Aruffo and Seed, 1989; Balk et al, 1989; Calabi et al, 1989a: 
mouse sequences- Bradbury et al, 1988; Balk et al, 1991: rabbit sequences- Calabi et al, 
1989b). 
3.3.2 Overview Of The Ovine CD1 Nucleotide And Amino Acid Sequence 
Data. 
By homology to the known human, murine and rabbit CD1 sequences, the ovine nucleotide 
sequences encode a polypeptide with three extracellular domains each approximately ninety 
amino acids long. 
The 1377bp SCD1A25 composite cDNA sequence (Fig.1) contains a 145bp 5' untranslated 
region preceding the presumed translation initiation codon ATG. The 3' untranslated region is 
262bp long with a consensus polyadenylation signal at position 1363 -68, 15bp upstream of 
the poly A tail. Insertion of a single nucleotide (N) at position 602 of the sequence enabled a 
predicted amino acid sequence of 334 residues to be derived (Fig.2). The first sixteen amino 
acids constitute a signal peptide which would be cleaved to produce the mature protein. 
The 1382bp SCD1B-42 composite cDNA sequence contains a 148bp 5' untranslated region 
followed by the translation initiation codon (Fig.1). The 3' untranslated region contains a 
consensus polyadenylation signal at an equivalent position to that observed in the SCD1A25 
sequence. The long open reading frame extends from position 97 to position 1099 and 
encodes a polypeptide of 334 residues (Fig.2). Cleavage of the sixteen residue amino 
terminal signal sequence would produce a mature protein consisting of three extracellular 
domains, a hydrophobic transmembrane domain and a short cytoplasmic tail, similar to the 
human and murine CD1 molecules. 
The 1067bp SCD1 B -52 cDNA clone sequence contains a 33óp 5' untranslated region 
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Figure 2: Alignment Of The Deduced Ovine CD1 Amino Acid Sequences. 
The four deduced ovine CD1 amino acid sequences were aligned using the PILEUP 
programme of UWGCG 7.3. Note that the insertion of one nucleotide at position 602 in the 
SCD1 A25 nucleotide sequence enabled an amino acid sequence to be derived for this 
clone. 
Domain boundaries were defined by comparison to the most closely related human 
sequence, HCD1 B, and are denoted by vertical dashed lines. 
The amino acid numbering is based on the SCD1 B -42 sequence. Dashes indicate identity to 
the SCD1 B -42 sequence. Dots indicate gaps introduced to maintain the sequence 
alignment. 
Conserved cysteine residues are highlighted by an asterisk in bold type above the sequence. 
Potential N- linked glycosylation sites (N- X -S/T, where X is anyamiv10 acid) are marked in bold 
type. 
A plain asterisk denotes the translational stop codon at position 334. 
1 Leader I Alpha 1 Domain 50 





SCD1A25 A --V---1 V I 
51 100 
SCD1B-42 DDLQIHGWES DSGTAIFLKP WSKGNFSDEE ITELVDLFRV YLIGFIREVQ 
SCD1B-52 ---K T--- M---E-I--A -F-F-TQ--- 
SCD1T10 
SCD1A25 -N--LY--D- -P--T V---EE TL--- 
101 1 * 
SCD1B-42 DRVNEFQLEY IPFVIQVIEGC 
SCD1B-52 I A 
SCD1T10 .GLQ---F-- I G-A 
Alpha 2 Domain *150 
ELHSGEAIES SLRGALGGLD VLRIQNHSCM 
W A 











K--Q- F--AGFE--- FVS-E----V 
---P-K-V-- F-K--F---- FVS-K-D--A 
* 200 
GTSDIIERLV SETCPRYLLG VLDAGKAELQ 
-I L 
-ILA--D--L -K H 
AIC-T-AK-L L F-S 
2011 Alpha 3 Domain * 250 
SCD1B-42 RQIVKPEAWLS SGPTPGPGRL LLVCHVSGFY PKPVQVIWMR GKQEQPGTQQ 
SCD1B-52 --1 
SCD1T10 --I 
SCD1A25 --1 W-M--- -E--E 
R-M--- -E 
251 * I 300 






301 TM Domain * ICYT Domain 334 
SCD1B-42 IGLILVAIIV PSLILSICLA LWFIWRRWSYQ NIL* 
SCD1B-52 L---- ---1 HR ---* 
SCD1T10 ----F L---- ---I TV-* 
SCD1A25 T---F S----L---- ---I L T--* 
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I - - -MY 
V I 
preceding the ATG initiation codon (Fig.1). The 3' untranslated region is 262bp long and 
contains a consensus polyadenylation signal in the equivalent position to that observed in 
SCD1 A25 and SCD1B-42. The 723bp open reading frame encodes a polypeptide of 241 
residues (Fig.2), consisting of only two extracellular domains (a1 and a2) as well as the 
transmembrane and cytoplasmic domains. The a3 domain has been precisely deleted in this 
clone, as discussed in section 3.1. 
The 1382bp SCD1T10 cDNA clone insert is a truncated CD1 sequence beginning 26óp 
upstream of the start of the a2 domain (Fig.1). The 3' end of the a1 domain, the a2, a3, 
transmembrane and cytoplasmic domains are encoded by an open reading frame of 700bp. 
This is followed by a long 3' untranslated region of 642bp, which lacks both a consensus 
polyadenylation signal and a poly A tail, as discussed in section 3.1. 
3.3.3 Ovine CD1 Sequence Analysis. 
A. Nucleotide Seauence Analysis. 
The ovine CD1 sequences have been analysed by alignment of the sequences and by 
pairwise sequence comparisons. Alignment of the four ovine nucleotide sequences reveals a 
high degree of sequence conservation throughout all domains (Fig.1). The 3' untranslated 
region is the least conserved in terms of deletions or additions to the sequences, as indicated 
by the number of gaps required to maintain the sequence alignment. Most of the differences 
between the ovine nucleotide sequences are dispersed single base changes, although 
there are a few regions which contain clustered changes. This pattern of sequence variation 
has also been observed in the human CD1 sequences (Martin et al, 1986). The high degree 
of homology between the ovine sequences was confirmed by pairwise comparisons to 
determine percentage nucleotide identity. This analysis was performed for both the full -length 
coding sequences (Tablel , plain type) and for each domain within the sequence (Table2, 
plain type). 
Pairwise comparisons of the ovine CD1 coding sequences reveals that they are >85% 
identical at the nucleotide level (Table 1). This confirms the high degree of homology 
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Table 1: Comparisons Of The Ovine CD1 Sequences. 
The table in panel A shows the results of pairwise comparisons of the ovine CD1 
sequences. The results are presented as percentage identity values. The figures in plain type 
above the diagonal represent nucleotide sequence comparisons. The figures for the 
deduced amino acid sequence comparisons are shown in bold type below the diagonal. 
Two figures are given for each SCD1 B -52 comparison, since this clone lacks the sequence 
encoding the a3 domain.The first figure denotes comparison of sequence upstream of the 
a3 domain and the second figure denotes comparison of sequence downstream of the a3 
domain. 
Note that the insertion of a gap at position 602 of the SCD1A25 sequence enabled an amino 
acid sequence to be derived for use in this analysis. 
Linear representations of the four ovine CD1 sequences are shown in panel B to facilitate 
visualisation of the comparisons made in the table in panel A. 
A 
SCD1 A25 SCD1 B-42 SCD1 B-52 SCD1 T10 
SCD1 A25 85.22 81.19/88.80 85.59 
SCD1 B-42 78.68 94.56/97.41 86.65 
SCD1 B-52 71.92/83.78 88.18/92.11 79.20/89.66 
SCD1 T10 78.45 79.64 66.67/81.58 
B 







CYT 3' UT 
I 
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indicated by the sequence alignment (Fig.1). Pairwise domain comparisons of the ovine 
sequences shows that the greatest homology within the coding sequence is in the a3 
domain ( >90 %) and the least homology on the a2 domain ( >77 %). The homology in the 
3'untranslated region drops to -65% between the SCD1A25 and SCD1T10 sequences. 
There are only 36 differences between the SCD1 B -42 and SCD1B-52 nucleotide sequences 
within the coding region, although it should be noted that SCD1 B -52 completely lacks the a3 
domain. The pairwise comparison of SCD1 B -42 and SCD1B-52 over the same region gives a 
value of -96% identity (Table 1- 96% is an average of the two figures given in the table). The 
nucleotide identity between equivalent domains in SCD1B-42 and SCD1B-52 is > 93% in 
each case (Table 2). Even the 3' untransiated regions are highly homologous (96.1% 
identity). A discussion of the possible allelic relationship between SCD1 B -42 and SCD1B-52 
is provided in section 3.5. 
B. Deduced Amino Acid Sequence Analysis. 
The amino acid sequences derived from the four ovine cDNA sequences have been 
analysed by alignment of sequences and pairwise comparisons in the same manner as the 
nucleotide sequences. The ovine sequences are >75% identical at the amino acid level 
(Table 1, bold type). Pairwise domain comparisons (Table 2, bold type) confirm the nucleotide 
data showing that the greatest homology lies in the a3 domain ( >90 %) and the least 
homology in the 0.2 domain (60.2 -86 %). This holds true for pairwise comparisons between 
SCD1 B -42 and SCD1B-52 sequences only, where the lowest percentage identity is 
observed in the a2 domain (86 %). 
Alignment of the four ovine amino acid sequences (Fig.2) reveals several interesting features 
worthy of comment. The four cysteine residues at positions 120, 184, 224 and 279 in the a2 
and a3 domains are conserved in the ovine sequences with the exception of SCD1B-52 
which completely lacks the a3 domain (Fig.2). These four cysteine residues are also 
conserved in number and position in all other CD1 sequences and, on the basis of homology 
to the MHC molecules, are predicted to form intradomain disulphide bridges (Balk et al, 1989; 
116 
Table 2: Domain Comparisons Between The Ovine CD1 Sequences. 
The table in panel A shows the results of domain by domain comparisons of the ovine CD1 
sequences.The results are presented as percentage identity values. 
Figures in plain type represent nucleotide sequence comparisons, while figures in bold type 
represent deduced amino acid sequence comparisons. The insertion of one nucleotide at 
position 602 in the SCD1A25 nucleotide sequence enabled an amino acid sequence to be 
derived for this clone. 
Linear representations of the four ovine CD1 sequences are shown in panel B to facilitate 
visualisation of the comparisons made in the table in panel A. 
A 
SCD1B-42 SCD1B-52 SCD1T10 
A25 81.92 84.85 
5'UT B-42 93.94 
B-52 
A25 82.35 87.50 84.31 87.50 
Leader B -42 98.04 100.00 
B -52 
A25 85.92 81.92 84.48 78.72 
al B-42 95.31 88.30 
B-52 
A25 76.98 60.22 77.34 62.37 79.50 66.67 
a2 B-42 93.19 86.02 79.57 64.52 
B-52 79.21 66.67 
A25 91.76 90.32 90.32 90.30 
a3 B-42 92.12 92.47 
B-52 
A25 88.50 85.19 88.50 83.78 88.50 83.78 
TM/CYT B-42 97.35 96.30 90.27 84.21 
B-52 89.38 81.58 
A25 75.77 80.35 65.72 
3'UT B-42 96.10 81.30 
B-52 71.52 
B 
5'UT L ALPHA 1 ALPHA 2 
TM/ 


























Calabi et al, 1991). There are 64 amino acids in the a2 loop and 54 amino acids in the a3 loop 
of all known CD1 sequences. In ovine CD1 as in all other CD1 a chains, extra cysteine 
residues are observed which may mediate intermolecular associations such as covalent 
bonding with the CD8 molecule (Calabi and Milstein, 1986; Ledbetter et al, 1985; Snow et al, 
1985). The three other cysteine residues observed in the ovine CD1 molecules are also 
conserved and are located at positions 149 and 163 in the a2 domain and position 318 in the 
transmembrane domain. The one exception is the lack of a cysteine residue at position 163 in 
the SCD1A25 sequence, although there is an extra cysteine residue located at position 173 
in this sequence. 
The variable positions in the ovine CD1 molecules are scattered throughout the region 
contained within the disulphide bonded loops. This is similar to the situation observed for 
human CD1 and for TL/Oa class lb molecules, but is in contrast to the situation for the classical 
presentation molecules, where the variable positions are mainly located outside the 
disulphide bonded loop (Martin et al, 1986). 
Residue 280, adjacent to the second cysteine in the a3 domain, is an arginine residue (R) 
and is conserved in all ovine CD1 sequences which contain an a3 domain. An arginine 
residue in an equivalent position has been observed in all other human, mouse and rabbit 
sequences. It was initially suggested that such an arginine may contribute to the weak 
association of the HCD1 a and HCD1 b a chains with ß2microglobulin, which facilitates the 
exchange of human ß2m with bovine ß2m present in the culture medium (Martin et al, 1986; 
Calabi et al, 1991; Bernabeu et al, 1984; Amiot et al, 1986). However it has subsequently 
been observed that the HCD1c molecule is actually strongly associated with 132m despite the 
fact that it has an arginine residue at this position (Knowles and Bodmer, 1982; Amiot et al, 
1986). 
There are three conserved potential N- linked glycoslyation sites in the ovine CD1 sequences, 
located at positions 38 -40, 75 -77, and 146 -148. The SCD1A25 sequence contains an extra 
site at position 258 -260. Only one site is conserved in all known CD1 molecules and this is 
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located at an equivalent position to the conserved N- linked glycosylation site in the MHC class 
11131 domains (Balk et al, 1989; Calabi et al, 1991). 
The intracytoplasmic tails of the human and murine CD1 molecules can be divided into three 
distinct classes (Calabi et al, 1991). The CD1 a tail is short and does not contain any potential 
target residues for phosphorylation. The tail predicted from the CD1 E nucleotide sequence is 
much longer than any other CD1 cytoplasmic tail. The third group comprises the HCD1 b, c 
and d, and the MCD1.1 and MCD1.2 tail sequences. The ovine CD1 cytoplasmic tails fall into 
this group, as expected because of their homology to HCD1B (see section 3.3.2.3). 
However, only the SCD1 B -42 and SCD1T10 cytoplasmic tails contain the consensus 
sequence S /A- Y- Q- X -I /V, where X is any amino acid, which is present in the tails of other 
members of this group (Balk et al, 1991 a). 
3.3.4 Ovine CD1 Sequences Are HCD1B Homologues. 
Initial comparisons of each of the four ovine CD1 nucleotide sequences to the known human, 
murine and rabbit sequences revealed that all are most homologous to the human CD1 B 
cDNA sequence (Table 3, plain type). Domain boundaries were subsequently assigned 
based on HCD1B homology. The derived amino acid sequences for the ovine CD1 molecules 
are also most homologous to HCD1b (Table 3, bold type). The second highest identity values 
were observed for comparisons of ovine sequences with the domestic rabbit sequence ( -77- 
80% nucleotide identity, -65 -71.5% amino acid identity), which is itself most homologous to 
HCD1 B. The figures for comparison of the SCD1 B -52 amino acid sequence to the HCD1B 
and domestic rabbit sequences are 5 -7% less than the values for equivalent comparisons of 
the other three ovine sequences. This reflects the lack of an a3 domain in the SCD1B -52 
sequence and emphasises the point that the a3 domain is the most conserved region in the 
CD1 molecules (see Table 4). Comparison of the results from SCD1 B -42 and SCD1 B -52, 
which are the most closely related ovine CD1 sequences (90% amino acid identity), enables 
the conserved nature of the a3 domain to be observed more clearly. By discarding the 
HCD1B and domestic rabbit comparisons in this data (because the ovine sequences are all 
homologues of these two sequences), it can be seen that the comparisons for SCD1 B -52 are 
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Table 3: Comparisons Of The Ovine, Human, Murine and Rabbit Sequences. 
The table in panel A shows the results of pairwise comparisons between the ovine 
sequences and the human, murine and rabbit sequences. The results are presented as 
percentage identity values. 
Figures in plain type represent nucleotides sequence comparisons, while figures in bold type 
represent deduced amino acid comparisons. The insertion of one nucleotide at position 602 
in the SCD1A25 nucleotide sequence enabled an amino acid sequence to be derived for this 
clone. 
Two figures are given for each SCD1 B -52 comparison, since this clone lacks the sequence 
encoding the a3 domain. The first figure denotes comparison of sequence upstream of the 
a3 domain, and the second denotes comparison of sequence downstream of the a3 
domain. 
* Coding sequence for HCD1 E was derived from the genomic clone rather than from a cDNA 
clone. 
+ The domestic rabbit sequence comprised the leader and al domains only (see panel B). 
A The cottontail rabbit sequence comprised the a1, a2 and a3 domains only (see panel B). 
Linear representations of all the CD1 molecules are presented in panel B to facilitate 
visualisation of the comparisons made in the table in panel A. 
A 
SCD1A25 SCD1B-42 SCD1B-52 SCD1T10 
HCD1A 70.8 69.12 63.24/63.37 71.78 
60.06 58.84 49.01/56.25 64.38 
HCD1B 81.02 79.64 75.23/82.76 79.38 
74.17 73.35 67.98/68.42 75.00 
HCD1C 70.54 70.17 65.73/68.14 70.94 
58.43 58.86 50.74/45.95 59.19 
HCD1 D 64.24 64.37 55.68/56.90 68.84 
50.45 50.30 35.15/39.48 53.81 
* HCD1E 65.81 64.10 59.33/52.63 68.32 
51.70 51.70 43.43/21.88 56.54 
MCD1.1 60.80 59.78 55.68/45.13 62.89 
43.54 44.31 34.65/27.03 48.66 
MCD1.2 60.00 59.48 54.04/38.80 62.44 
42.94 43.71 32.18/27.03 47.77 
+ Dom Rab 79.27 79.88 77.44 
69.73 71.56 65.14 
A CtRab 65.41 65.33 55.68 69.71 
50.00 52.92 33.15 57.30 
B 










Table 4: Domain Comparisons Between The Ovine CD1 Sequences And The 
Most Closely Related Human Sequence, HCD1 B. 
The table in panel A shows the results of pairwise domain comparisons between the ovine 
CD1 sequences and the HCD1 B sequence. Results are presented as percentage identity 
values. 
Figures in plain type represent nucleotide sequence comparisons, while figures in bold type 
represent deduced amino acid sequence comparisons. The insertion of one nucleotide at 
position 602 in the SCD1 A25 nucleotide sequence enabled an amino acid sequence to be 
derived for this clone. 
Linear representations of the four ovine CD1 sequences and the HCD1 B sequence are 
shown in panel B to facilitate visualisation of the comparisons made in the table in panel A. 
A 
SCD1A25 SCD1B-42 SCD1B-52 SCD1T10 
HCD1B 5'UT 73.33 77.78 75.76 
HCD1B 76.47 75.00 66.67 68.75 68.63 68.75 
Leader 
HCD1B al 80.51 72.34 78.34 71.28 77.26 69.15 
HCD1B a2 77.70 67.74 74.91 66.67 74.55 66.67 73.84 69.89 
HCD1B a3 86.74 87.10 86.38 83.87 84.95 84.95 
HCD1B 77.88 62.16 83.19 71.05 82.30 68.42 78.76 63.16 
TM/CYT 




ALPHA 1 ALPHA 2 ALPHA 3 
TM/ 







6 -20% less than the SCD1 B -42 comparisons. This clearly indicates the contribution made by 
the more highly conserved a3 domain to the full -length percentage identity comparisons. 
The HCD1B-like nature of the ovine sequences was confirmed by aligning the amino acid 
sequences to each of the three "classical" human CD1 sequences, HCD1a, HCD1b and 
HCD1c (Fig.3). No alignments were made to CD1 sequences from the HCD1 D -like group 
because the initial comparisons of the ovine sequences indicated that they were HCD1B-like 
and were therefore grouped with the "classical" CD1 molecules. The three groups of 
sequence alignments reveal that the ovine sequences are more homologous to HCD1B 
(Fig.3A) than to HCD1A (Fig.3B) or HCD1C (Fig.3C), particularly in the al , a2 and 
transmembrane domains. The ovine sequences are identical in length to the HCD1B 
sequence each being 334 amino acids long (Fig.3A). In contrast, the ovine sequences are six 
amino acids longer than the HCD1A sequence (Fig.3B). These differences comprise two 
single residue additions, at positions 11 and 312, and four extra residues located in the cytoplasmic 
tail. Although the ovine sequences are equivalent in overall length to the HCD1C sequence, 
a one residue gap is observed in the ovine sequences at position 168 and a one residue gap at' 
position 313 in the HCD1C sequence. There are seven cysteine residues in the HCD1A, B 
and C sequences and also in the ovine sequences. The positions of five of these are 
conserved across HCD1A, B and C, and the other two are variable. In the ovine sequences all 
seven residues are conserved in the same positions as for HCD1B, with one exception in the 
SCD1A25 sequence. In this case the cysteine residue at position 163 in HCD1B is found at 
position 173 in SCD1A25. The two variable cysteine residues in HCD1A (at positions 325 and 
327) and HCD1C (at positions 155 and 327) are not conserved in the ovine sequences. The 
final feature of the ovine sequences which provides evidence that they are all HCD1B-like 
concerns potential N- linked glycosylation sites. Three of the four sites are conserved in 
position across HCD1A, B, C and the ovine sequences. The fourth site in HCD1B at position 
258 -260 in the a3 domain, is conserved in one of the three ovine sequences which contains 
an a3 domain (SCD1A25). In contrast, the fourth potential glycosylation site in either HCD1A 
(position 60 -62) or HCD1C (position 70 -72) is not conserved in any of the four ovine 
sequences. 
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Figure 3: Aligment Of The Deduced Ovine CD1 Amino Acid Sequences With 
The Human CD1B (FIG. 3A), Human CD1A (Fig. 3B) and Human CD1C (Fig. 
3C) Amino Acid Sequences. 
All sequences were aligned using the PILEUP programme of UWGCG 7.3. 
Amino acid numbering is based on the top sequence in each aligment. Dashes indicate 
identity to the top sequence in the aligment. Dots indicate gaps introduced to maintain 
sequence aligment. 
Cysteine residues in the top sequence of each alignment are highlighted by a bold asterisk 
above the sequence. 
Potential N- linked glycosylation sites (N- X -S/T, where X is any nucleotide) are marked in bold 
type. 




Alpha 1 Domain 50 
HCD1B MLLLPFQLLA VLFPGGINSEH AFQGPTSFHV IQTSSFTNST WAQTQGSGWL 
SCD1B-42 LL--G -IL---IDN-D V L K-I-T-V--- ---NL--Q-- 
SCD1B-52 LL--G -IL---IDN-D V L K-I-T-V 
SCD1T10 
I 


























SCD1T10 -E E-- 
SCD1A25 -V-G M-- 
I-T-A--- ---N 
















E- -T----L--- -LI--TL--- 
Alpha 2 Domain *150 
ELHSGGAIVS FLRGALGGLD FLSVKNASCV 
E--E- S V-RIQ-H--M 
E--E- S VWRIQ-H--A 
K--Q- ---AGFE--- -V-IE-H--- 
---P-K-VE- --K--F---- -V-I--D--A 
* 200 
GIMETVRILL YETCPRYLLG VLNAGKADLQ 
-L---LS--- -TSDIIER-V S 
N----MT--- --SDILER-- S 
W--VF-T--- --LAIIDR-- SK 





201! Alpha 3 Domain * 250 
HCD1B RQIVKPEAWLS SGPSPGPGRL QLVCHVSGFY PKPVWVMWMR GEQEQQGTQL 
SCD1B-42 --I T L Q-I--- -K---P---Q 
SCD1B-52 --I 
SCD1T10 --I T R 





251 * I 300 
HCD1B GDILPNANWT WYLRATLDVA DGEAAGLSCR VKHSSLEGQD IILYWIRNPTS 
SCD1B-42 ---M---D-- ----V- N- A GD IGH--- 
SCD1B-52 IGH--- 
SCD1T10 -N-IL--D-- ----V A GD IGH-MY 












ICYT Domain 334 
LWYIMRRRSYQ NIP* 
- -FIW - -W --- --L* 
-- FIW - -W -HR --L* 
-- FIW- -W - -- TVL* 









I Alpha 1 Domain 49 
MLFLLLPLLA .VLPGDIGNAD GLKEPLSFHV IWIASFYNHS WKQNLVSGWL 
--L-P-L--G VI---GID-E- VFQG-T---L KQ-ST-V-ST -A---G-Q-- 
--L-P-L--G VI---GID-E- VFQG-T---L KQ-ST-V-ST -A--QG---- 
--L-P-L--- VIV--GID-E- VFQG-T---- -Q-ST-A-ST -A--QG---- 
50 99 
HCD1A SDLQTHTWDS NSSTIVFLWP WSRGNFSNEE WKELETLFRI RTIRSFEGIR 
SCD1B-42 D---I-G-E- D-G-AI--K- --K----D-- IT--VD---V YL-GFIREVQ 
SCD1B-52 D--KI-G-E- D-G-AI--K- --K---TD-- MT---DI--A YF-FFTQEVQ 
SCD1T10 

















* Alpha 2 Domain 149 
PFEIQVTGGC ELHSGKVSGS FLQLAYQGSD FVSFQNNSWL 
--V---IE EAIE- S-RG-LG-L- VLRI--H-CM 
-V -A EAIE- S-RG-LG-L- VWRI--H-CA 
--V--GIA AIQ- --RAGFE-L- ---IE-H-CV 
--V--DIA-- ---P AVE- --KG-SG-L- ---IK-D-CA 
150 * * 199 
PYPVAGNMAK HFCKVLNQNQ HENDITHNLL SDTCPRFILG LLDAGKAHLQ 
-A-DS--RGQ KL-AL-S-Y- GTS--IER-V -E----YL-- V E-- 
-A-DS-TRGQ N--ALMT-Y- GIS--LER-- -E----YL-- V E-- 
-E-EG-SE-Q W--VFIT-Y- GILA-IDR-- -K----YL-- V E-H 
-V-GG-S--Q R-YELII-YH AIC-TIAK-- LE----YFLS V E- 
2001 Alpha 3 Domain 
HCD1A RQIVKPEAWLS HGPSPGPGHL QLVCHVSGFY 
SCD1B-42 --1 S--T----R- L 
SCD1B-52 --I 
SCD1T10 --I S--T----R- L 



















GDILPSADGT WYLRATLEVA AGEAADLSCR VKHSSLEGQD 
---M-N--W- ----V--N G GD-- 
-N-ILN--W- ----V--D 
---M-N-NW- -H D 









I * * 328 
LWFIRKRCFC* .... 
- -- IWR -WSYQ NIL* 
- -- IWR -WSHR NIL* 
- -- IWR -WSYQ TVL* 














1 Leader I Alpha 1 Domain 50 
HCD1C MLFLQFLLLA LLLPGGIDNAD ASQEHVSFHV IQIFSFVNQS WARGQGSGWL 
SCD1B-42 --L-PL---G VI---GI--E- VF-GPT---L K--ST---ST --QNL--Q-- 
SCD1B-52 --L-PL---G VI---GI--E- VF-GPT---L K--ST---ST --QN 
SCD1T10 I 
SCD1A25 --L-PL---- VIV---I--E- VF-GPT---- ---ST-A-ST --QN 
51 100 
HCD1C DELQTHGWDS ESGTIIFLHN WSKGNFSNEE LSDLELLFRF YLFGLTREIQ 
SCD1B-42 -D--I---E- D---A---KP D-- ITE-VD---V --I-FI--V- 
SCD1B-52 -D-KI---E- D---A---KP TD-- MTE--DI--A -FIFF-Q-V- 
SCD1T10 












* Alpha 2 Domain 150 
PFEVQVKAGC ELHSGKSPEG FFQVAFNGLD LLSFQNTTWV 
--VI--IE EAI-S SLRG-LG--- V-RI--HSCM 
--VI--T EAI-S SLRG-LG--- VWRI--HSCA 
--VI-GI AIQS -LRAG-E--- FV-IE-HSC- 
--VI-DI--- ---P AV-S -LKG--G--- FV-IK-DSCA 
151 * * * 200 
HC1DC PSPGCGSLAQ SVCHLLNHQY EGVTETVYNL IRSTCPRFLL GLLDAGKMYV 
SCD1B-42 -A-DS-NRG- KL-A--S.-- Q-TSDIIER- VSE----Y-- -V AEL 
SCD1B-52 -A-DS-TRG- NF-A-MT.-- Q-ISDILER- LSE----Y-- -V AEL 
SCD1T10 -E-EG--E-- WF-VFIT.-- Q-ILAIIDR- LSK----Y-- -V AEL 
SCD1A25 -V--G--M-- RFYE-II.-- HAICD-IAK- LLE----YF- SV AEL 
2011. Alpha 3 Domain * 250 
HCD1C HRQIVRPEAWL SSRPSLGSGQ LLLVCHASGF YPKPVWVTWM RNEQEQLGTK 
SCD1B-42 Q--I-K G-TP-P-R V Q-I-- -GK---P--Q 
SCD1B-52 Q--I 
SCD1T10 ---I-K G-TP-P-R V R-M-- -G----P--Q 
SCD1A25 Q--I-K G-TP-P-R V M-- -G---EP--Q 
251 * 1300 
HCD1C HGDILPNADG TWYLQVILEV ASEEPAGLSC RVRHSSLGGQ DIILYWIGHHS 
SCD1B-42 Q---M----W ----R-T-N- -AG-A K D- I--PT 
SCD1B-52 I--PT 
SCD1T10 Q-N-IL---W ----R-T-D- -AG-A K D- I--PM 
SCD1A25 Q---M---NW --H-RAT-D- -AG-A K D- - -V ---I --PT 
CYT Domain 
301 TM Domain I * 334 
HCD1C SMNWIALVVI VP.LVILIVL VLWFIKKHCSY QDIL* 
SCD1B-42 -IGL-LVAI- --S-ILS-C- A---IWRRW-- -N--* 
SCD1B-52 -IGL-LVAI- --S-IL--C- A---IWRRW-H RN--* 
SCD1T10 YIGL-FVAI- --S-IL--C- A---IWRRW-- -TV-* 
SCD1A25 -TGL-FVAI- -SS-IL--C- A---IWRRW-- LT--* 
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Altogether, the features highlighted above confirm the results from the percentage identity 
comparisons that all four ovine CD1 sequences are most homologous to the human CD1 B 
sequence. 
3.3.5 Do SCD1B-42 and SCD1B-52 Represent Alleles From A Single Locus? 
The SCD1B-42 and SCD1B-52 clones were both isolated from the ST -2 thymocyte cDNA 
library which had been generated from one eight week old lamb thymus (Hein et al, 1989). 
Despite the lack of the a3 domain in SCD1B-52, comparison of these sequences at the 
nucleotide level gives a value of -96% identity overall (Table 1) and >93% identity in each 
domain including the 5' and 3' untranslated regions (Table 2). These results indicate that 
SCD1B-42 and SCD1B-52 may represent alleles of a single gene. An alternative possibility is 
that SCD1B-42 and SCD1B-52 represent the result of a recent gene duplication event in the 
ovine CD1 locus. All other pairwise nucleotide comparisons between the ovine CD1 
sequences give values of 85 -87% identity overall and values of 81.3 % or less in the 3' 
untranslated regions. Similar results were obtained for amino acid sequence comparisons - 
the overall identity between SCD1B-42 and SCD1B-52 is -90% in contrast to -75 -80% for 
the other comparisons (Table 1). Domain by domain comparisons between SCD1B -42 and 
SCD1B-52 coding sequences gave values of >86% in each case (Table 2). 
It is particularly notable that the SCD1B-42 and SCD1B-52 sequences are -96% identical in 
the 3' untranslated regions (Table 2), in contrast to <81.3% identity for comparisons between 
other ovine CD1 sequences in this region. This observation is rather surprising given that 3' 
untranslated regions lack the structural constraints of coding sequences and therefore retain 
less percentage sequence identity than coding domains. Indeed, the human 3' untranslated 
sequences are 40 -60% identical and the two mouse 3' untranslated sequences are -55% 
identical. In human and murine polymorphic MHC class I genes the 3' untranslated regions of 
alleles from the same locus show a mean homology of 96 +1 -2.3 %, whereas the homology 
between alleles from different loci is in the range 74 -95% (Ennis et al, 1988). Similar results 
were obtained for pairwise comparisons of the three extracellular domains. An analysis of 
human class I sequences has shown that there can be up to 11% variation across the 274 
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amino acids encoding the al , a2 and a3 domains of alleles from a single locus, and that the 
majority of these differences are in the al and a2 domains (Bjorkman and Parham, 1990). 
Comparison of SCD1B-42 and SCD1B-52 in the equivalent regions, i.e. across the al and a2 
domains only, gives a percentage identity value of -87 %. This value is comparable to the 
greatest differences observed between MHC class I alleles, given that the homology of the 
a3 domains of SCD1 B -42 and SCD1 B -52 is likely to be even greater than the -90% identity 
between other ovine a3 domains. Given that it is probably more appropriate to compare the 
CD1 genes to other nonpolymorphic class lb genes, it is interesting to note that alleles of the 
class lb genes in mice differ in sequence by 1% or less, in contrast to the human classical class 
I alleles (Hedrick, 1992). Significant polymorphism of CD1 sequences would, however, be 
unprecedented. Previous studies in mouse and man have shown that CD1 polymorphism is 
extremely limited (Calabi et al, 1991). In humans, only minor differences, mainly single base 
substitutions, have been detected in the coding regions of cDNA clones isolated from several 
individuals, and it is likely that these we-red cloning or sequencing artefacts. In the 
mouse, only one RFLP has been detected by Southern blot analysis of 11 inbred laboratory 
mouse strains using an a3 region probe (A. Bradbury, PhD Thesis). A more sensitive analysis 
was conducted by nuclease protection assays using exon specific probes (Bradbury et al, 
1988). This analysis was expected to detect most multiple mismatches and some but not all 
single base differences within the probe length. Two independent variants of the a3 domain 
were detected, probably involving single base changes. The extent of CD1 polymorphism in 
the rat was similarly assessed by Southern blot analysis in 12 strains of laboratory rat using 
5'UT/al/a2/a3 and TM /CYT /3'UT probes (Ichimiya et al, 1994). Three allelic variants of the rat 
CD1 gene were detected using the TM /CYT /3'UT probe. However, the nature of this probe 
did not enable variation in the TM /CYT domain to be distinguished from variation in the 3'UT 
region. 
The question of an allelic relationship between SCD1 B -42 and SCD1 B -52 can only be 
resolved when the genomic organisation of the ovine CD1 gene family has been established. 
It is particularly difficult to resolve the question of allelic relationships in animals like sheep due 
to the unavailability of inbred strains. This problem does not arise in inbred laboratory mice 
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where a non -allelic relationship can be confirmed by the presence of both gene products in 
an inbred strain. For example, the putative nonclassical allelic gene products Qa -1 a and Qa -1 b 
were investigated using PCR. The results indicated that B10.M mice express Qa -1 b but not 
Qa -1 a, suggesting that these molecules are the products of a single polymorphic gene 
(Connolly et al, 1993). It is possible that SCD1B-42 and SCD1B-52 represent genes 
produced by a very recent duplication event within the CD1 gene complex, in a similar manner 
to that proposed for the two mouse genes (Hughes, 1991). This could be investigated by 
hybridisation analysis of genomic DNA using probes which would differentiate between the 
two sequences. Given the small number of differences between SCD1 B -42 and SCD1 B -52 it 
may be difficult to generate such a probe, although one promising region is the section 
between nucleotides 349 and 389, within which there are nine differences between the two 
sequences. An alternative approach would be to analyse genomic DNA digested with a 
regular cutter enzyme from a variety of sheep using a probe which does not differentiate 
between the two sequences. If SCD1B -42 and SCD1B -52 represent two different genes, 
two distinct bands would always be observed, even in homozygous sheep. 
3.3.6 Relationship Between Ovine CD1 and MHC Class I Molecules. 
The resolution of the 3 -D crystal structure of MHC class I molecules has permitted not only the 
identification of structural features important for peptide binding and T cell recognition but 
also characterisation of residues involved in interaction with ß2m and CD8 as well as peptide 
docking residues. The following three sections deal with the analysis of ovine CD1 molecules 
for the potential to interact with ß2m, CD8 and peptide ligands. 
3.3.6.1 Interaction of Sheep CD1 a Chains With 132- microglobulin. 
Balk and colleagues (1989) analysed the ß2m contact residues in human CD1 heavy chains 
using the unrefined crystal structure data of HLA -A2 at 0.35nm resolution (Bjorkman et al, 
1987). They found that none of the possible contact points between the HLA class I a3 
domain and ß2m were conserved in CD1 with the exception of an Asp residue at position 238 
in HLA class I. Similarly, Tysoe- Calnon and colleagues (1991) used the refined crystallographic 
data for HLA -A2 and HLA- Aw68.1 at 0.26nm resolution (Garrett et al, 1989) in conjunction 
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with sequence alignments of ninety classical and nonclassical a chains and secondary 
structure predictions to analyse class 1432m interactions. The human CD1 amino acid 
sequences were included in this analysis. The majority of conserved (32m contact residues in 
CD1 were located in the a2 domain and the major contact region in the a3 domain. Together 
with the results of secondary structure predictions, they concluded that the top part of the a3 
domain would bind to 132m in an MHC class I -like manner, but that the al and a2 domains may 
fold differently and hence bind to ß2m in a non -MHC class I -like manner. The authors point out 
that biochemical evidence exists to support this conclusion in that CD1 has been shown to 
form an intermolecular complex with class I on human thymocytes (Amiot et al, 1988). If the 
CD1 a chain is binding to 132m already bound to the class I a chain, it is presumed that the ß2m 
contact sites cannot be the same in both a chains. 
The HLA -A2 crystal structure has since been further refined by Saper et al (1991) and has 
been used to analyse the potential ß2m contact residues in the ovine CD1 a chains (Figure 4). 
The most homologous human sequence, HCD1 B, has also been included in this analysis. 
The results show that of the thirty -one ß2m contact residues identified in the refined HLA -A2 
crystal structure, the majority are neither conserved nor conservatively replaced in the ovine 
CD1 sequences (Table 5). Three of the nine contact sites in the a2 domain are completely 
conserved between HLA -A2, HCD1B and the ovine CD1 sequences. The alanine (A) residue 
at position 117 in the a2 domain of HLA -A2 is conserved in three of the four ovine sequences 
and in HCD1 B. The fourth ovine sequence has a glycine (G) residue at this position, identical 
to that observed in the ovine class I sequence. The a3 domain of the class I a chain is the 
main site of interaction with ß2m. Of the nine contact residues located in the a3 domain loop 
that interact with í32m (residues 231 -244), only two are conserved in two of the three ovine 
sequences- the proline (P) at position 234 and the aspartic acid (D) at position 237. The 
proline residue at position 234 is also conserved in the HCD1 B sequence. It is also notable 
that of the thirty -one ß2m contact residues identified in the HLA -A2 structure, there are only 
six which differ between sheep and human class I molecules (at positions 9, 23, 116, 117, 121 
and 235- see Table 5). Three of these differences are conservative substitutions - 
leucine /isoleucine at position 23, glycine /alanine at position 117, and arginine /lysine at 
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Figure 4: Alignment Of The Deduced Ovine CD1 Amino Acid Sequences 
With Other MHC and CD1 Sequences. 
The deduced ovine CD1 amino acid sequences have been aligned with the human class I 
consensus sequence (Tysoe -Calnon et al, 1991), the mouse class I consensus, mouse class 
Il consensus and human class II consensus sequences (Martin et al, 1986) and the mouse 
CD1 consensus sequence (Bradbury et al, 1988). The alignment is based on that of Tysoe- 
Calnon et al, 1991. 
Dashes indicate positions where no consensus residue was available, as defined in the 
original papers. 
Blank spaces are gapsint(bduced to maintain the sequence alignment. 
The numbered vertical dashes mark the end of every block of ten amino acids in the human 
class I consensus sequence. 
Residues marked in bold type are amino acids in human class I molecules which interact with 
ßzmicroglobulin (Saper et al, 1991). 
Underlined residues are amino acids in human class I molecules which interact with CD8 
(Salter et al, 1989). 
Shadowed residues are amino acids which have been identified as being essential for 
anchoring the amino and carboxy terminals of peptides in the peptide binding groove of class 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5: Analysis of Known Class I /p em Interaction Sites in The Ovine CD1 
Molecules. 
This analysis was based on the crystal structure results of Saper at al, 1991. 
The position numbers are for the HLA consensus sequence shown in Figure 4. 
The sheep class I sequence was derived from the nucleotide sequence of pSC112, a full - 
length class I clone obtained by Grossberger and coworkers, 1990 (Acc. No. M34676). 
Residues in bold type are identical to those in the same position in both the sheep class I 
sequence and the HLA consensus sequence. 
Residues with a single underline are identical to that observed in the same position in the HLA 
class I consensus sequence but not to that in the sheep class I sequence. 
Residues with a double underline are identical to that observed in the same position in the 
sheep class I sequence but not to that in the HLA consensus sequence. 
The * sign indicates that due to the introduction of gaps in the CD1 sequence which are 
required to maintain alignments (see Fig. 4), no equivalent residue to that in the class I 
sequence exists in the CD1 sequences. 
Domain Position Sheep Class I HLA Class I SCD1 H C D 1 B 
Consensus 
alpha 1 8 F F 3S S 
9 S Y 3T S 
10 T T 3F F 
12 V V 3N N 
23 L I * * 
25 V V 3S S 
27 Y Y 3W W 
32 Q Q 2 Q,1 K Q 
35 R R 3G G 
48 R R 3W W 
alpha 2 94 T T 4V E 
96 Q Q 4Q Q 
115 Q Q 3R,1K R 
116 F Y 3G,1A G 
117 G A 3A,1G A 
119 D D 3G,1E G 
120 G G 4G G 
121 R K 4L L 
122 D D 4D D 
alpha 3 192 H H 3G G 
202 R R 3V V 
204 W W 3H H 
231 E E 2D,1N D 
232 T T 31 I 
235 P P 2 P,1 L P 
236 S A 3N N 
237 G G 3A A 
238 D D 2D,1N N 
23`) G G 3W W 
242 Q Q 2Y,1H Y 
244 W W 3R R 
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position 235. 
In contrast to the results obtained for the analysis of CD1 a chain /ß2m interactions, Flajnik and 
colleagues (1993) found that the majority of the f32m interaction sites in Xenopus classical 
class I molecules (defined on the basis of the refined HLA -A2 crystal structure of Saper and 
colleagues, 1991) are identical or conservatively replaced in Xenopus nonclassical class Ib 
molecules. This suggests that both classical and nonclassical Xenopus class I genes encode 
a chains capable of associating with a putative Xenopus ß2m molecule. Given that the 
Xenopus class Ib genes are non MHC- linked (Flajnik et al, 1993), it is interesting that their 
products have the potential to interact with ß2m in a classical class I -like manner in contrast to 
the products of the non MHC- linked CD1 genes. 
The data suggest that the ovine CD1 genes encode heavy chains which interact with f32m in a 
manner which differs from the known MHC class1/132m interaction but which is similar to the 
HCD1 B /ß2m interaction. Determination of the ovine CD1 crystal structure would enable the 
exact nature of the a chain/ ß2m interaction to be defined. 
3.3.6.2 Interaction of Sheep CD1 a Chains With CD8. 
Characterisation of mutant murine and human class I molecules with substitutions at positions 
227 and 245 indicated that the a3 domain is the principal site of contact with the CD8 
molecule (Potter et al, 1987: Salter et al, 1989). Salter and colleagues (1990) substantiated 
this hypothesis and defined a minimum CD8 binding site by measuring levels of adhesion 
between CD8 and forty -eight point mutants of HLA -A2.1. Three clusters of a3 residues 
contribute to the binding with the CD8 a chain- residues 223 -229, 233 -235 and 245 -247. 
The exposed negatively charged loop (residues 223 -229) was found to play a dominant role 
in adhesion to CD8 with 0226 and D227 thought to be the most important residues. The 
mutants were also analysed for T cell recognition and the data showed a good correlation 
between CD8 binding and cytotoxic T cell recognition. 
The three clusters of residues comprising the putative CD8 binding site have been examined 
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in the a3 domain of the CD1 sequences (Figure 4). Only one of the residues in the dominant 
loop of HLA -A2.1 is conserved in the CD1 sequences (T228). The absence of residues 
Q226 and D227 in this region is particularly noteworthy. Two of the three ovine sequences 
contain a P residue identical to that at position 235 (equivalent to position 255 in Figure 2) in 
the second CD8 binding cluster. Similarly, only one of the three ovine sequences contains an 
A residue at position 245 (equivalent to position 265 in Figure 2) identical to that in the third 
CD8 binding cluster of HLA -A2.1. The most homologous human molecule, HCD1B, contains 
four of the thirteen residues implicated in interaction with CD8 (Q226, T228, P235, A244, 
which are in equivalent positions to 0245, T248, P255 and A264 in Figure 2). 
Similar studies of potential CD8 interaction sites have been carried out in a variety of other 
species including shark, chicken and frog. The shark class I sequence was found to contain a 
Q residue at an equivalent position to the major CD8 contact residue Q226 in HLA -A2.1 
(Hashimoto et al, 1992). One of the three residues comprising the second cluster is also 
conserved in the shark sequence (P235). In the chicken class I sequence both 0226 and 
D227, the most critical CD8 binding residues, are conserved (Kaufman et al, 1992), although 
none of the other residues that have been described as important for CD8 binding are 
conserved. In the frog, neither of these two residues are conserved in the Xenopus classical 
class I sequence nor in the Xenopus nonclassical class lb sequences (Shum et al, 1993; 
Flajnik et al, 1991). The authors suggest that compensatory changes will probably be 
detected in the MHC binding site of the as yet uncloned Xenopus CD8 molecule. 
Interestingly, Bahram and coworkers (1994) have recently reported the identification of a 
family of related sequences in the human MHC which are only distantly related to the MHC 
classical class I chains. These MIC genes (MHC class I chain -related genes) contain none of 
the residues implicated in binding of CD8 to class I molecules. 
This analysis suggests that the ovine CD1 a chains do not contain typical CD8 binding 
residues, although it is possible that other residues outwith the minimum CD8 binding site are 
able to perform this function. 
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3.3.6.3 Interaction of Sheep CD1 With Peptide. 
The crystallographic structure of the HLA -A2 molecule has provided a structural basis for the 
direct binding of peptide to class I molecules ( Bjorkman et al, 1987; Bjorkman and Parham, 
1990). A putative binding groove is formed by the a1 and a2 domains of the class I heavy 
chain. The sides of the groove are formed by two long a- helices and the base of the groove 
by an eight- stranded antiparallel [3-pleated sheet. The groaeis located on the top surface of 
the molecule and was found to be filled with electron dense material not accounted for by the 
HLA molecule. This material was proposed to be peptide(s) filling the binding site. 
Refinement of the HLA -A2 structure and solution of the structure for HLA -Aw68 yielded 
further insights into the detailed architecture of the peptide binding groove (Garrett et al, 
1989). The structural differences between the two molecules demonstrate how 
polymorphism creates and alters subpockets (A to F) in the peptide groove. Determination of 
the X -ray crystallographic structure of HLA -B27 revealed electron density in the antigen 
binding grove which was interpreted to be the image of a nonameric peptide in a largely 
extended conformation (Madden et al, 1991; Madden et al, 1992). The clarity of the electron 
density in the groove enabled detailed interactions of the peptide with the class I molecule to 
be observed. The crystallographic structures of various murine and human class I molecules 
complexed with peptides of different lengths have now been determined (Fremont et at, 
1992; Matsumara et al, 1992; Zhang et al, 1992). The overall structure of each molecule is 
similar but the important feature of all is the conservation of non -polymorphic residues at each 
end of the peptide binding cleft. These residues form extensive hydrogen bonds with the 
peptide amino and carboxy termini which determine the orientation of the peptide in the cleft 
and restict the length of peptides which can be accommodated (van Bleek et al, 1993; Forquet 
et al, 1993, Parham, 1992). Slightly longer peptides are able to bind by a bulging out of the 
middle portion of the peptide to compensate for the extra length. 
Residues which are conserved in essentially all of the human classical class I proteins have 
been identified that are crucial in anchoring the amino and carboxy termini of antigenic 
peptides (Madden et al, 1991; Madden et al, 1992). All eight of these docking residues are 
conserved in the known ovine class I sequences (Grossberger et al, 1990), but none are 
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conserved in the ovine CD1 sequences (Table 6 and Figure 4), indicating that if the CD1 
molecules can bind peptides, as suggested by the CD1 antigen presentation study by 
Porcelli and colleagues (1992), then they do so in an alternative manner to that observed for 
classical class I molecules. Determination of the crystal structure of CD1 together with 
attempts to elute and analyse peptides from CD1 molecules should help clarify the nature of 
putative CD1 antigen presentation. 
Similar studies have been carried out to search for peptide docking residues in other 
nonclassical class I molecules. The protein product of the H2 -M3 gene in mice has been 
shown to present N- formyl peptides of mitochondrial and prokaryotic origin to CD8 +T cells 
(Shawar et al, 1991; Vyas et al, 1992). Two of the four carboxy terminal docking residues are 
conserved in the M3 molecule (Tyr84 and Thr143) but Lys146 is replaced by Arg and Trp147 
with Leu (Wang et al, 1991). At the other end of the cleft, three of the four conserved Tyr 
residues which interact with the peptide amino terminus are present in M3, but Tyr171 is 
replaced by a Phe residue. The extra space formed by the replacement of tyrosine 171 with 
phenylalanine could accommodate an N- formylated peptide terminus. In the Xenopus 
classical class I molecule, all eight docking residues are conserved (Flajnik et al, 1993). The 
situation for the Xenopus XNC (nonclassical class I) molecules is somewhat different. There is 
a lack of conserved residues at the peptide carboxy terminus site although there is better 
conservation of amino terminus docking residues (Flajnik et al, 1993). Mutational analysis has 
recently suggested that amino terminal docking is more critical for peptide binding than 
carboxy terminal binding (Latron et al, 1992). In the murine nonclassical class I molecule Qa- 
1 a, the four residues which stabilise the amino terminus of the peptide are all present and two 
of the four carboxy terminal docking residues are also conserved (Connolly et al, 1993), 
suggesting that Qa -1 a is capable of binding peptides in a similar manner to classical class I 
molecules. The Thr143 and Trp147 are both replaced by Ser in the Qa -1 a molecule. The 
effect of these changes is to open up the binding groove, perhaps permitting the binding of 
peptides with bulky carboxy termini. In the molecules encoded by the MIC genes, a recently 
identified second lineage of conserved MHC genes distantly related to the class I genes, only 
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Table 6: Analysis Of Known Class I Peptide Docking Residues In The Ovine 
CD1 Molecules. 
The docking residue details are from Madden et al, 1991. 
The residue numbering is based on the HLA consensus sequence shown in Figure 4. 
Docking Residues SCD1 Sequences 
Peptide N- terminus 
Tyr 7 (Y) 3 Ile (I) 
Tyr 59 (Y) 1 Ile (I), 1 Met (M), 1 Val (V) 
Tyr 159 (Y) 4 Leu (L) 
Tyr 171 (Y) 4 Val (V) 
Peptide C- terminus 
Tyr 84 (Y) or Arg 84 (R) 2 Asn (N), 1 Ser (S) 
Thr 143 (T) 2 Gly (G), 2 Ala (A) 
Lys 146 (K) 1 Leu (L), 3 Phe (F) 
Trp 147 (W) 3 Cys (C), 1 Tyr (Y) 
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three of the eight docking residues are preserved- Tyr7 and Tyr171 in the putative amino 
terminal binding pocket and Thr143 in the carboxy terminal binding pocket (Bahram et al, 
1994). It is debatable whether the putative MIC molecules are capable of associating with 
peptide ligands, although sequence analysis indicates that the MIC molecules may fold in a 
similar manner to the class I chains despite being highly divergent. 
3.3.6.4 Comparison Of The CD1 a3, Class I 3 and Class Il 132 Domains. 
The CD1 genes are members of the immunoglobulin supergene family according to various 
characteristics. For example, the derived CD1 amino acid sequences contain a pair of cysteine 
residues in both the a2 and a3 domains which can putatively form disulphide bridges in a 
manner analogous to the immunoglobulin domain loops. There is also a highly characteristic 
tryptophan residue (W) in the a3 domains at position 217 in a homologous position to that in 
the immunoglobulin chains (see Fig. 4). 
The human CD1 molecules have been found to be approximately equally related to the class I 
and class II MHC molecules, suggesting that the CD1 genes arose early in evolution (-80mya) 
at a time close to the divergence of the class I and class II gene ancestors (Milstein et al, 1987; 
Martin et al, 1986; Calabi and Milstein, 1986). Comparison of the ovine CD1 a3 domains to 
the class I a3 and class II (32 domains (Table 7) produced similar results. The data indicate that if 
anything, the ovine CD1 a3 domains are slightly more related to the class II ß2 domains than to 
the class I a3 domains (- 30 -33% identity with class II (32 compared to 25 -30% identity with 
class I a3 domains). The a3 domain alignments in Figure 4 illustrate the similarities and 
differences between the ovine CD1 molecules and various other CD1, class I and class II 
sequences. The sheep data confirms the observations made in the human CD1 system by 
Milstein and colleagues (Milstein et al, 1987; Martin et al, 1986) that the CD1 molecules are 
approximately equally related to the class I and class II molecules. Detailed phylogenetic 
analysis would be required in order to comment in further detail on the CD1 /MHC relationship. 
3.3.6.5 Summary And Conclusions. 
One of the main points which has emerged during this analysis is that the data support the 
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Table 7: Comparisons Between Homologous Domains Of Ovine CD1, MHC 
Class I and MHC Class II Amino Acid Sequences. 
The results of pairwise amino acid sequence comparisons between the ovine CD1 a3 
domains, ovine class I a3 domains (S class I) and ovine class Il ß2 domains (S class II) are 
shown in the table. The genebank accession numbers for the sheep sequences used in this 
analysis are given in Appendix 3. 
The figures in bold type are percentage identity results. 
The figures in plain type are percentage similarity results. 
SCD1A25 SCD1 B-42 SCD1 T10 
S class I -1 27.28 51.11 26.27 46.67 26.67 47.78 
S class 1 -2 24.44 48.49 24.45 45.56 27.27 51.14 
S class 1 -3 27.28 51.11 26.67 47.78 28.41 53.41 
S class 1 -4 30.34 53.94 29.21 50.56 29.21 50.56 
S class II -1 30.77 50.55 30.77 51.65 31.87 49.45 
S class II -2 31.87 54.95 31.87 53.85 32.97 56.05 
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view that SCD1A25, which contains an apparent single nucleotide deletion at position 602, 
encodes an expressed gene. The SCD1A25 amino acid sequence contains seven cysteine 
residues, six of which are conserved in position in all of the ovine CD1 molecules.Similarly, 
three of the four N- linked glycosylation sites in the classical CD1 sequences are conserved in 
all of the ovine sequences. A fourth site (258 -260 in the a3 domain of HCD1 B) which is 
specific to the HCD1 B sequence is also conserved in SCD1A25. Furthermore, the SCD1A25 
data obtained from the analysis of 132m contact sites, CD8 interaction residues and class I 
peptide anchor residues did not differ from the results obtained with the other three ovine 
CD1 sequences. Taken together, these results imply that the single base deletion at position 
602 in the SCD1A25 nucleotide sequence is an artefact which probably arose during the 
cDNA synthesis stage in preparation of the thymocyte library. 
Previous studies have noted the divergence between CD1 molecules and MHC class I 
molecules despite their similar domain structure and association with CD1 ( Calabi et al, 1989a; 
Balk et al, 1989). Recent developments in the analysis of MHC class I crystal structure have 
allowed a more thorough analysis of the interactions of ovine CD1 alpha chains with í32m, CD8 
and peptide ligands to be carried out. The results indicate that CD1 a chains interact with ß2m 
in a non -MHC class I -like manner. This may be interpreted to imply that the conservation of the 
a3 domains in the CD1 family is influenced by factor(s) other than the necessity for interaction 
with 132m. An alternative view is that residues in the a3 domain of ovine CD1 molecules are 
conserved in order to preserve sites of interaction with 132m, but that these sites differ from 
those utilised by MHC class I a chains. This latter view is supported by the biochemical 
evidence for interactions between CD1 a chains and ß2m (detailed in the literature review). 
The ovine CD1 sequences also lack typical CD8 binding residues and residues which are 
crucial for the docking of peptides in the groove. Taken together, the data suggest that the 
ovine CD1 molecules may not function in the same manner as MHC class I molecules to 
present peptide antigen to T cells, and indeed, there has only been one report to date which 
provides evidence for the involvement of exogenous antigen in CD1- specific T cell activation 
(Porcelli et al, 1992). 
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3.4 Southern Hybridisation Analysis of Ovine CD1. 
3.4.1 Introduction. 
The complexity of the CD1 gene family has been investigated in several species. Southern 
blot analysis of Molt4 DNA digested with EcoR I and probed with the insert from clone FCB6 
(Calabi and Milstein, 1986) identified five hybridising bands (Martin et al, 1986). These bands 
were found to correspond by size to the EcoR I fragments of five different clones isolated 
from a genomic DNA library and represent the five different human genes, HCD1A, B, C, D 
and E. In the mouse, two highly homologous genes have been identified. The first gene, 
MCD1.1, was isolated by screening a genomic library with the insert from clone FCB6 
(Bradbury et al, 1988). The second gene, termed MCD1.2, was isolated by screening a 
genomic library with a subclone of MCD1.1 which spanned the a3 domain. In the domestic 
rabbit, the complexity of genomic Southern blots provides evidence for the existence of eight 
or more CD1 genes (Calabi et al, 1989b). CD1 genes have also been detected by Southern 
blot analysis in other mammalian species including cattle, rats and monkeys (Calabi et al, 
1991). 
In order to detérmine the complexity of the ovine CD1 gene family, a Southern blot analysis 
was performed using a homologous a3 domain probe. 
3.4.2 Southern Blot Analysis. 
Genomic DNA was isolated and Southern blot analysis performed as described in section 
2.11. A homologous a3 domain probe was used to detect the CD1 genes as this domain 
displays the highest sequence homology among the CD1 genes of various species (76 -87% 
nucleotide identity among human, mouse, rabbit and sheep genes). The homologous probe 
was derived from the SCD1T10 clone by FOR amplification (see section 2.14), as outlined in 
Figure 1B and C. The various restriction endonucleases used to digest the genomic DNA 
were selected such that none of the digestion sites were located within the a3 domain of the 
known ovine sequences (Fig.1A). This was accomplished by analysing the restriction 
endonuclease digestion sites of the ovine a3 domain sequences using the MAP programme 
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Figure 1: 
A. Diagrammatic Explanation of Southern Blot Protocol. 
The top line in the diagram is a linear representation of a CD1 molecule with the domain 
boundaries indicated by vertical dashed lines. Below this are linear representations of the 
three ovine CD1 sequences which encode a3 domains- SCD1A25, SCD1 B -41 and 
SCD1T10. The SCD1B -52 sequence has been omitted as it does not encode an a3 domain. 
The arrowheads indicate the positions of various restriction enzyme sites, numbered as 
follows: 
1.AccI 7.Hincll 
2.Xbal 8. Barn Hl 
3. Eco RI 9. Eco RV 
4. Pst l 10. Sac l 
5. Stu I 11. Bgl II 
6. Ssp l 12. Bgl l 
Note that the Stu I site (5) in SCD1A25 is only 11 nucleotides downstream from the 5' end of 
the a3 domain. Similarly, the Eco RV site (9) in SCD1T10 is only 17 nucleotides upstream 
from the 3' end of the 0(.3 domain. 
B and C. Preparation of The PCR Derived Homologous a3 Domain Probe. 
Panel B shows a partial sequence of the insert from the SCD1T10 cDNA clone, with the 
borders of the a3 domain indicated by the arrowheads. 
The primers G5936 (on the sense strand) and G5935 (on the antisense strand), as indicated 
in bold type, were used to amplify the a3 region using the PCR technique. 
C . The photograph shows 10% of the PCR product analysed by gel electrophoresis. 
Molecular weight markers are indicated in base pairs. 
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of UWGCG version 7.3 (Devereux et al, 1984). The two enzymes shown in Fig. 1A which cut 
just within the a3 domain of two of the ovine sequences were not considered problematic, 
since the overlaps with the probe sequence were minimal. 
3.4.3 Results and Discussion. 
Figure 2A shows the results of the overnight digestion of the genomic DNA analysed by gel 
electrophoresis. The observation of distinct bands in many of the tracks reflects the existence 
of satellite sequences in the DNA and provides evidence that the DNA had been thoroughly 
digested. Figure 2B shows a Southern blot of these genomic digests probed with the 
homologous a3 domain probe. The results indicate the existence of up to seven ovine CD1 
genes, assuming at least one cut site per enzyme between each gene. The enzymes used 
were carefully selected to minimise the risk of observing more than one band derived from a 
single gene. However, the number of CD1 genes cannot be stated precisely, due to the 
possible existence of enzyme cut sites within the a3 domains of genes which have not yet 
been isolated and sequenced. 
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Figure 2: Analysis of Ovine CD1 by Southern Hybridisation of Genomic DNA. 
Panel A shows the results of overnight digestion of sheep genomic DNA with a variety of 
restriction endonuclease enzymes, with lanes numbered as follows: 
1. Sac l 
2. Bam HI 
3. Eco RI 
4. Pst I 
5. Hinc II 
6. Eco RV 
7. Bgl I 
8. Xba I 
9. Ssp I 
10.AccI 
11. Stu I 
12. Bgl I 
Approximately 1014 of genomic DNA was digested with each enzyme and analysed by gel 
electrophoresis. Molecular weight markers (Eco RI /Hind Ill cut X DNA) are indicated in the left 
hand lane. 
Panel B shows the result of Southern hybridisation of the DNA digests shown in panel A. 
The DNA was blotted onto nylon membrane and probed with the homologous a3 domain 
probe. 
Molecular weight markers are indicated in kilobase pairs. 
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3.5 PCR Analysis Of CD1 mRNA Transcription In The Intestinal 
Mucosa. 
3.5.1 Introduction. 
All four ovine cDNA clones were isolated from thymocyte cDNA libraries and were found to be 
homologues of the human CD1B gene. Various studies have additionally detected CD1 
expression, at both the mRNA level and on the cell surface, in tissues other than the thymus 
in both humans and mice, and in particular, CD1 expression has been observed in the 
intestinal mucosa. 
In the mouse, the highest levels of transcription of the two CD1 D -type genes were detected 
in the thymus, liver and spleen, and much lower, probably insignificant, levels were detected 
in the kidney and brain (Bradbury et al, 1988). MCD1.2 transcripts were approximately five -fold 
less abundant than those of MCD1.1 in all tissues except for the thymus where mRNA levels 
were equal. In a similar study, murine CD1 message was low or undetectable in the thymus by 
Northern blot analysis (Balk et al, 1991a). Bleicher and colleagues (1990) detected murine 
CD1 expression at the cell surface in the thymus and intestine, and cytoplasmic expression in 
liver hepatocytes, using the anti -murine CD1.1 monoclonal antibodies 1H1 and 3C11 to stain 
tissue sections. Similarly, Mosser and coworkers (1991) used a rabbit antimurine CD1.2 
polyclonal antiserum to analyse CD1 expression in mouse tissues. They found that CD1 was 
expressed in the thymus, spleen, liver and lungs of adult mice and additionally in the brain, 
kidney, heart and intestine of foetal mice. The discrepancies in detection of intestinal CD1 
expression have been resolved by in situ hybridisation analysis, which indicated that only 
Paneth cells in the epithelium express CD1 message at high levels (Lacasse and Martin, 
1992). 
In humans, the protein products of the CD1 A, B and C genes are differentially expressed on 
immature thymocytes, Langerhans cells, dendritic cells and a subset of B cells ( Calabi et al, 
1991). In addition, expression of the CD1D gene product has been detected predominantly 
on intestinal epithelial cells. Human CD1d expression was detected in the intestinal 
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epithelium using the anti -murine CD1.1 monoclonal antibodies 1H1 and 3C11 as well as an 
HCD1d- specific antipeptide antiserum. A human intestinal CD8 +, aß +T cell line was found to 
exhibit significant CD1- specific cytolytic activity (Balk et al, 1991). The monoclonal antibody 
3C11 was additionally found to inhibit CD8 +T cell proliferation in a mixed lymphocyte reaction 
(MLR) where the stimulator cells were normal intestinal epithelial cells but did not cause 
inhibition in a conventional MLR (Panja et al, 1993). Most recently, human CD1d was found to 
be expressed in the intestinal epithelium as a 37kD protein that was ß2m- independent with no 
N- linked carbohydrate (Balk et al, 1994). 
Overall, the studies in both humans and mice indicate that CD1 expression is not confined to 
the thymus, and that CD1d expression is predominantly detected in the intestine. Since the 
ovine cDNA sequences were all isolated from thymocyte libraries, it was considered important 
to investigate CD1 expression in an extra -thymic site. Consequently, the PCR technique has 
been employed in an attempt to detect ovine CD1 transcription in the intestinal epithelium as 
outlined below. 
3.5.2 Experimental Rationale 
The simplest and quickest approach to the analysis of CD1 expression in the intestinal 
mucosa involved use of the PCR technique to detect CD1 gene transcription. The primers 
used were the degenerate 5' primer B199 (see section 3.2, Fig. 2B) in conjunction with the 3' 
primer G7206. Primer G7206 is based on a conserved region located fourteen nucleotides 
downstream of the translational stop codon in all four ovine cDNA clones (Fig. 1). In theory, 
this primer combination would amplify any CD1 specific cDNA present in an intestinal sample, 
assuming the conservation of both primer sequences in all ovine CD1 mRNA transcripts. 
Subsequent blotting and hybridisation of any PCR product(s) with an a3 domain probe 
would confirm that the product was CD1. In addition, hybridisation with clone- specific probes 
would indicate whether the PCR product represented a previously isolated ovine CD1 or an 
alternative CD1 sequence. Any PCR products could be cloned and sequenced to confirm the 
identity of the amplified product. 
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Figure 1: Derivation And Use Of The Primer G7206 in Analysis Of CD1 
Transcription In The Intestinal Mucosa. 
A. The diagram shows a linear representation of a CD1 molecule with the domain boundaries 
indicated by vertical lines. The approximate locations of the 5' degenerate primer B199 and 
the 3' primer G7206 are also indicated. 
B. The aligned sense strand sequences illustrate the derivation of the 3' antisense primer 
G7206. The highly conserved 18mer sequence is located fourteen nucleotides downstream 
of the translational stop codon in the 3' untranslated region. The nucleotide numbering refers 
to the SCD1 B -42 sequence in Fig. 1, section 3.3. 
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3.5.3 PCR Protocol For Analysis of Intestinal CD1 Transcription. 
Total RNA was isolated from sheep ileum and thymus as described in section 2.12. cDNA was 
synthesised using random hexanucleotide primers in order to overcome potential annealing 
problems with the use of specific primers, as discussed previously ( see section 3.2.2 and 
3.2.5). The suitability of the cDNA for use in subsequent PCR reactions was tested by 
performing an ATPase PCR reaction on all samples. The ATPase message should be 
detectable in all tissues (Schull et al, 1985)- failure to do so indicates poor cDNA synthesis. 
The primers B199 and G7206 were used in an attempt to detect CD1 message in the 
intestinal mucosa. Two rounds of PCR amplification were performed- the template for the 
second round of PCR was 4tI of product from the first round and the same primers were used 
in the second round reaction. Details of all PCR reactions are given in section 2.14. The 
sequences of the ATPase, B199 and G7206 primers used are listed in Appendix 2B. Control 
PCR reactions included negative controls where the cDNA template was replaced with an 
equal volume of SDW, and positive controls using a thymus cDNA template and a sample of 
double- stranded plasmid DNA from the SCD1 B -52 clone (the SCD1 B -52 clone insert is the 
only ovine clone which contains both the 5' and 3' primer sites). 
A single band of the expected size (approximately 1000bp) was detected in the ileum sample 
following two rounds (70 cycles) of PCR amplification (Fig. 2A, lane 3). Control PCR reactions 
gave the expected results with the exception of the thymus tissue positive control sample 
which was negative (Fig. 2A, lane 2). However, the second positive control which employed 
double- stranded SCD1 B -52 plasmid DNA as the template produced a single band of the 
expected size (- 850bp, Fig. 2A, lane 1), suggesting that the primers were amplifying the 
appropriate target sequence. It seems that there may have been a problem with the cDNA 
synthesis step, although the ATPase positive controls gave the expected results. The single 
band produced in the ileum sample was cloned using the TA Cloning kit (Invitrogen). Several 
insert- positive clones were obtained for sequencing. The results of Eco RI digests of four 
plasmid DNA samples are shown in Fig. 2B. Two insert bands were observed in each case 
( -650bp and 350bp), indicating the presence of an additional Eco RI site within the insert. 
The insert from a representative clone was sequenced on each strand with the M13 forward 
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Figure 2: PCR Analysis of CD1 Transcription In The Intestinal Mucosa. 
A. The photograph shows the results of PCR amplification using the primers B199 and 
G7206 as outlined in the text. 10% of the PCR products from the second round of PCR were 
analysed by gel electrophoresis. 
Lane 1: Positive control PCR using SCD1 B -52 dsDNA as the template. 
Lane 2: Positive control PCR using thymus cDNA as the template. 
Lane 3: PCR using ileum cDNA as the template. 
B . Eco RI digests of dsDNA from four plasmid samples analysed by gel electrophoresis after 
cloning the ileum PCR product using the TA cloning kit. 



















and reverse sequencing primers (Appendix 2A) using the dideoxy chain termination 
technique (Sanger et al, 1977). The initial sequence data for each strand revealed a G7206 
primer site at each end of the insert. Furthermore, the initial sequences showed no homology 
to known CD1 sequences, when compared using the GAP programme of UWGCG 7.3. A 
search of the genEMBL database using the FASTA programme of UWGCG 7.3 revealed that 
the ileum PCR sequence gave the highest score when compared to the C. elegans N- 
acetylgalactosyaminyltransferase sequence. No further sequence analysis was performed for 
the ileum PCR samples. 
3.5.4 Discussion. 
The PCR technique has been used in an attempt to detect transcription of ovine CD1 genes 
in the intestinal mucosa. The single band obtained by PCR amplification from an ileum cDNA 
sample was cloned and partially sequenced. Pairwise comparisons of the initial sequence data 
for the cloned PCR product against the human and ovine CD1 sequences gave percentage 
identity values in the range 37 -45 %. The results indicate that the PCR product represents an 
inadvertent amplification of a sequence other than the target sequence, as confirmed by a 
FASTA search of the genEMBL database. 
It is not possible to comment on CD1 expression in the intestinal mucosa on the basis of the 
above results, and no further experiments were performed given the limited time available. 
However, various alternative strategies could be pursued in order to investigate this further. 
Specific PCR primers could be derived for each ovine CD1 clone and the specificity confirmed 
by positive control PCR reactions using clone DNA and thymus cDNA. Blotting and 
hybridisation of the PCR products with an a3 domain probe would confirm that they were CD1 
sequences. These primers could subsequently be used to analyse CD1 expression in the 
intestinal mucosa by PCR. A negative result would then be interpreted as lack of expression 
of CD1 mRNA corresponding to the ovine CD1 sequences already isolated. However, this 
procedure would not allow the cloning and sequencing of a previously unknown ovine CD1 
sequence, in contrast to the PCR protocol outlined above (3.5.2). The results of this 
procedure may be complicated by the potential specificity of the PCR primers for any 
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unknown transribed CD1 genes. 
An alternative method for investigation of CD1 gene transcription would be Northern blot 
analysis using an a3 domain probe (which should hybridise to all transcribed CD1 genes) in 
conjunction with clone specific probes (to assign transcripts to the known ovine CD1 genes). 
This analysis would enable the number, variability and relative abundance of CD1 transcripts in 
the intestine and other tissues to be determined. 
A third possible approach to an analysis of CD1 mRNA transcription would be in situ 
hybridisation (ISH) using an a3 domain probe and clone specific probes as mentioned above. 
This technique allows the detection of gene products which are not necessarily expressed at 
a high level on the cell surface and which may only be expressed on a subset of cells within a 
complex tissue. 
Recent studies in the sheep using a panel of mAbs raised against sheep and cattle 
thymocytes, DC's and intestinal epithelial cells have indicated that ovine CD1 is, in fact, 
expressed in the intestinal mucosa, although it is not yet clear which cell types within the 
tissue are positive for CD1 staining (S. Rhind, personal communication ). 
150 
4. Discussion. 
The CD1 molecules are a family of ß2m- associated glycoproteins with broad structural 
homology and weaker sequence homology to the MHC class I antigens. The CD1 molecules 
are characterised by limited polymorphism, low surface expression and a restricted pattern of 
tissue distribution in comparison to the classical MHC class I gene products. 
CD1 genes have now been characterised in humans (Calabi et al, 1991), mice (Bradbury et al, 
1988), rabbits (Calabi et al, 1989b) and most recently in the rat (lchimiya et al, 1994). CD1 
molecules have additionally been identified by monoclonal antibodies in cattle (MacHugh et 
al, 1984; Howard et al, 1993 a and b), pigs (Pescovitz et al, 1984; Pescovitz et al, 1990) and in 
the sheep (Mackay et al, 1985; Dutia and Hopkins, 1991; Bujdoso et al, 1989). 
4.1 The Ovine CD1 Gene Family. 
To date, the limited information available for the ovine CD1 family has been obtained using a 
small panel of anti -bovine and anti -ovine CD1 mAbs in a series of biochemical and histological 
assays. All mAbs were found to detect a 46kD a chain in association with (32m. In order to 
extend our understanding of these molecules, the ovine CD1 family has now been 
characterised at the molecular level. 
Four ovine CD1 clones have been isolated by library screening of thymocyte cDNA libraries. 
The first clone identified, SCD1A25, was isolated using a human CD1C a3 region probe_ A 
homologous probe obtained by PCR amplification of the a3 /TM /CYT region of SCD1A25 was 
subsequently utilised to isolate an additional three ovine clones, SCD1 B -42. SCD1 B -52 and 
SCD1T10. Interestingly, all four ovine clones are most homologous to the human C 1B 
gene. Southern blot analysis has indicated the existence of up to seven ovine CD1 genes 
and it is possible that several expressed ovine CD1 genes remain to be identified. Three of 
the four clones (SCD1A25, SCD1 B -42 and SCD1 T10) contain inserts truncated at the 5' end. 
The fourth clone (SCD1 B -52) contains an insert which is intact at the 5' end but has a precise 
in -frame deletion of the a3 domain. The missing 5' sequences (part of the 5' untranslated 
region as well as the a1 domain) for the SCD1A25 and SCD1 B -42 clone inserts were 
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obtained by PCR amplification. 
The ovine CD1 sequences were compared to the human, murine and rabbit sequences. In 
addition, a detailed structural analysis of the interactions of ovine CD1 a chains with ß2- 
microglobulin, CD8 and peptide was performed based on the data obtained from crystal 
structure analysis of the MHC class I molecules. The results indicate that the CD1 a chains 
apparently interact with (32- microglobulin in a non- MHC class I like manner. The ovine CD1 
sequences also lack typical CD8 binding sites and residues which are crucial for the docking 
of peptides in the MHC class I groove. Taken together, the data imply that CD1 molecules may 
not function in an identical manner to the class I molecules to present peptide antigen to T 
cells. 
Several areas of future work have been suggested by data reported in this thesis. It will be 
necessary to pursue appropriate experiments in order to correlate the results from the mAb 
and molecular work. This could be achieved by transfecting appropriate cells with constructs 
containing the cDNA for both SCD1 B -42 and SCD1 B -52 and screening transfected cells by 
FACS analysis with the available mAbs. In the case of SCD1 B -42, it would first be necessary to 
ligate the 5' UT /a1 DNA sequence obtained by PCR amplification to the main cloned cDNA 
sequence. In order to analyse SCD1 T10 in this system, it would first be necessary to obtain 
DNA sequence for the 5'UT and a1 domains. It would only be possible to analyse SCD1 A25 
using this procedure by first of all rescreening a thymocyte cDNA library in order to obtain a 
true, in -frame cDNA clone, since the currently available cDNA clone contains a single 
nucleotide deletion. Analysis of SCD1 B -52 in this system could prove interesting, since 
SCD1 B -52 does not contain the a3 domain. This is the main site of interaction with (32m, and it 
is now known that the human CD1 d molecule does not require interaction with ß2m for cell 
surface expression (Balk et al, 1994). It may also be possible to confirm SCD1 B -52 membrane 
expression by generating an antipeptide antiserum against an epitope encoded by the 
junction of the a2 and TM domains, although a negative result obtained when screening with 
such an antiserum would not necessarily imply a lack of SCD1 B -52 cell surface expression. 
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The characterisation of the ovine CD1 molecules at the molecular level will now permit the 
generation of molecular probes for use in in situ hybridisation and Northern blot analysis of 
CD1 transcription in various tissues. Use of an a3 domain probe in conjunction with clone 
specific probes (for example, an a2 /TM probe specific for SCD1 B -52) in a Northern blot would 
enable the number, variability and relative abundance of CD1 transcripts in various tissues to 
be determined. These probes could also be employed in in situ hybridisation which would 
enable a detailed analysis of CD1 cell and tissue expression to be performed. Such 
experiments would be particularly interesting in intestinal tissue, since CD1d is predominantly 
expressed on human intestinal epithelium and has been implicated in antigen presentation to 
CD8 +T cells at this site (Balk et al, 1991; Panja et al, 1993). 
4.2 Evolutionary Relationship Between CD1 and MHC Molecules. 
Two major theories have been proposed to explain MHC evolution. One theory holds that 
class I molecules evolved first as the result of a recombination event between an Ig -like C 
domain and the peptide binding domain of an HSP70 molecule (Flajnik et al, 1991, 1993). 
This model was proposed as a consequence of noting the similarities between class I a 
peptide binding domains and the peptide binding region of members of the HSP70 family 
(Ripmann et al, 1991). The second major theory of MHC evolution holds that class II molecules 
evolved first, and that class I molecules subsequently evolved as a result of a recombinatorial 
event. These two theories are discussed in further detail below and form the context for a 
discussion of CD1 evolution. 
The class I first theory of MHC evolution developed by Flajnik and colleagues was primarily 
based on the observations and ideas of the Milstein group. Calabi and Milstein (1986) first 
proposed that the CD1 genes arose before the separation of the primate and rodent 
branches around the same time as the divergence of the class I and class II ancestor genes 
when they analysed the CD1 A gene. They noted that although both the CD1 and class lip 
genes had diverged from class I a genes to an almost equal extent, only the CD1 genes 
retain the interaction with p2- microglobulin. This theory was further expanded by the Milstein 
group (Martin et al, 1986; Milstein et al, 1987) when they suggested that the large divergence 
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between the CD1 and MHC families must have involved a duplication of an ancestral gene and 
subsequent transposition to a different chromosome around the time of the class I /class II 
separation. They proposed that the ancestral precursor of all MHC -type genes was probably 
(32- microglobulin associated i.e. class I -like, and that the CD1 genes may have arisen from the 
class II ancestor after it separated from class I but before it lost its association with ß2m. 
Flajnik and colleagues proposed a model for MHC evolution basing their ideas on those 
already discussed by Martin, Milstein et al. Essentially, this group had cloned a Xenopus class I 
MHC molecule (Flajnik et al, 1990) which, on sequencing, was found to have some similarity to 
the human HSC70 sequence (24% identity with gaps inserted). HSC70 is a member of the 
HSP70 heat shock protein family, molecules which stimulate a high proportion of y8 T cells 
( Porcelli et al, 1991 ; Born et al, 1990) and which have been implicated in presentation of 
antigenic peptides to T cells, possibly through "feeding" of the peptides to MHC molecules 
(Vanbuskirk et al, 1989). Despite the low homology between the Xenopus class I sequence 
and HSC70, further analysis proved interesting. Secondary structure predictions indicated 
that the Xenopus class I and HSC70 binding domain sequences conform to the structure of 
human class I predicted by crystal structure analysis. Hydropathy plots suggested that many 
hydrophobic and hydrophilic amino acids are similar between the class I and HSC70 
sequences. In addition, several features of HSC70 were mapped to homologous positions in 
the class I crystal structure. The authors concluded that the peptide binding domains of class I 
and HSC70 may adopt a similar symmetrical structure and on this basis proposed that genes 
encoding a peptide binding structure were transferred en masse to a gene segment 
encoding an immunoglobulin domain during MHC evolution. This scenario is illustrated in 
Figure 1, which shows the proposed evolution of the CD1 genes from the class II gene 
ancestor. 
The second major hypothesis on MHC evolution holds that the class II MHC evolved first and 
that the class I a chain arose from a recombinatorial event that brought together in one gene 
the exon encoding a class II a1 domain and the exons encoding the class II (31 and ß2 
domains (Lawlor et al, 1990). This model was originally proposed on a thermodynamic basis in 
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Figure 1: Evolution Of MHC and CD1 Molecules From An MHC Class I -like 
Ancestor. 
The diagram illustrates schematically the model of MHC and CD1 evolution proposed by 
Flajnik and coworkers and the Milstein group (see text). This model holds that MHC class I 
molecules evolved first as a result of a recombination between an immunoglobulin -like C 
domain and the peptide binding domains of an HSP70 heat shock protein. The class I gene 
and the gene ancestral to ß2m then duplicated in tandem, followed by a recombination event 
which brought together the al domain of the three -domain gene with the C domain gene 
thus giving rise to the class II a chain gene. The three -domain gene which lost the al domain 
became the two- domain ancestor of class II ß. In this model, it was proposed that the CD1 
genes evolved from the class Il ancestor after it had separated from class I but before it lost its 
association with ß2m. 
The dotted domains represent domains homologous to class I a1 . 
The striped domains represent domains homologous to class I a2. 
The blocked domains represent domains homologous to class I a3 (i.e. to immunoglobulin C 
domains). 
transfer of peptide binding 
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that a heterodimer composed of two two- domain proteins is expected to be more stable than 
a heterodimer of two chains composed of different numbers of domains (Flajnik et a1,1991). 
Hughes and Nei (1993) undertook a thorough analysis of sequence data for MHC and related 
genes, and composed various phylogenetic trees using their sequence alignments.The 
results supported the phylogenetic analysis of Hood and coworkers (1985), grouping the 
class II a chain with ß2m and class Il ß with class I a, but opposed the results obtained by Flajnik 
and colleagues (1991). The latter group had used an alternative method for derivation of their 
phylogenetic tree which had been shown to be less effective for sequences with large 
differences. Similar phylogenetic relationships had been obtained by Hughes (1991) when 
he examined the evolution of CD1 in greater depth. A phylogenetic tree based on the 
number of nonsynonymous nucleotide substitutions per site in the a3 region of CD1 and 
related genes showed that the CD1 genes grouped with the class I genes but were more 
closely related to the avian class 1 genes than to any human, bovine or murine class I gene. 
The short branch lengths within the CD1 cluster compared to longer branch lengths leading 
to the cluster indicated that the separation of the CD1 genes from MHC genes was 
accompanied by many amino acid changes but that the a3 domains of CD1 genes have since 
been conserved among the mammalian orders. The tree suggested the divergence of CD1 
genes at around the time of the bird /mammal divergence (250- 300mya), approximately 150- 
270 million years after the separation of the class I l a and ß chain genes. A second 
phylogenetic tree based on the number of nonsynonymous changes in the al /a2 domains 
was constructed. This tree supported the hypothesis of Calabi et al (1989a) that the CD1 
genes fall into different classes which arose by gene duplication prior to divergence of the 
mammalian orders. However, it differs from the Calabi results in indicating that HCD1 B 
represents a separate lineage that diverged prior to the HCD1 A and HCD1 C grouping. This is 
an extremely interesting result given that all of the known sheep CD1 genes are HCD1 B -like. 
The Hughes model of evolution is summarised in Figure 2. 
The majority of the evidence thus supports the hypothesis that the ancestral MHC molecule 
had a class II -like structure and that the CD1 molecules diverged -150 -270 million years after 
the separation of the class II a and f3 chain genes. 
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Figure 2: Evolution Of MHC and CD1 Molecules From An MHC class Il -like 
Ancestor. 
The diagram illustrates schematically the model of MHC and CD1 evolution proposed by 
Hughes and colleagues. This model holds that MHC class II molecules evolved first. The two - 
domain ancestral class Il gene duplicated giving rise to the class Il a/ß heterodimer. The a and 
ß chain genes then duplicated in tandem. The class I a chain gene arose by the transfer of an 
al domain exon to an a chain gene. the loss of this exon left a single domain gene which 
became the ß2m ancestor. In this model, the CD1 a chain genes are proposed to have arisen 
from the class I ancestor and diverged from the class I a chain genes at around the same time 
as the bird /mammal divergence (250- 300Mya). 
The dotted domains represent domains homologous to class a1 . 
The striped domains represent domains homologous to class I a2. 
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4.3 What Is The Function Of The CD1 Molecules? 
Although the structure and expression of the CD1 molecules have been extensively studied 
in a variety of species, their function(s) remain ill- defined. The broad structural similarity to the 
MHC class I molecules and their preferential expression on thymocytes and antigen 
presenting cells suggests a functional role for the CD1 molecules. In particular, a functional 
role for the CD1 molecules in antigen presentation to T cells, and specifically to y6T cells, has 
been proposed (Strominger, 1989; Janeway et al, 1988; Calabi et al, 1991). The influence of 
various cytokines, including GM -CSF, IL -4, TN Fa and IL -6, on CD1 expression, and the 
evidence that CD1 molecules are linked to a cellular activation pathway, lends further support 
to the idea that CD1 molecules are antigen presenting structures. However, no direct 
evidence has yet been produced to demonstrate that CD1 molecules are capable of binding 
peptides and presenting them to T cells. 
Indirect evidence supports the idea of a role for the CD1 molecules in thymocyte 
development. In the thymus, CD1 molecules are expressed on immature cortical thymocytes 
in inverse correlation to the MHC class I molecules ( Calabi et al, 1991; Blue et al, 1989) at a 
time when these cells are undergoing positive and negative selection for MHC restriction and 
tolerance. Together with the documented covalent association of CD1 and CD8 molecules 
(Snow et al, 1985; Ledbetter et al, 1985) and the evidence to indicate linkage to a cellular 
activation pathway (Theodorou et al, 1990), these facts provide strong circumstantial 
evidence that CD1 is performing a particular function in the thymus. It seems that expression 
of the CD1 molecules is necessary at a time when it would be inappropriate to express the 
class I molecules themselves. Recent developments in foetal thymic organ culture (Jenkinson 
and Owen, 1990; Hogquist et al, 1993) may now permit the precise role of CD1 in the thymus 
to be more thoroughly defined. 
The postulated role of CD1 in antigen presentation was originally proposed on the basis that 
the limited germline diversity of 78 TCR's implied recognition of relatively nonpolymorphic 
ligands (Janeway et al, 1988; Strominger, 1989). However, it is now known that the y8 TCR 
repertoire is actually larger than the a(3 TOR repertoire due to the great potential for junctional 
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diversity (Porcelli et al, 1991). The original simplified view of antigen presentation to y& T cells 
has also been challenged by the discovery that nonpolymorphic ligands, such as the class lb 
molecule Qa -2, are potentially capable of binding a diverse array of peptides and not just a 
limited set as was previously assumed (Rotzschke et al, 1993; Joyce et al, 1994). 
Since aß T cell recognition requires antigen presentation by MHC molecules, it has been 
commonly assumed that y& T cell recognition also follows the same set of rules. However, this 
basic assumption has now been challenged by two recent reports which have suggested that 
the molecular nature of -y5 T cell recognition is fundamentally different to that of aß T cells 
(Schild et al, 1994; Sciammas et al, 1994). Schild and colleagues analysed the recognition of 
MHC molecules by the y& T cell hybridomas LBK5, which is specific for the class II molecules 
IEk,b,s and G8 which recognises the nonclassical MHC class I molecule TL. The reactivity of 
neither clone required functional class I nor class II processing pathways in the stimulator cells. 
Furthermore, the LBK5 epitope was mapped distal to the peptide binding groove by 
analysing the response of the clone to a panel of thirteen antigen presenting cell lines and 
comparing the results to normal aß T cell responses. Sciammas and colleagues (1994) 
obtained similar results when they investigated the stimulation requirements of the y& T cell 
clone Tg14.4 which recognises a Herpes simplex glycoprotein in an MHC class I /class II 
independent manner. When expressed in the antigen processing mutant cell line RMA/S, the 
glycoprotein was capable of being recognised by Tg14.4. Furthermore, it was demonstrated 
that Tg14.4 can recognise whole unprocessed glycoprotein in the absence of any antigen 
presenting cells. Additional support for the view that y5 T cells do not recognise antigen in a 
manner analogous to aß T cells was produced by Rock and colleagues (1994) when they 
characterised the length distribution of CDR3 regions in various immune receptor chains. The 
results indicated that the CDR3 lengths of both a and 13 TOR polypeptides are nearly identical 
and are highly restricted in length. This size constraint was attributed to the requirement for 
recognition of small peptides in the groove, since the CDR3 region is critical in antigen 
recognition (Davis and Bjorkman, 1988). In contrast, CDR3 lengths of immunoglobulin H 
chains are long and variable, while L chain CDR3's are shorter and less variable. For the y& 
TCR, & chain CDR3 lengths are long and variable, while those of y chains are longer and more 
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constrained. In this respect, y6TCR's resemble the immunoglobulins in containing CDR3 
regions of discordant length, whereas aß TCR's contain CDR3 regions which are virtually 
identical in length. 
The recent developments in our understanding of antigen recognition by yS T cells have 
further clouded the original picture that the nonpolymorphic CD1 molecules may participate in 
peptide presentation to these cells. In the past decade, experiments designed to 
characterise the specificity and function of y8 T cells have been based on our detailed 
knowledge of aß T cell biology. I view this as a "square peg in a round hole" scenario, given 
that almost a decade of intense investigation has failed to produce a consensus view on the 
specificity and function of yS T cells. Similarly, studies designed to elucidate the functions of 
the CD1 molecules can be viewed in this way i.e. it has been assumed that CD1 molecules, by 
virtue of their broad structural similarity to the class I molecules, will perform similar functions to 
the class I molecules. However, the discovery that the p51 molecule, an Fc receptor on 
intestinal epithelial cells of the neonatal rat, is a ß2m- associated class I -like structure has 
already demonstrated that class I -like structure does not necessarily imply a class I -like 
function (Simister and Mostov, 1989). A non -class I -like function for the CD1 molecules is 
further supported by the results from the detailed structural analysis of the ovine CD1 
molecules. The analysis indicated that CD1 molecules do not possess the structural 
requirements for presentation of peptides in an MHC class I -like manner, although it cannot be 
concluded that they do not present peptides in some other manner. 
In order to further elucidate the function(s) of CD1, it will be necessary to pursue several lines 
of investigation. In particular, recent developments in the ability to identify peptides eluted 
from MHC molecules should allow the question of the peptide binding capacity of the CD1 
molecules to be resolved. Determination of the crystal structure of CD1 will permit the detailed 
structure of these molecules to be established. Development of transgenic mice which do not 
express CD1 may also help establish the precise role of CD1, particularly in the thymus and in 
intestinal tissue. Finally, it may be fruitful to investigate further the association of the CD1 
molecules with intracellular cell signalling pathways, given the recent advances which have 
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been made in this field. In particular, there is increasing evidence to show that, in addition to 
their role in antigen presentation, MHC class II molecules can transduce signals which are 
important in regulating APC function during cognate T -B cell interactions (Scholl and Geha, 
1994). It will therefore be interesting to determine whether class I molecules and other 
molecules implicated in antigen presentation, such as CD1 and class lb molecules, can also 
deliver signals which modulate cell function. 
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Adjust to pH7.2 
10xTE buffer (Tris-EDTA) 
100mM Tris.Cl, pH8.0 
10mM EDTA, pH8.0 
10xTAE buffer (Tris- Acetate -EDTA) 
400mM Tris.acetate 
10mM EDTA, pH8.0 
10xTBE buffer (Tris- borate -EDTA) 
900mM Tris.borate 
20mM EDTA, pH8.0 
Adjust to pH8.3 
This buffer is equivalent to 10xTBE -M buffer. 
10xTBE -A buffer 
13.4mM Tris base 
4.5mM boric acid 
10mM EDTA, pH8.0 
STE (sodium chloride- tris -EDTA) 
0.1M NaCI 
10mM Tris.Cl pH8.0 
1mM EDTA pH8.0 
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20x550 buffer (Sodium chloride- sodium citrate) 
3M NaCI 
300mM Tris.sodium citrate 
Adjust to pH7.0 
Solutions Used For RNA /DNA Preparations 
DEPC -Treated SDW 
Sterile deionised distilled water is treated overnight with 0.02% diethylpyrocarbonate (DEPC) 
and then autoclaved at 151bs /in2 form 15 minutes to inactivate the DEPC. 
GTC (Guanidinium isothiocyanate) 
4M guanidinium isothiocyanate 
0.5% (w /v) N -lauryl sarcosine 
25mM sodium citrate pH7.0 
0.7% (v /v)2- mercaptoethanol 
10xMOPS (morpholino -propanesulfonic acid 
0.2M 3- (N- morpholino) -propanesulfonic acid 
0.05M sodium acetate 
0.01M EDTA 
41.8g MOPS is added to 800m1 DEPC- treated SDW and the pH adjusted to 7.0 with NaOH or 
acetic acid. Add 16.6m1 of 3M DEPC- treated sodium acetate and 20m1 0.5M DEPC- treated 
EDTA, pH8.0. Make the volume up to 1 litre with DEPC- treated SDW and filter sterilise. 




211I ethidium bromide @10mg /ml 
use at 3 -5x sample volume. 
RNA dye mix 
30% (w /v) ficoll 
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0.05% (w /v) bromophenol blue 
5xMOPS 
100µg /ml ethidium bromide 
Phenol /Chloroform 
mix redistilled phenol and chloroform in a 1:1 ratio. 
Add hydroxyquinolone to 0.05% (w /v). 
Equilibrate the mixture to pH7.4 with 1 xTE or with DEPC- treated SDW for RNA work. 
DNA sample buffer 
40% (w /v) sucrose 
0.25% (w /v) bromophenol blue 
0.25% (w /v) xylene cyanol FF 
TFB solution (Hanahans buffer) 




3mM HaCoCI3 (hexamine cobalt [III]chloride) 
Adjust to pH6.5. 
Streile filter through 0.24m filter and store at 4 °C. 
If BI 














2.25M in 40mM KoAc pH6.0 
Solution I (GTE:glucose- Tris -EDTA) 
0.05M glucose 
0.024M Tris.Cl pH8.0 
0.01M EDTA pH8.0 
Solution II (alkaline -SOS) 
0.2M NaOH (made fresh) 
1% (w /v) SDS (sodium dodecyl sulphate) 
This solution must be made up just prior to use. 
Solution Ill (potassium acetate solution) 
Dissolve 207g KAc.3H20 or 133g KAc in 300mí SDW. 
Make up to 443m1 and add 57ml acetic acid. 
solution 3M and 5M for acetate. 
Southern Blot hybridisation and prehybridisation buffer 
25mM NaPO4 pH7.4 
5xSSC 
0.5% (w /v) milk powder 
50µg /ml yeast tRNA 
50% (v /v) formamide 
1% (w /v) SDS 
Colony Screening hybridisation buffer 
0.5% (w /v) milk powder 
10mM Tris.Cl pH7.5 
6xSSC 
1mM EDTA pH8.0 
1% (w /v) SDS 
0.1 mg/ml yeast tRNA or sonicated salmon sperm DNA 
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Lysis buffer for Genomic DNA Prepration 
1M NaCI 
50mM Tris.Cl pH8.0 
1mM EDTA pH 8.0 
0.5% SDS 
30% acrylamide for Sequencing Gels 
Make up acrylamide /N -N methylene bisacrylamide in the ratio 29:1(30% w /v). 
Filter sterilise, wrap bottle in foil and store at 4 °C. 
Bacterial Culture Reagents 
LB broth 
1% (w /v) tryptone 
0.5% (w /v) yeast extract 
0.17M NaCI 
pH7.0 
2xYT broth (yeast /tryptonel 
1.6% (w /v) tryptone 




2% (w /v) tryptone 








SM buffer (sodium /magnesium) 




IPTG stock solution 
24mg /m1 isopropylthio- ß- D- galactoside in SOW. 
Filter sterilise and store at -20 °C. 
X -gal stock solution 
40mg /n1 5- bromo -4- chloro- 3- indolyl -f3 -D galactoside in DMF (dimethyl formamide). 
Wrap container in foil and store at -20 °C. 
Ampicillin stock solution 
25mg/ml ampicillin in SDW. 
Filter sterilise and store at 4 °C. 
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human CD1C clone 
5'ends PCR clones 
gut CDl clone 
B PCR Primers 
Primer Name Primer Sequence 
5' 3 
AA A GA C 
PCR Reaction 
' 
B199 *** G GAAGTCA A AGAG 5'ends PCR 
GG G CT T gut CD1 PCR 
5801 see seq. primer list A25 a3/TM/CYT 










* * *GCTATGTCCTGGATCACAAAGG 
* * *CAAGAAGCTTTCTACGGCCT 
* * *CATCCAGTCCTCCTAAAGCT 














see seq. primer list 
see seq. primer list 
GCTGACTTGGTCATCTGC 
CAGGTAGGTTTGAGGGGATAC 
SCD1A25 5' end 
PCR 
SCD1B -42 5' end 
PCR 
SCD1T10 a3 PCR 
gut CD1 PCR 
anchored PCR 
for 5'ends 




ATCGATGAATTC (Clal /EcoRI enzyme adaptor seq.) 
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Appendix 3: Genbank Accession Numbers 
The accession numbers for human CD1 (HCD1), mouse CD1 (MCD1), rabbit CD1 
(DomRab /CtRab), sheep (S) class I, and sheep (S) class II nucleotide sequences are given 
below. The HCD1 E sequence and both rabbit sequences originated from genomic DNA 
whereas all the other sequences were from cDNA clones. 
Molecule Accession Number Reference 
HCD1A M28825 Aruffo and Seed, 1989 
HCD1B M28826 Aruffo and Seed, 1989 
HCD1C M28827 Aruffo and Seed, 1989 
HCD1D J04142 Balk et al, 1989 
HCD1 E X14975 Calabi et al, 1989a 
MCD1.1 M63695 Balk et al, 1991 
MCD1.2 M63697 Balk et al, 1991 
DomRabCD1 M26248 Calabi et al, 1989b 
CtRabCD1 M26249 Calabi et al, 1989b 
S class 1 -1 M34676 Grossberger et al, 1990 
S class 1 -2 M34675 Grossberger et al, 1990 
S class I -3 M34674 Grossberger et al, 1990 
S class 1 -4 M34673 Grossberger et al, 1990 
S class II -1 M73984 none published 
S class II -2 L08792 none published 
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